Development of a hybrid microwave-optical system to monitor human thermoregulation by Al-Armaghany, AM
Development of a Hybrid
Microwave-Optical System to Monitor
Human Thermoregulation
Allann Al-Armaghany
A thesis submitted for the degree of
Doctor of Philosophy
of
University College London
Sensors, Systems and Circuits Group
Department of Electronic and Electrical Engineering
University College London
February 2015
2I, Allann Al-Armaghany, confirm that the work presented in this thesis is my own.
Where information has been derived from other sources, I confirm that this has been
indicated in the thesis.
16/02/2015
Abstract 3
Abstract
Warming of human tissue causes vasodilation and therefore, increase in blood volume.
Such thermal responses allow the assessment of hemodynamics in the tissue, provid-
ing physiological and clinically important information of the diagnosed subject. Local
warming is often accomplished on the skin because of its accessibility and simplicity.
To allow the investigation into deeper tissue such as the muscle, an innovative hybrid
microwave-optical system has been developed. This comprises of a microwave system,
an optical monitoring and cooling system. The tissue warming is induced by a novel
microwave applicator, which was based on microstrip patch design operating at 2.45
GHz with a superstrate interface layer to improve the coupling of electromagnetic (EM)
waves into the skin. The active cooling was introduced to reduce skin heating. While
the optical sensors based on Near-Infrared Spectroscopy (NIRS), was used to measure
the changes in tissue oxygenation including the muscle. This thesis demonstrates the
development procedure, covering the design and operation of the entire system. More-
over, the majority of the work is based on the four developed applicators, where each
design was evaluated using EM and thermal simulation based on numerical phantoms.
The study evaluates the distribution of absorbed EM energy in the tissue known as the
specific absorption rate (SAR). The applicators are developed in the following order:
(i) Applicator I was fabricated for preliminary study for general tissue heating with the
integrated optical probes. This early study provided an insight to the importance of
superstrate thickness and material. (ii) Applicator II, which introduces a new approach
to skin cooling based on Thermoelectric Coolers (TEC) and high thermal conductive
superstrate. This design could cool the skin and monitor tissue oxygenation, skin per-
fusion and temperature. (iii) Applicator III was an updated model of the predecessor,
resolving cooling configuration and the discrepancy in operating frequency, and was
capable of minimising skin heating effectively (iv) Circularly polarized (CP) Applica-
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tor aimed at reduction of the SAR in the superficial layer, and hence skin heating.
The simulated thermal study of all developed applicators was validated with ex-
vivo (mimicked phantom) and in-vivo experimental trials. The measurements and the
simulation model were in agreement, apart from the CP applicator due to the complex-
ity of measurement. The results from the phantom and human calf indicated superfi-
cial heating was reduced by about 5.0-6.0 ◦C when skin cooling was applied, while
the temperature change in muscle was not significantly affected. The measurement
with mimicked tissue showed the applicator was capable of elevating muscle tempera-
ture by approximately 3.0-4.0 ◦C. This is a sufficient increase to cause tissue dilation,
and therefore, change in the thermal response. The hybrid microwave-optical system
has been developed and examined on three human calves during in-vivo physiological
study. The results using Applicator II illustrated that the device can successfully stim-
ulate and measure thermal responses in terms of oxy/deoxy/total haemoglobin concen-
trations changes (∆HbO2/∆HHb/∆HbT). The slope (rate of change) of ∆HbT curve
during microwave exposure is defined as the thermal response. This parameter is es-
sential in studying physiological responses between different subject, particularly in
vascular diseases, transplanted free flaps and other conditions, including chronic spinal
cord injury. Subjects with such conditions will have a distinguishable response to tis-
sue heating than a healthy subject. The monitored haemodynamic signals of Applicator
II are primarily based on superficial responses. However, measurements with Appli-
cator III showed the potential of the applicator. The measured thermal response was
0.83×10−3 µ M/s without skin cooling, which was dedicated by skin heating. The
introduced cooling system has reduced the skin temperature and maintained the local
skin micro-circulation, which was monitored with the secondary optical system based
on Laser Doppler Flowmetry (LDF). This probe measures blood flow at superficial
depth, and consequently, was used as a validation tool to demonstrate the cooling effi-
ciency. The measured thermal response with skin over-cooling was -0.08×10−3 µ M/s.
The negative response indicates arterial constriction, and therefore, the skin heat was
eliminated while the simulations study to indicate the muscle temperature was elevated
by 3 ◦C. However, the response was dominant by the superficial response. Obtaining
a response from muscle only was challenging and currently being solved in numerous
applicator and cooling technique, which have been presented in the thesis.
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Research Contribution
This corresponds to the novelty aspects of the work and general contribution to today’s
technology development of biomedical devices.
• The developed hybrid system is a novel diagnostic technique to assess blood
volume change in superficial and deep tissue. Current non-invasive devices are
limited to skin assessment, and therefore, measuring muscle responses is not
achievable. The system uses microwave to induce heat and causes blood volume
to increase. The applicator accommodates for the integrated NIRS probes to
monitor the blood volume alterations. This approach has not been previously
investigated.
• The applicator design was centred on thermal characteristics, where a high ther-
mal conductive (HTC) substrate and superstrate were used. This was specially
designed to consider active cooling, optical and temperature monitoring. More-
over, a superstrate material acting as a matching medium and isolation of ra-
diating element to tissue was first time used with microwave patch antenna for
inducing heat to tissue and the same time optimised for skin cooling efficiency.
The presented work in this thesis shows results in EM and thermal point of view.
• One of the distinguished design feature is the considered skin cooling approach
with use of peltier coolers. This is a novel approach which have not been em-
ployed by other therapeutic applicators, where water cooling is typically used.
The cooling mechanism coincides with the applicator design and the optimised
thermal material for increase cooling efficiency.
• The microwave system used is based on solid-state frequency synthesizer con-
trolled by an Arduino microcontroller, which allows for greater flexibility, ad-
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vanced monitoring and safety mechanism. The system introduces a sweeping
function which allows for direct and self calibration of optimal operating fre-
quency before every experiment. This feature is essential for applicators oper-
ating in close proximity to tissue (reactive near-field regions). This microwave
system is integrated with cooling system for real time monitoring and control of
exposure and temperature levels.
• This research work also explores circularly polarised applicators, which have not
been previously investigated in greater depth, particularly with the current ad-
vancement in computation technology to solve complex EM problems. The pre-
sented work (simulation and validation) shows a virtually important characteris-
tics, where the peak superficial tissue absorption of EM energy was significantly
reduced while maintaining the muscle absorption. This investigation allows for
future development of CP applicators for improved deep tissue warming with
reduced superficial hot spots to the linearly polarised applicators.
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1.1 Overview
Inducing local heating into biological tissue will increase the metabolic rate, which el-
evates the intermediate product known as metabolites. This process is responsible for
causing vasodilation in the nearby vessels, which increase blood flow to regulate the
excess of heat. Evaluation of the human thermoregulation system during an induced
heating may provide further information to psychophysiology of various diseases or
injuries. Currently, studies on thermoregulation have been limited to skin surface mon-
itoring. It is easily to diagnose superficial tissue with the use of direct-contact resistive
heating element integrated with skin perfusion meter to dilate and monitor the skin mi-
crocirculation. The monitoring technique is based on laser doppler flowmetry, which is
commercially available.
Thermal responses can also occur in the muscle as it was indicated in the literature
[1, 2]. In another study, it was demonstrated the muscle blood flow was increased by
four times during warming [3]. Deep tissue such as muscle cannot be accessed. Inva-
sive approach was employed to measure blood flow using radioactive tracer washout
[2, 3]. This method was limited by the regulated usage of radioactive material, which
restricted the study. The motivation of this work is the development of the device that
is capable of monitoring deep tissue thermal responses. A hybrid microwave-optical
probe is introduced in this thesis to provide a new non-invasive modality that can cause
dilation in the muscle while monitoring the thermoregulation response of the tissue
from the skin surface. This is based on the employed microwave applicator (therapeu-
tic antenna) to induced EM energy muscle warming at a depth of 12.0-16.0 mm from
the skin surface. The developed Near Infrared Spectroscopy (NIRS) system utilises
optical probes to detect changes in blood volume and therefore tissue oxygenation in
deep tissue. The configuration and the basic operation of the proposed hybrid probe in
this thesis are illustrated in Figure 1.1. An LDF monitor was also integrated as a com-
parison tool for skin and muscle responses. The device integrates a cooling system, to
reduce skin perfusion caused by superficial warming of interacting EM energy.
The growth of biomedical engineering is led by the collaboration between engi-
neering and medical sciences. The diagnosis and treatment techniques for complicated
medicinal problems have been leaping forward. The continuous developments in health
care have significantly improved the quality of life, and overall increase in the survival
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Figure 1.1: Hybrid probe concept model.
rate. Microwaves and Radio frequency (RF) devices are employed in medical appli-
cation, including, implants telemetry, diagnosis, imaging and thermal therapy [4–6].
Radio frequency range between 300MHz-300GHz are known as microwave radiation
[7], which are commonly used in daily devices. Microwave radiation also categorized
as a non-ionising radiation for its insufficient energy to damage biological cells, unless
significant power is applied to deliberately overheat the tissue for therapeutic applica-
tions [4, 8].
The interaction between Electromagnetic (EM) fields and biological tissue is
known as bioelectromagentics, the biological tissue absorbs the EM energy, and in
turn it is converted it into heat. In microwave radio frequency range, EM field currently
is used in non-invasive thermal physiotherapy treatments, with typical applicators such
as cavity backed dipole antenna for an external treatment [9]. One of the main disad-
vantages of such system is the poor efficiency in which the field aims at depositing into
the tissue for deep heating treatment, always overheating the skin surface especially
when driven by higher power source.
Biological tissues are complex media to investigate due to the numerous water
compositions at different parts of a human body. Consequently, the tissue is a lossy di-
electric medium, which absorbs the EM energy, and generates heat by the inter molec-
ular vibration. This outcome causes the propagating microwave to attenuate inside the
tissue. This is the fundamental reason why the non-invasive antenna arrangements must
be efficiently coupled to the skin surface to deposit EM field to achieve greater pene-
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tration depth. This work investigates the characteristics of biological tissue in relation
to the performance of the radiated EM field.
1.2 Research Objectives
The general aim of this work is to develop a non-invasive device that is capable of
warming and monitoring the tissue (muscle) while reducing superficial heating to pro-
vide a new insight of human physiology in deeper tissue. This involves the development
and validation process of the hybrid system, which is based on microwave applicator
for inducing heat and NIRS to monitor thermoregulation in tissue. To achieve this, the
work is divided into smaller tasks.
• To develop an applicator that is capable of elevating muscle temperature by about
3.0-4.0 ◦C. The design needs to be directly contact to tissue to reduce leakage to
the surrounding. The applicator design should be well coupled to tissue, reducing
skin absorption and maximising EM energy into deeper tissue. The applicator
must also be specifically designed to include the optical probes in the appropriate
geometry. This part of work is largely reliant on EM simulation package.
• Integrate a cooling system to the applicator for mitigating the superficial hot spot
produced by the absorbed microwave. With cooling element in mind, the design
of the applicator must be carefully considered for efficient EM coupling and skin
cooling simultaneously.
• In vivo, measurements will be the essential step in this project, by evaluating the
physiological response introduced by the microwave warming on to human sub-
jects. To achieve this safely, the fabricated applicator must be validated on tissue
equivalent phantoms. This also needs to be fabricated with dielectric properties
identical to biological tissue at the desired operating frequency. The simulation
study can then be contrasted with the measured thermal distribution.
• Microwave source is required to induce microwave to the radiating element. The
aim of this study to design a microwave system that is capable of supplying de-
sired RF power with integrated power meter for safety features.
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1.3 Thesis Outline
The achieved work during this PhD period is presented in this thesis
Chapter 2 provides general literature review corresponding to the investigation.
This includes previous studies of therapeutic applicators and other employed tech-
niques of inducing heat to the tissue. Moreover, this chapter also explores the current
modalities of measuring change of blood volume and perfusion introduced by external
heating. A comparison of methods has been outlined, highlighting the advantage of the
hybrid system when considering deep tissue monitoring. The literature review is also
expanded specifically within each chapter.
Chapter 3 introduces the general background theory, including interaction of EM
energy into biological tissue. This is an essential chapter in understanding the be-
haviour of the absorbed EM field in a lossy dielectric medium. This includes early-
stage study of SAR and evaluation of the biological heat generated by the deposited
microwave energy. This chapter includes human physiological effect introduced by
tissue heating.
Chapter 4 briefly describes the current ex-vivo techniques of evaluating applicators
on tissue mimicked phantoms. Then one of the reviewed phantom recipes was used
to develop multi-layered tissue. The dielectric property of each fabricated layer was
measured and compared with the corresponding actual tissue properties. This part of
the PhD was essential for validation of the developed applicators.
Chapter 5 shows the development procedure of the hybrid system. This includes
specific background review, characterising microwave components and finally the com-
bined operation. Detailed control system is presented with the integration of cooling
element. This chapter ends with a brief discussion and operation of the used optical
system.
With the system and the phantom being developed to allow for early stage study.
The focus was shifted toward the core topic of this thesis, which was the linear po-
larised applicator design presented in chapter 6. This chapter introduces microstrip
antenna theory, and the modelling techniques used for simulation study of each appli-
cator. Three applicator designs were introduced in this chapter, and all were validated
using thermal imaging of either on phantom or on human calf. The study conducted to
evaluate performance of the applicator at different conditions, including composition of
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tissue, proximity of applicator (superstrate thickness) cooling configurations and more.
Chapter 7 expands the applicator study into the excitation of circular polarisation,
with detailed evaluation of feeding techniques. The antenna was modelled for SAR
comparisons with the previous linear polarised design. The CP applicator was then
developed and validated via thermographic imaging.
Chapter 8 presents the experimental protocol, safety precautions, tissue thickness
measurement and finally the in-vivo haemoglobin concentration results for Applica-
tor I & II. The chapter highlights the main goal of the hybrid system, by effectively
measuring thermal response induced by the microwave applicator.
Chapter 9 this chapter concludes the work in this thesis and highlights the outcome
of the results. This chapter ends with the future development of segment of the hybrid
monitor.
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Chapter 2
Literature Review
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The literature review of general work in this thesis is presented. This investigates
the heating technique conducted by other studies. Detailed literature on the RF appli-
cators is presented, including therapeutic devices for cancer treatment or sport injury
recovery of diathermy.
2.1 Induced Heating in Bioloigcal Tissue
The use of heat in medical applications dates back to approximately (2500 B.C.) in
Egypt [10], and Rome in (200 A.D), where a hot iron used to provide superficial heat-
ing to tumour for pain relief, and in 1989 the use of hot-water circulation cisterns
resulting in palliative effect for different tumours. Recently, microwave antenna and
high intensity focused ultrasound (HIFU) are common applicators for hyperthermia
treatment with various benefits and drawbacks. Hyperthermia induced by microwave is
commonly used for superficial heating, caused by the attenuation in biological tissue,
Microwave diathermy operating at 2.45 GHz is an example of superficial heating for
physiotherapy treatments. Recent study suggests a non-invasive microwave applicator
for superficial heating have an average depth of 10 to 40 mm depending on the oper-
ating frequency and water contents of tissue [11]. Microwave applicator also used to
assist in cancer treatment in conjunction with radio and chemotherapy [12, 13]. Cur-
rent research studies show the use of an antenna array for focused cancer hyperthermia
treatments to achieve uniform regional heating [14]. HIFU provides a non-invasive
local hyperthermia treatment for cancer at greater depth up to 60 mm in the tissue
(operating between 1.0-3.0 MHz)[15], since ultrasound waves are less vulnerable to
attenuation in the medium particularly in the fat layer. However, one of the limitations
of HIFU is the obstruction of bone that can absorb or reflect the beam, and therefore in-
troducing undesirable effects. Radio frequency applicators are considered for regional
warming, simple to design and implement. However, the downside is fat burns caused
by the E-field components which cannot be controlled [16]. This method is limited to
superficial layer only. Th methods are listed and compare in Table 2.1
2.2 Electromagnetic Field in Therapy
The interaction of EM field with biological tissue dates back to the discovery of elec-
tromagnetic, in 1791 Galvni and Volts experimented the EM field effect on frog legs.
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Table 2.1: Tissue warming techniques.
Technique Advantage Disadvantage Comments
Ultrasound
50-100 mm depth, no
hot spot in fat layer,
no interference with
temperature sensors
Localised heating,
Require to be coupled
to tissue, problematic
if bone is present
Used for cancer
treatment typically
head and neck.
RF
Regional warming
and simple to
implement
Limited to tissue with
thin fat thickness,
E-field components
cannot be controlled
Used for superficial
cancer treatment
Microwave can be miniaturised,
hot spots can be
mitigated
Limited penetration
depth 10-40 mm,
shielding is required
particularly lower
bands.
used in conjunction
with chemotherapy
for superficial cancer
treatment
Not until 1927 when high-frequency currents were used by d’Arsonval, Tesla, at that
point it was realized the potential of EM in localized hyperthermia [17], during same
year diathermy was named, which had a meaning of ”deep heating” and spread of EM.
Recently, hyperthermia has been investigated not only for cancer treatment but also
into physiological effect and for tissue muscle recovery and joint healing [1, 18]. On
the other hand, EM applicators proved to be used for obtaining valuable information of
biological tissues such as imaging, cancer diagnosis and implant communication [19].
Large amount of literature established on the antenna array for breast cancer diagno-
sis and imaging with use of radar techniques. [20, 21], while another literature shows
the use of the antenna array for a non-invasive microwave hyperthermia, primarily for
cancer treatment [22, 23].
2.2.1 Applicator Placement
Antennas and other electromagnetic devices are clinically used for therapeutic applica-
tions. Microwave hyperthermia can be achieved with use of invasive or non-invasive
techniques as demonstrated in Figure 2.1 [7]. Figure 2.1a show an example of a non-
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contact applicator, this approach typically has greater leakage to the surrounding en-
vironment, where treatment has to be implemented in a special isolated room [24]. A
non-contact applicator will be of larger applicator size as it is not loaded to a high di-
electric material, and therefore, heating area is also larger depending on the spacing
of the applicator to the tissue (regional warming). Figure 2.1b is a typical microwave
applicator operating in direct contact separated by a coupling medium, which is of-
ten a water bolus for skin cooling. This approach offer reduced microwave leakage,
localised-regional warming, skin cooling and miniaturised applicator geometry[25, 26]
This is approach was adopted for the Hybrid probe for ease of integration with optical
probes. However, excluding the water bolus, where other means of cooling are ex-
plored in this work. Figure 2.1c is an interstitial probe for superficial confined heating
area. This device is minor invasive (not required to penetrate the muscle), which is
capable of raising local temperature by over 50 ◦C to effectively kill the tumour cells in
a short exposure duration of 1-3 minutes. The main advantage of this approach is the
heating directly localized to the area of interest. Figure 2.1d is also an interstitial probe
for deep tissue, which is completely invasive. This is typically used for deep tissue
ablation [27, 28].
The electric field produces heat in tissue when a capacitor plate applicator is used
with typical operating frequency of 27.12MHz within ISM band. Capacitive heating is
a simple method. However, the problem is the overheating of fat tissue caused by the
large dielectric mismatch between fat and muscle layer that reflects and discontinues
the perpendicular E-field components which is the most significant [29]. At low RF
Non-contact
applicator
Direct-contact
applicator
Interstitial 
probe
(superficial)
Interstitial 
probe
(deep tissue)
(a) (b) (c) (d)
Figure 2.1: Microwave applicators in therapy. a) non-contact applicator, (b)non-invasive direct
contact applicator, c) superficial microwave ablation, d) deep tissue microwave ablation
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band the quasi-static condition is applied to solve Maxwell’s equations. This is due to
the fact the biological tissue becomes an electrically small object in comparison to a
significantly large wavelength.
An alternative method for low frequency operation is by inductive heating, which
is magnetically induced hyperthermia. A typical H-field applicator consists of a
solenoid current loop or coaxial loop [30], where eddy current is induced in the tis-
sue with the E-field is tangential to the skin interface, which minimises the overheating
problem in the fat layer and thus increases penetration depth. Magnetic-field applicator
typically operates at RF band such as 13.56, 27.12 and 40 MHz [19]. A noticeable
problem with H-field applicator is the heating pattern, due to the fact the shape of the
coil which produces a null or low temperature at the centre of the coil [31].
The final investigated tissue warming method is the radiative heating, which is
the considered method for this project typically operating in the microwave frequency
band. Unlike the low frequency RF applicators mentioned above where the quasi-static
approximation is needed to be considered for the significantly large wavelength in com-
parison to the object dimension [32]. In the microwave radiative applicator, coupling of
EM power into tissue have been achieved with the use of waveguides, dipoles and mi-
crostrip patch antennas [19, 33]. Microwave’s applicators are generally more compact
in size in comparison to RF applicators because of the shorter wavelength requirement,
which also provide a selective focused heating in local area rather than regional. In
addition further control can be achieved with microwave applicator with use of match
loading or coupling medium to minimise skin warming and to provide uniform de-
posited energy in the tissue [9].
2.2.2 Microwave Applicators
Microwave hyperthermia currently investigated in frequency range of 433, 900 MHz
and 2450 MHz. Therapeutic applicators with microwaves allow for non-invasive hyper-
thermia and microwave diathermy treatment, particularly used for superficial heating,
due to the high absorption caused by the high-water contents of muscle tissue. More-
over, recent research has been encouraging in overcoming the problems of penetration
depth by implementing beam forming antenna array, thus by focusing energy on the tu-
mour site where all the energies are coherently added [23, 34]. Despite the penetration
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depth limits for a single element applicator, microwave diathermy remains to be used
clinically for superficial heating without causing heating or burns to the skin, a com-
plete non-invasive method. Biological Tissue in the microwave operating region can
absorb energy 7000 times more effectively than shortwave radio frequency [35], this
is caused by the interaction of microwave with lossy and high-water content medium.
The average depth of interest in microwave diathermy for rehabilitation is between 10
and 40 mm as a function of frequency [11]. Microwave diathermies have an advantage
over ultrasound in superficial heating, particularly on the anatomical sites where the
bones are present, whereas microwave can penetrate through [36].
2.3 Clinical Application
EM and thermal simulation were employed to study the heating pattern of a generic
direct contact microwave applicator at 2.45 GHz, compared against a resistive heater.
Both methods are based on an anatomical model, which includes all the necessary elec-
trical and thermal properties as discussed in Chapter 3 and 6. The cross section thermal
distribution results are presented in Figure 2.2. It can be seen with a resistive heater
Figure 2.2a uniform peak surface temperature is achieved at approximately 42.6 ◦C.
However, the peak temperature in the muscle is 38.7 ◦C, that is only elevated by 1.7 ◦C.
In contrast; the thermal distribution with microwave warming in Figure 2.2b shows a
superficial warming peaking at about 41.5◦C and muscle warming approximately 41.5
◦C. This is an increase of about 5 ◦C from original temperature of 37.0 ◦C. This ba-
sic study illustrates the difference between current clinical studies of superficial tissue
warming using a resistive heater with LDF monitor in contrast to the hybrid system,
which utilises microwave warming the muscle combined with NIRS, which measures
blood volume in deep tissue.
Currently measuring thermal responses provide useful information on pathophys-
iology. The use of LDF with resistive skin heating element, is already established in
many applications. In most cases, where local warming is induced to dilate the super-
ficial tissue and measure the blood flow. Typical Applications, including assessment of
amputation level [37], predicting outcome of burn wounds [37], human chronic spinal
cord injury and free flap monitoring [38–40]. The main limitation of this modality, is
measuring thermal response on superficial layer up to 2.0 mm. Therefore, measuring
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Figure 2.2: Cross sectional cut of thermal distribution for simulated direct contact Applicator
against resistive heater: (a) resistive heating (b) microwave warming .
deep tissue thermal response may provide beneficial physiological information about
a disease or tissue injury. Some work has been established on measuring muscle ther-
moregulation. This was achieved by immersing an animal in a hot-water bath [2], which
is not sufficient for the limited penetration of the heat as shown in the thermal simula-
tion. However, microwave applicators have been employed on human subject in many
various therapeutic applications involving to heat up the muscle [1][3]. Those works
were aimed at treatment, and there was no actual measurement or integration of the
optical system to study blood flow in the muscle. This is where the hybrid microwave-
optical probe is aimed to achieve. Starting a new modality technique, which can aid the
physiotherapist in comprehensive evaluation of the already established application but
with muscle responses. Table2.2 compares the current commercial available approach
against the hybrid system.
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Table 2.2: Comparisions of hybrid system with commercial aviliable devices
Existing Approach Hybrid System
Target warming Skin warming Deep tissue (muscle)
Warming tech-
nique
Resistive Coil superficial
warming
Microwave deep and
superficial warming
Thermal
response
measurement
Skin blood flow / perfusion
(Superficial)
Blood volume and
oxygenation changes
Measurement
technique Laser Doppler flowmetry Near infrared spectroscopy
Remarks
Commercially available
probe: Skin heating and LDF
monitoring Probes:VHP1/2/3
(Moor Instruments)
Skin cooling is required to
minimise microwave hot spot
in the skin and fat layer
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Chapter 3
Theory
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This chapter covers the background theory of the propagating EM field in biolog-
ical tissue. The EM interaction with a lossy dielectric medium such as organic tissue
is a frequency-dependent problem. Moreover, the loss factor in the medium is directly
related to the to absorption, which leads to tissue heating. The generated heat induces
thermoregulation and physiological changes of the living biological medium. There-
fore, the amount of heating required is defined to the particular application which must
be identified before proceeding to any numerical or experimental study.
3.1 Electromagnetic Interaction in Biological Tissue
Electromagnetic (EM) field arises from electrically charged objects, excited by the fun-
damental force known as electromagnetism. The EM field is a force field with energy
that capable of causing an act over a remote distance. This work focuses on EM field
in microwave operating frequency, since the lower frequency region will have different
characteristics when interacted with organic tissue. Electromagnetic device in medical
application is a well-established field, with common known applications such as hyper-
thermia for therapy and radiometry for diagnosis on human subjects [23, 41]. However,
other studies shown greater interest on EM field absorption in a biological body, and
particularly on head models for mobile phone dosimetry [42]. Other studies looked
into further details such as the interaction with biological membrane [43], with nervous
system [44], and into molecular effects [45, 7].
The interface of EM waves in a biological system is vital for establishing the field
behavior in the tissue. The interaction not only depends on the exposure of EM field
but depends on the reaction of the organic tissue. The biological system is capable of
neutralizing to external influences, especially of EM sources [7]. The compensation
can be pathological, which imposes structural alteration, particularly with high power.
Living system also exerts physiological effects to the elevated temperature inside the
tissue, further detail in Section 3.2.
Organic tissue composites of water and ion content, therefore, human tissues are
lossy dielectric medium, which can attenuate and absorb the propagating EM waves.
The rate of deposited power per mass of tissue is known as specific absorption rate
(SAR) [35]. The water content in the medium varies from one organ to another, yielding
a complex non-homogenous medium that exerts additional complication to the prop-
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agating microwave radiation. Furthermore, understanding the interaction and the be-
havior of EM field in biological tissue, it is essential to study the physics behind it
by reviewing Maxwell’s equations in a dielectric and dispersive medium. The study
of EM exposure to biological media assists the development of biological antenna for
deep tissue heating.
3.1.1 Wave Propagation in Lossy Dielectric Medium
The behavior of electromagnetic field propagating in biological media is determined
by the dielectric properties of the tissue, since the human body is inhomogeneous in
both physical and electrical properties. Every organic material in the body has its own
relative permittivity, and each can vary in dielectric properties between healthy and
deceased state. The electromagnetic field is often viewed as the combination of electric
(E-field) and magnetic field (H-field). The E-field is derived from coulomb’s law and
expresses the interaction between two electric point charges, resulting in a vector field
with unit of volts per meter (V/m). The movement of charges exerts another force
between the charges, which is the magnetic field with units of Amps per meter (A/m).
The magnetic flux density relationship is similar to the electric flux density but with
use of permeability, however, biological tissues at high frequencies are non-magnetic
and therefore assumed as unity value. When a material is subjected to an EM field,
the charged particles of the material produce current and alter the wave propagation
compared to in free space. In a homogeneous and linear medium, the dielectric constant
is static. However, this is not the case in biological tissue a better approximation would
be considered as a an anisotropic medium. The dielectric properties of the organic
medium have dependence on frequency, temperature, polarization and location [46,
47]. In this situation the analysis of dielectric constant must be treated as complex
permittivity with magnitude and phase, this is expressed with use Maxwell constitutive
relations [7].
D = εˆE + P (3.1.1)
J = σE (3.1.2)
Where D is the electric flux density (C/m2), which has proportional characteris-
tics to the electric field E (V/m) in the dielectric medium. The complex permittivity εˆ
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(F/m) is the essential property that describes the interaction of E-field with material.
The induced current density given in Equation 3.1.2 is defined as J (A/m2), whereas
σ is the electrical conductivity of the medium (S/m), like the permittivity both pa-
rameters are a function of field strength in a particular position inside the medium. In
addition P is the polarization density or charge density, were applied E-field becomes
polarized in a lossy dielectric material, due to the change or the addition in electric
dipoles that corresponds to dielectric properties of the medium. The electric dipole
moment is the measure of the overall polarity that is defined by the separation between
positive and negative charges. The dielectric property of a medium is a function of
frequency known as dielectric spectroscopy as shown in dielectric spectroscopy Figure
3.1.
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Figure 3.1: Dielectric spectroscopy [48].
The dielectric spectroscopy is a measure of dielectric properties as a function of
frequency as shown in Figure 3.1. The frequency of EM field reflects to the material
polarization. Moreover, the change in dipole polarization is not instantaneous to the
applied EM field. The phase difference represents the response of the medium to an
applied field, and hence the requirement of complex permittivity. In the microwave
operating region, the interaction of E-field in a dielectric medium causes the electric
dipole in the medium to change orientation and thus polarization, which can be ex-
pressed in detail with dielectric relaxation theory described by the Debye model in
Equation 3.1.3.
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3.1.2 Complex Permittivity
The exposures of EM field to biological tissue are generally characterized in a complex
form with respect to relative permittivity, conductivity and angular frequency. The
permittivity of a material are often normalized to the constant permittivity of free space
εo = 8.85× 10−12. The complex permittivity definition is defined by εˆ :
εˆ = εo(ε
′ − jε′′) (3.1.3)
Where ε′ the real part of the permittivity , while ε′′ is the imaginary part of the permit-
tivity, which is defined as out of phase loss factor that can be further elaborated into:
ε′′ =
σ
ωεo
(3.1.4)
By substitution the previous equations, the complex relative permittivity of a lossy
media is given by
εˆ = εo (ε
′ − jε′′) = εo
(
εr +
σ
jωεo
)
(3.1.5)
From Equation 3.1.5 the real part of complex permittivity is also represented by to
the relative permittivity of the medium ε′r = εr. The imaginary part of the complex
permittivity is related to the conductivity of the medium with respect to the angular
frequency. The real part of the permittivity ε′ is a measure of how much energy from an
external electric field is stored in a material. The Imaginary part of the permittivity ε′′, is
the loss factor and it is a measure of how dissipative or lossy a material is to an external
electric field. These values are used to describe the characteristics at single frequency
as the value may change with frequency. The real part of the permittivity decreases with
increasing frequency, whereas the conductivity increases with frequency. The relation
between the imaginary and the real part complex permittivity defined as the loss tangent
or the dissipation factor as shown in Equation 3.1.6
tan δe =
(
ε′′
ε′
)
(3.1.6)
The complex permittivity vector diagram, indicates the relative permittivity and the loss
factor are 90 ◦out of phase. The loss tangent is the resultant angle which explains the
ratio of the lost to the stored energy. The propagation of EM field in a medium induces
current density from the moving charges of the free electrons. For a good a conduct-
ing material Maxwell’s diffusion equation is used to demonstrate the exponential field
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decay known as the skin depth δs in meters, given in Equation 3.1.7.
δ =
1√
piµfσ
(3.1.7)
] kin depth is an important parameter that can be beneficial, where it describes the pene-
tration depth of propagating field with respect to conductivity and frequency. However,
the biological medium not considered as a good conductors, where the current dis-
placement current is a function of frequency. Consequently, significant attenuation is
expected to the propagating wave. A general equation was found as shown below in
Equation 3.1.8 [7].
δ =
(
1
ω
){(µε
2
) [(
1 + ρ2
) 1
2 − 1
]} 1
2
(3.1.8)
Where the resistivity ρ = σ
ωε
, and µ = µo for biological media. Skin depth is essential
for frequency selection for particular application and medium.
3.1.3 Dielectric Relaxation
The EM dispersion in biological tissue can be characterised by the relaxation theory,
which defines the time required for dipoles to be oriented or polarized when exposed
to electric field. In 1957 Schwan provided significant enhancement in interpretations
of different relaxation mechanism [49], and then introduced three types of relaxation
regions (αi, βi, γi) to characterise the electric properties of biological tissue over a wide
range of frequency. The γ dispersion operating in gigahertz region is induced by the
polarization with water molecules. Whereas βi dispersion operating at around hun-
dreds of kilohertz is due to the polarization of the cell membranes and for even lower
frequency α1 dispersion occurs due to the ionic diffusion process. Each of these relax-
ation regions is characterised by a time constant τ , which is taken for the reorientation
of the molecular dipoles, this can take as short as pico-second [47].
From Figure 3.1 dipolar relaxation occurs in the biological mediums at microwave
radiation. The movement of dipoles and electric charges occurs due to the applied EM
field, where the interaction is a function of frequency. The Debye relaxation model is
often used to approximate the dielectric properties of material based on time constant
τ [50], the relaxation mechanisms are not instantaneous. Debye model was derived
from the frequency response of the first-order system, with complex permittivity in a
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frequency domain as shown below considered for a single relaxation time.
εˆ = ε∞ +
εs − ε∞
1 + jωτ
(3.1.9)
Where εs is the static permittivity for lower frequency range at ωτ  1 , while ε∞ is
the infinite permittivity at high frequencies were ωτ  1, and τ is the relaxation time
constant recognized as the time constant of molecular polarization, as fc = 12piτ , where
fc is the centre frequency. The Debye model [51] modified to account for the electrical
conductivity is,
εˆ = ε∞ +
εs − ε∞
1 + jωτ
− jσs
ωεo
= ε′ − jε′′ (3.1.10)
Where σs is the static ionic conductivity, this extension allows for approximation of
losses in biological tissue caused by the conduction current of free ions. However,
the derived Debye model so far only characterise for a single relaxation, and can be
modified for multi dispersion or multi-poles for characterising the material over the
wider frequency band. Moreover, the second-order Debye model was characterised for
accurate approximations, particularly in a vast complicated mediums, give by:
εˆ = ε∞ +
εs1 − ε∞
1 + jωτ1
+
εs2 − ε∞
1 + jωτ2
(3.1.11)
Biological tissue can impose further complication due to its composition, the De-
bye theory can account for multi dispersions regions as discussed, however it does
not account for the broadening of the dispersion that caused by the composition of tis-
sue. The was resolved by the introduction of the distribution parameter αn to the Debye
model, this solution is known as Cole-Cole equation given below, where ∆εn = εs−ε∞
[52]:
εˆ (ω) = ε∞ +
∑
n
∆εn
1 + (jωτn)
(1−αn) +
σs
jωεo
(3.1.12)
To summarise, the electrical properties of biological tissue over wide-band frequency
can be approximated with use of Debye or Cole-Cole models based on relaxation the-
ory. This theory is vital for numerical calculation with accurate approximation of di-
electric properties of a large bandwidth analysis such as the case with Gaussian pulse.
Moreover, the Cole-Cole dielectric relaxation was applied to the simulation model in
this thesis (CST microwave studio) producing best-fit tissue electrical properties as a
function of frequency.
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3.1.4 Dielectric Properties of Biological Tissue
The electrical properties of biological tissue are previously measured by Gabriel et
al, which is available in the literature [53, 54]. The frequency range of the measure-
ment was between 10 Hz to 20 GHz with the use of the open-ended coaxial probe for
impedance measurements. A parametric model was later developed based on Debye
and Cole-Cole model to describe the changes in dielectric properties as a function of
frequency [52]. The model can function from 10Hz up to 10 0GHz with a large database
of biological tissue samples. However, for this thesis only the primary tissue layers are
required and used for the numerical study. Table 3.1 shows the extracted electrical
properties (Cole-Cole model) of the primary tissue layers at a single frequency of 2.45
GHz . The data shows clearly the muscle has significantly greater relative permittivity
(about 10 times) and electrical conductivity in comparison to the fat layer. The loss
factor in the muscle indicates large attenuation in muscle, which causes an increase
in E-field absorption in the tissue. The skin layer also considered as a lossy medium
after the muscle. Based on the Cole-Cole model it was possible to plot conductivity of
the primary used tissue as a function of frequency as shown in Figure 3.2. It can be
observed, the conductivity increases with the frequency caused by the interaction with
water molecules, which acts as a short circuits at the upper frequency range [51]. In
Figure 3.3 the relative permittivity decreases with increasing frequency, and the change
is unnoticeable for fat tissue over frequency range.
Figure 3.4, shows the penetration depth dependency with frequency for the se-
lected biological tissue. The penetration depth also known as the skin depth (previ-
ously discussed), which is defined at the propagating field reduces by approximately
Table 3.1: Properties of biological tissue at 2.45 GHz [52].
Tissue
Relative
permittivity
Conductivity
(S/m)
Penetration
depth (mm)
Density
(kg/m3)
Skin 38 1.46 11.07 1100
Fat 5.33 0.10 52.06 910
Muscle 52.86 1.71 9.88 1041
Bone 11.38 0.39 9.88 1850
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36.8% of its original value [51]. The penetration depth decreases exponentially with
the increasing frequency. This shows an inverse relationship with the previous figure
of the conductivity. Fat tissue has the greatest penetration depth because of the low
conductivity.
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Figure 3.2: Conductivity of biological tissue as a function of frequency.
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Figure 3.3: Relative permittivity of biological tissue as a function of frequency.
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Figure 3.4: Penetration depth of biological materials as a function of frequency.
3.1.5 EM Interaction Between Two Dielectric Medium
So far, the interaction and the characteristic of propagating EM energy was consid-
ered in an isotropic medium as a function complex permittivity. In reality, biological
medium is inhomogeneous and consists of numerous layers with different dielectric
properties. For simplicity, the propagation of EM wave can be considered as optical
propagation. This study introduces the wave impedance (η), reflection (Γ) and trans-
mission coefficientsTin. Figure 3.5 illustrates a schematic of propagating propagation
EM wave in medium-1 with a particular wave impedance of (η1) incident on the tissue
boundary of medium-2 with a new-wave impedance of (η2)[51]. Assuming medium-1
is air and medium-2 is biological tissue, where η = 120pi in free space. The incident
perpendicular field component (Pi) will partially reflect from the surface of the second
medium (Pr) caused by the difference of electrical properties. The transmitted field (Pt)
will experience slower velocity and shorter wavelength as demonstrated in Figure 3.5.
This is a similar process to the tangential fields, where Ei corresponds to the incident
electric field, Er is the reflected and Et is the transmitted field.
The reflected field can be characterised by the reflection coefficient, that is defined
as the ratio of reflected field intensity to the incident field, as demonstrated in Equation
3.1.13. The expression for the transmission coefficient is the ratio of transmitted field
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Figure 3.5: General EM field transmission and reflection at different medium.
to the incidence given in Equation 3.1.14.
Γ =
Er
Ei
pp (3.1.13)
Tp =
Et
Ei
(3.1.14)
Where Ei = η1Hi, Er = −ηiHr and Et = η2H2. The expressions are expanded in
terms of wave impedance shown below in Equation 3.1.15 and 3.1.16
Γ =
η2 − η1
η2 + η1
(3.1.15)
Tp =
2η2
η2 + η1
(3.1.16)
The general wave impedance can be estimated from the ratio of the electric to the
magnetic field of the propagating wave in the particular medium shown in Equation
3.1.17[55].
η =
√
jωµ
σ + jωε′
(3.1.17)
The reflection and transmission coefficient are derived further to evaluate for perpen-
dicular and tangential components. Furthermore, the equation solves for different angle
of incident generalized from Snell’s law [51].
3.1.6 Dosimetry
The propagating EM waves are absorbed by the biological medium, the rate of en-
ergy absorbed is associated with the loss factor of the tissue. The standard measure
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of dosimetry is the rate of energy absorbed per unit mass, and hence the specific ab-
sorption rate. The SAR is a time derivative of the applied energy (dW ) absorbed by
the mass derivative (dm) in a volume (dV ) with a given mass density (ρi) as shown in
Equation 3.1.18 [7].
SAR =
d
dt
(
dW
dm
)
=
d
dt
(
dW
ρi(dV )
)
(3.1.18)
The expression can then be evaluated to describe the EM field energy inside the
biological tissue with respect to the electrical properties. The energy absorbed by unit
mass is relative to the electric conductivity and density of the medium. This is shown
below in the general SAR equation.
SAR(x, y, z) =
σ
2ρi
|E(x, y, z)|2 (3.1.19)
Where σ is the electrical conductivity of the medium, and E is the propagating
electric field components in the x, y, z direction. The SAR is in W/kg and is based on
the listed parameters for 2.45 GHz (for this work) in Table3.1 The SAR is classified
into whole-body average and local peak average. The whole-body average SAR esti-
mates the elevation of core body temperature. When the tissue absorption increases it
means the temperature has elevated, which, therefore, could lead to tissue damage if the
absorption requirement was exceeded [56]. While local SAR is applied for a confined
region, for example, mobile phones RF exposure to human head [57].
There are two local SAR limits that must be adopted for commercial devices such
as mobile phone operating in near-field to the human brain. The ANS/IEEE C95.1
applied for United States, with an exposure limit of 1.6 W/kg for a 1g of cubic average
[58] The ICNIRP in European union developed an exposure limit of 2 W/kg [59].
While the whole-body exposure for both standards is 0.08W/kg. However, for medical
purposes, the limit is significantly higher, such as in therapeutic devices, where the
tissue temperature is elevated to 42-45 ◦C. To achieve such temperature, the SAR must
be approximately 235 W/kg and the power delivered to the applicator was 27.3 Watts
[60]. In the hybrid applicator the delivered power is only 3 Watts RMS. The study
SAR for applicator development is a significant step to a safe exposure of microwave.
The SAR is sensitive to many characteristics of the applicator, including operating
frequency, polarisation and proximity.
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In the early stages of this work, the SAR as a function of frequency was studied in
a simple EM simulation. The investigation was based on a plane-wave EM boundary
condition and biological medium model, which consisted of skin, fat and muscle. The
detail of simulation method will be discussed in Chapter6 Section 6.4.1. The numerical
results are presented in Figure 3.6, which are normalised SAR. In the first scenario,
where the skin thickness was 2.0 mm, and fat was 10.0 mm. The SAR was based
on 1g of tissue averaging. The skin absorption for 2450 MHz was 50 % higher than
operating at 915 MHz and a 310% increase from 450 MHz. The SAR in the muscle is
dominated by the lower frequency bands of 915 MHz and 434 MHz. Operating at 434
MHz the loss factor is inferior to the other operating frequencies. Consequently, higher
power is required to achieve the required SAR. Figure 3.6b shows the normalised SAR
for 1.0 mm skin and 7.0 mm fat layer. By inspection, the absorption at 2450 MHz is
significantly high at the skin surface than the previous study. In contrast, operating at
915 MHz and 434 MHz presents no significant change when the tissue thickness was
varied. This study indicates operation at higher frequency is a function of skin and
fat thickness because of the short wavelength. This is vital to study with the actual
applicator, as the result indicated the tissue warming can be significantly different with
respect to tissue thickness.
The specific absorption rate can be directly related to temperature as shown in
Equation 3.1.20. The SAR can be determined by measuring the E-field at a desired
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Figure 3.6: Simulated SAR as a function of frequency in the multi-layered biological medium
with the skin, fat and muscle thickness of (a) 2.0,10 and 200 mm, (b) 1.0,7.0 and 200 mm
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location or point, these measurements can be implemented for phantoms study, typ-
ically with mobile phones with head models. Where C is the specific heat capacity
of the tissue exposed to E-field (J/kg ◦C), ∆T is the temperature difference between
the elevated temperature and the core temperature of the tissue before exposure ( ◦C).
Whereas ∆t is time duration of the exposure.
SAR = C∆T/∆t (3.1.20)
Moreover, for enhanced estimation of the elevated temperature the expression is
expanded to account for cooling mechanisms of the biological tissue. This is based on
the following Equation 3.1.21 found in literature study[13]. Where Pm is the metabolic
heating rate, Pc and Pb are the dissipated power by thermal conduction and blood flow
per unit volume respectively.
∆T
∆t
=
(SAR + Pm − Pc − Pb)
C
(3.1.21)
Figure 3.7 demonstrates a typical diathermy transient temperature change in tissue
with and without blood flow [13]. This schematic are typically used to estimate SAR
with the use of Equation 3.1.20 and 3.1.21. Consequently, the rate of tissue absorption
can be estimated from the linear slope in the first 3-minutes of exposure. After 10-
minute of microwave exposure the temperature difference ∆T is large enough to start
the vasodilation process, which acts to dissipate the applied heat away with the aid of
thermal conduction. In contrast, tissue without blood flow the temperature continues to
elevate until it reaches the steady state. At this point, equilibrium is met and therefore,
SAR = Pc. In the scenario with the dilated tissue, the heat dissipation increases with
the blood flow, which halts the temperature curve from further elevation and forces
early steady state at lower temperature level (SAR=Pc + Pb). The figure clearly indi-
cates the significance of ensuring a safe level of deposited energy by taking into the
consideration if the subject or the diagnosed site is poorly dilated. Therefore, tempera-
ture is increased beyond the safety level, caused by the poor blood flow and therefore,
heat dissipation. This study can be also used in the same manner to the approximation
of blood flow rate (mbf ) in the muscle by estimating the slope decline produced by the
vasodilation with the use of following Equation 3.1.22[13].
mbf = pb/k2Cb∆T
′ (3.1.22)
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Figure 3.7: Schematic of transient exposure against the temperature change in a human tissue
with and without blood flow [13].
Where pb is the density of blood, k2 = 0.698 is a constant, Cb is the specific heat
capacity of blood. For therapeutic such as hyperthermia, the exposure power must
be increased sufficiently to override the blood flow cooling effect. In contrast, for
hybrid system, the induced cooling mechanism is the sole purpose of this PhD work.
The intended power is low and just sufficient to dilate the tissue for monitoring the
thermoregulation process.
3.2 Thermal Therapy
Tissue warming such as hyperthermia is a general physical therapy in which tempera-
ture raised between 41◦C to 45◦C while maintained over time period [9]. Temperature
elevation in biological tissue for any therapeutic application is determined but the en-
ergy deposited in the tissue and the physiological response of the human body. The
amount of heat produced is defined by joule’s law, specifying the produced heat is di-
rectly proportional to the square of the field intensity, the resistance of the media and
duration of the exposure [61].
The deposited energy via microwave and other EM applicators has further com-
plications with dependency to operating frequency, input power, polarizations of the
field and tissue electrical properties. In addition, these factors determine the penetra-
tion depth at which EM can propagate through the medium. With heat is generated
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due to the absorbed EM energy, human body responds to the change in temperature
with the increase in blood flow caused by the dilated blood vessels to diminish the ex-
cess of heat from warm to normal regions. The physiological responses can increase
the healing rate in diseased or damaged tissue due to the increase in white blood cells
and antibodies while the increase in transport taking away the toxin and debris away
from the treated area. In addition, the heating provides decreased muscle spasm and
promotes pain relief and relaxation [9, 61].
3.2.1 Bioheat Transfer
The temperature elevation inside the human body is determined by absorption and
transfer of energy or heat, where the absorbed energy is proportional to the operat-
ing frequency and electrical properties of the tissue. The energy transfer is due to the
metabolic rate and the generated blood flow in the biological tissue. The human ther-
moregulatory system maintained body temperature of about 37 ◦C at a wide range of
environmental conditions. The blood flow in the body varies depending on three factors
[62]:
• Body metabolisms, where the blood transport oxygen to entire body and takes
away carbon dioxide from cells.
• Heat transferee for system thermoregulation, where the blood can have dual in-
fluence to increase or decrease in temperatures, it can act as a heat sink to cool
down the local tissue, or it can be as a thermal source.
• Vascular system is essential in regulation of blood pressure to allow alteration of
blood flow distribution leading an increase the cardiac output to maintain blood
flow in a thermal stress region.
From the discussed three factors, it can be drawn that the blood flow serves its
function as to remove or release heat. Penne’s in 1948 [63] introduced the bioheat
equation, which considers the effect of blood in tissue modelled as a heat source or
sink. this was modified to include external heat sourcee such as EM exposure (defined
by SAR) as shown in Equation 3.2.1. The equation is used in the simulation model to
study the thermal distribution by the induced EM power of the applicator.
ρiC
∂Tt
∂t
= k
∂2Tt
dx2
+ k
∂2Tt
dy2
+ k
∂2Tt
dz2
+ ωbCb(Ta − Tt) +Qm + ρiSAR (3.2.1)
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Where, ρi is the density of the tissue (kg/m3),C is the heat capacity of the medium
in (kJ/(kgK)) , k is the thermal conductivity (W/(mK)), ωb is the blood perfusion
rate in volume (kg/m3/s), Tt is the temperature elevation in ◦C, Qm is the metabolic
heat generation in the tissue and Ta is the constant body temperature 37 ◦C. ρ(SAR) is
the absorbed power density caused by the exposure of the microwave radiation. In the
model the blood perfusion is assumed to be uniform across the entire tissue.
The transient thermal simulation is based on Equation 3.2.1 requires the thermal
properties of the biological tissue. The parameters are listed in Table 3.2 which are col-
lected from multiple literatures, including the built-in library of the simulation package
[35, 64]. Simulation also requires tissue response and thermal properties, which are
obtained from literature [35, 65] as shown in Table 3.2. It can be seen clearly the
metabolic rate and blood flow coefficient of skin is significantly higher than muscle
and fat.
The microwave thermal therapy is categorised into three levels based on the el-
evated temperature as shown in Table 3.3. The table lists physiological effects, and
the clinical applications based on the elevated temperature [56]. Low temperatures of
up to 41.5 ◦C is a generally unharmed region with use microwave diathermy, intend-
ing to increase the metabolic rate for physiotherapy treatment. This temperature range
is sufficient for vasodilation and therefore, can be the operating region of the hybrid
system. While temperatures of up to 45 ◦C, this is the upper limit without causing im-
mediate cell death, this region generally applied to non-invasive cancer hyperthermia
in conjunction with chemotherapy. Temperatures between 45-50 ◦C are not commonly
Table 3.2: Thermal properties of biological tissue [35, 65].
Tissue
Thermal
Conductivity
W/(mK)
Specific
heat
kJ/(kgK)
Bloodflow
coefficient
(W (m3K))
Metabolic
rate
W/m3
Skin 0.293 3.50 9100 1620
Fat 0.201 2.50 1700 300
Muscle 0.530 3.55 2700 480
Bone 0.410 1.3 3400 610
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Table 3.3: Applications of thermal therapy at different temperatures
Low temperature
40-41.5◦C
Moderate temperature
42-45◦C
High temperature
>50◦C
Application
Diathermy for
physiotherapy
General non-invasive
hyperthermia
Invasive thermal
ablation
Effects
Increase blood flow
and Metabolism in
tissue
Improve sensitivity to all
radiation therapy, by
increasing tumour blood
flow and cell
oxygenation level
Cell damage,
coagulation and
vaporization
overall
Aid in accelerating
tissue repair
Cell death overtime
duration
Rapid cell death
considered for non-invasive devices, due to the increase in microwave exposure to the
surroundings. High temperature with range of 50-100◦C uses an invasive method with
microwave or RF probe (also known as catheter) inserted inside the body. This has
become an important therapy for Cardiac Arrhythmias, in which the heart beats irregu-
larly [66]. This technique is known as RF ablation.
3.3 Chapter Summary
This chapter has covered the principles of EM propagation in a lossy media such as
the biological tissue. The permittivity of the medium is a complex function, which
was derived. The complex permittivity consisted of dielectric constant of the medium
and the loss factor. This was extended to understand the dielectric properties as a
function of properties, few models were derived for biological tissue estimation such
as the Cole-Cole model. The wave impedance of an EM field interfacing between
two dielectric medium has been characterised. Moreover, the transmitted wave was
evaluated in terms of the amount of energy was absorbed by the tissue. The absorption
mechanism is combined with a thermal model to characterise the elevated heat from
the absorbed EM energy as a function of the cooling mechanism of biological tissue.
This chapter will contribute to the understanding of the simulation models.
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Chapter 4
Tissue Mimicked Phantom
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4.1 Background
Biological tissue compromises of complex structure from anatomical composition
to frequency-dependent electrical properties. Radiating devices are often approved
through numerous validation methods before applied for human trials (in-vivo). Simu-
lation’s studies cannot be entirely relied on prior to clinical trials. Researchers require
early stage ex-vivo testing of various medical modalities. This had been achieved with
use of tissue mimicked phantom (TMP). Phantoms have already been used for devel-
opment and testing of many medical diagnosis and treatment’s applications, such as
in PET/CT scans, ultrasound, RF heating and MRI thermal monitoring [67–69]. In
EM field, TMP is designed specifically to mimic the dielectric properties of biological
organs at predefine frequency range; operating at ultra-wide band (UWB) and some
at a precise desired band[70].In field of microwave; phantoms are typically used to
evaluate SAR, thermal distribution and breast cancer detection of microwave antennas
[71, 69, 72]. For RF applications TMP can be fabricated indifferent states such as liquid
[73], semi-solid [74, 70] and solid [75, 76].
Liquid phantom’s are often used to mimic the average dielectric properties of tis-
sue. This is achieved by controlling the concentration of water, sugar and salt. Water
and salt increase the permittivity and conductivity respectively, while sugar reduces
the relative permittivity. Liquid phantoms are low-cost, simple to make and easily
produced in large volumes. They are typically used for antenna SAR measurements;
however, it is not ideal for multi-layered thermal distribution measurements. In con-
trast semi-solid phantoms are commonly used for thermal distribution mapping, and
heterogeneous structure can also be produced for realistic validation. The common
materials of semi-solid phantom are either a polyacrylamide or gelatin based. Litera-
ture study reveals polyacrylamide based phantom are frequently used for hyperthermia
studies as it can mimic electrical properties and also thermal properties of biological
tissue [74, 77]. The down side of polyacrylamide is the limited shelf life of just few
hours (can last longer when stored in an air-tight container) and restricted availability
of chemical ingredients. Alternatively, oil-in-gelatin based phantoms are much more
attractive due to longer shelf time (over nine weeks) ,wideband characteristics (500
MHz to 20 GHz), and construction of heterogeneous phantom [70]. Tissue mimicked
phantoms with little oil are appropriate for high-water content tissues, while phantom
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samples with a high percentage of oil are suitable for low water content tissue. Con-
sequently, the dielectric constant of the phantom sample decrease with increasing oil
percentages relative to other ingredients. The permittivity of the oil is 2.5 at 6 GHz
while the electric conductivity is approximately 0.05 S/m. Preservatives are typically
added to prevent the spread of bacteria and extend shelf life. il
4.2 Phantom Preparation
The fabrication of TMP requires the appropriate ingredient percentage for optimum
tissue electrical properties at desired frequency, which was obtained from the literature
[70]. The amount of ingredients required is calculated based on volume of the final
molding for three-layered phantom and additional samples of each layer for dielectric
measurements. The volume calculated based on the 12 cm diameter of air tight cylin-
drical container. The ingredients were not precisely of similar products to the literature,
such as the use of higher strength 225 bovine bloom gelatin rather than 200 calfskin
based bloom gelatin. The purpose of gelatin is to solidify the sample, however, derived
from different animal will have some effect to the electrical properties. The oil concen-
tration is based on 50% safflower oil that is commercially available and another 50%
based on paraffin (Kerosene). Table 4.1 contains the phantom ingredient and concentra-
tions mimicking tissue properties at 2.45 GHz adopted in this thesis. The construction
procedure requires uniform temperature, which was achieved by immersing the solu-
tion beaker into a heated water bath. The detailed step of fabrication is based on the
literature with some necessary modification as shown in Appendix A. The procedure,
used in this thesis, for each layer is produced in the following order as described below.
Muscle layer:
The preparation of a muscle phantom is straight forward as it only requires approxi-
mately 8% oil concentration, which can be easily mixed with the water. Table 4.1 gives
the corresponding weighting in percentage of the required materials to mimic the mus-
cle phantom. The actual weight values are based on the calculated desired phantom
volume.
Fat layer:
Fat has the lowest water content of the other tissues. To mimic the fat, concentration of
oil increased to approximately 80% of the entire ingredient, hence making fabrication
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process challenging as it becomes difficult mix water and oil togther. Slight modifi-
cation is necessary to the method by gradually pouring the oil solution to the gelatin
solution at 50%, important to maintain a uniform emulsion at all time. This procedure
requires more time and better temperature control to maintain the solution at 50 ◦C.
The volume of the solution is calculated based on the diameter of 12 cm and thickness
of 10mm. The fat layer is molded on top of the muscle layer, separated by a cling film.
This detachable approach between the two layers allows for future measurement of
thermal distribution using IR camera on the muscle surface, by immediately removing
the superficial skin and fat layer. The molded fat layer was not flat surface, resulted by
the quick solidified solution
Skin layer:
The fabrication of skin phantom is equivalent to the muscle, although the skin has
marginally lower water content, hence higher oil concentration of up to 30%. The
volume measurement of mimicked skin is based on the same standard 12 cm diameter
but with 2 mm thickness, achieving such thickness can be challenging. This is due
to the molding of the fat was not uniform surface; therefore, the corresponding skin
thickness can vary. To achieve 2mm thickness at the central location, a marked needle
was inserted in the center as a guide when the solution of the skin layer is molded on
top of the fat layer.
Table 4.1: Phantom Ingredients for all layers
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4.2.1 Dielectric Measurement Principle
All materials exhibit electrical characteristics that rely on its dielectric properties,
which can be measured in numerous methods. Moreover, it is possible to measure
the dielectric properties of the phantom over the desired frequency range for valida-
tion with actual tissue measurement. There are at least five common methods of mea-
suring dielectric properties, including Parallel plate, coaxial probe, transmission line
(free space and waveguide) and resonant cavity. Many factors must be considered for
the appropriate method such as operating frequency, sample dimension, sample state
(liquid, powder, solid), material contact, material loss, temperature and measurement
conditions. Table 4.2 shows the basic characteristics of dielectric measuring techniques
[78, 79]. The parallel plate approach is not considered due to operation on significantly
low frequency range. The operating frequency is one of the fundamental factors; it can
be seen from the table only open ended coaxial probe and transmission line methods
covers the frequency of interest at 2.45 GHz. The accuracies of the instruments are
also dependent on the electrical losses of the material. The open-ended coaxial probe
offers good accuracy for a lossy dielectric medium; however, the accuracy decreases
with the lower dielectric medium. Transmission line (waveguide) is an alternative low
cost solution, as long as the specimen is inserted along the transmission line between
two waveguide or probes. Resonant Cavity and Free space approach both provide the
best possible accuracy but with a downside of frequency, sample size and possible de-
structive approach.
The open-ended coaxial probe was used in this research. It is a common dielectric
measurement technique, used in many applications with high-water content samples,
Table 4.2: Dielectric measurement techniques [78, 79].
Frequency
Material
loss
Sample size Accuracy
Coaxial probe 0.02-50 GHz High Small 1-10%
Resonant cavity 5-80 GHz low Small 0.1-2%
Free space 5-500 GHz Moderate Large 1-2%
Transmission line 0.05-70 GHz Moderate Moderate 1-5%
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including biological tissue and phantom characterisation. The measurement technique
is achieved by immersing the probe in the liquid or firm contact on a flat surface of
the solid, which is a non destructive. Typically, The probe is connected to a calibrated
Vector Network Analyser (VNA) and emits EM fringing field into the sample; The
field is associated into complex permittivity. This measurement technique is known as
the input reflection coefficient, or the scattering parameter |S11|, the VNA needs to be
calibrated to ensure the reflection coefficient is from the instrument end. The dielectric
measurement setup of phantom is presented in Figure 4.1a, using a N5244A PNA-X
microwave network analyser operating between 10 MHz to 67 GHz. In conjunction
with PNA, a high temperature open ended coaxial probe by Agilent 85070E is used.
Before measurement, the tip of the probe was calibrated for free space, short and in
De-ionized water. For improved accuracy, the measurement acquired numerous times
on different locations until a consistent measurement is obtained. Errors can occur if the
air gap is presented between the sample and probe, hence the repetition of measurement
is required. Figure 4.1b shows the setup of subject biceps measurement for comparison
with three layered phantom. All measurements were obtained in room temperature of
approximately 22◦C.
(a) (b)
Figure 4.1: Measured dielectric properties. (a) three layered phantom, (b) biceps
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4.2.2 Skin Phantom
The dielectric properties of homogeneous skin mimicked sample was measured with
open-ended coaxial probe at frequency range of 0.8 to 5 GHz. Figure 4.2a shows the
relative permittivity of skin phantom. The marked dashed line indicates the frequency
of interest covering the ISM band. The phantom, measurement is compared with the an
actual tissue dielectric properties provided by literature[52–54]. The mimicked phan-
tom closely matched with the biological tissue in the frequency band under the ISM
region. The permittivity of phantom significantly deviates from the biologic tissue
measurement at the upper frequency spectrum. This is to be expected as the mimicking
ingredient was estimated for centre frequency, and is rather challenging to achieve very
high bandwidth. Table 4.3 compares the relative permittivity of phantom and tissue
at centre frequency (2.45 GHz), and the deviation between the two data set is 0.68%.
Figure 4.2b shows the measured conductivity of the phantom, were the mimicked skin
increase at a faster rate in the upper frequency range beyond 3 GHz. The skin phantom
is approximately 8% higher than actual tissue measurement as shown in Table 4.3 In
reality, biological tissue may vary from one human subject to another based on location
and age, thus these changes are not significant to the measurement.
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Figure 4.2: Measured dielectric properties of skin mimicked phantom. (a) relative permittivity,
(b) conductivity
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Table 4.3: Compared dielectric properties of homogeneous skin with fabricated phantom at
2.45 GHz.
Tissue
Relative
permittivity
Conductivity
(S/m)
Skin tissue 38 1.46
Skin phantom 37.74 1.585
% Change 0.68% 8.56%
4.2.3 Fat Phantom
The electrical properties of homogeneous the mimicked fat sample was measured and
shown in Figure 4.3. The Relative permittivity of fat is approximately 10 times smaller
than of muscle phantom, caused by the increase in oil concentration. The permittivity
of fat sample is higher at the lower frequency band and gradually decreases with the
increasing frequency. The recorded permittivity intersects the biological tissue plot
at approximately 3.5 GHz, away from the frequency of interest as shown in Figure
4.3a. The compared asset value of relative permittivity at 2.45 GHz is demonstrated
in Table 4.4, the phantom deviate by about 4.69%, which is not significant. It is worth
to mentioning the accuracy of the open-ended coaxial probe is reduced in a low loss
dielectric medium as stated in Section 4.2.1. Figure 4.3b is the measured conductivity
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Figure 4.3: Measured dielectric properties of homogeneous fat mimicked phantom. (a) relative
permitivity, (b) conductivity
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Table 4.4: Compared dielectric properties of fat tissue with fabricated phantom at 2.45 GHz.
Tissue
Relative
permittivity
Conductivity(S/m)
Fat tissue 5.33 0.1
Fat phantom 5.58 0.19
% Change 4.69% 90%
of fat phantom. The conductivity of the phantom deviates with the increasing fre-
quency, which is caused by a high-water concentration used during the fabrication.
The comparison is made at 2.45 GHz in Table 4.4, the estimated difference between
the tissue and phantom is about 90%. For such low electric conductivity, the mimicked
layer becomes sensitive to the oil and water concentrations. This will have some impact
to the measured thermal distribution. However, it will not be significant as the value
remains low in contrast to skin and muscle layers.
4.2.4 Muscle Phantom
The measured relative permittivity of homogeneous muscle phantom is contrasted with
the permittivity of biological tissue in Figure 4.4a. The dielectric constant of mimicked
tissue decreases rapidly, matching the data of the actual muscle tissue at the frequency
range of 3.0 to 3.4 GHz, where the two plots intersect. Figure 4.4b shows the con-
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Figure 4.4: Measured dielectric properties of homogeneous muscle mimicked phantom. (a)
relative permittivity, (b) conductivity
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Table 4.5: Compared dielectric properties of muscle with fabricated phantom at 2.45 GHz
Tissue
Relative
permittivity
Conductivity
(S/m)
Muscle tissue 52.73 1.71
Muscle phantom 54.72 2.2
% Change 3.5% 28%
ductivity of the muscle phantom increases at a higher rate in comparison to biological
tissue, which can be explained the overdose of water in contrast to oil concentration. A
comparison was made for dielectric properties at 2.45 GHz shown in Table 4.5, the dif-
ference of relative permittivity was only 3.5% where as the conductivity is 28%, which
is caused by the increase in water concentration.
4.2.5 Multilayer Phantom
The electrical property of the assembled three-layered phantom was also measured
with open-ended coaxial probe from the surface of the skin. For a valid comparison,
other measurements were conducted on a subject calf and biceps. The recorded di-
electric constant of three-layered phantom is comparatively identical to the human calf
as shown in Figure 4.5a. The relative permittivity of mimicked tissue are greater by
one unit to the biceps and two units to the calf, this was also noted by the homogeneous
measurements of each layer. The calf has a higher permittivity than biceps, which is im-
posed by the anatomical variation of biological tissue. Figure 4.5b shows the measured
conductivity of the tissue, and can be seen the phantom conductivity increases with
frequency. Despite the characteristics at the operating frequency are closely matched,
the variation can be mitigated in the future by reducing the water content accordingly.
The increase in water content will have an extra impact to the microwave absorption,
and hence the thermal distribution pattern. Further study was made to present the
change in electric property’s measurement with muscle contraction of the human bi-
ceps. This mechanism causes the muscle to push outward into a denser tissue, hence
increasing the dielectric properties. The measured data presented in Figure 4.6, the rel-
ative permittivity of contracted muscle increases by approximately four units and the
conductivity by 0.1-0.3 (S/m). This demonstrates one sort of variation that can occur
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Figure 4.5: Measured dielectric properties of three layered phantom in contrast to calf and
biceps. (a) relative permittivity, (b) conductivity
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Figure 4.6: Measured dielectric properties of human biceps with respect to muscle contraction.
(a) relative permitivity, (b) conductivity
between different subjects, and the applicator design must be able to accommodate for
the anatomical changes.
4.3 Chapter Summary
This chapter provides a brief introduction to a tissue mimicked phantoms, which they
are essential for early stage trials and verifications of EM simulation. In this study, the
primary focus was on the semi-solid gelatin based phantoms, which are optimal for
thermal distribution evaluation at different layers. It was shown the tissue properties of
each layer (Skin, Fat and muscle) are mimicked by adjusting the ratio of oil to water.
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Mimicked skin and muscle are made up of high-water content with reduced oil con-
centration, where as the fat phantom contains larger oil concentration. The fabricated
multi-layered phantom consists of skin, fat and muscle with thickness of 1 mm, 10 mm
and 40 mm respectively. Simultaneously, a homogeneous phantom was produced of
each layer for dielectric measurement to compare with modelled biological tissue. A
high temperature opened ended coaxial probe was used to measure the electrical prop-
erties of three constituent layers and the multi-layered phantom. The dielectric proper-
ties of fabricated phantom shows a close match to the actual biological tissue, however,
the fat later shows the largest deviation. The accuracy of the open-ended coaxial probe
deteriorates with lower loss dielectric medium. Moreover, the non-homogeneous phan-
tom shows a relative matching characteristic to the measured calf dielectric properties.
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Chapter 5
Development of Hybrid System
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5.1 System Overview
Over the last decade, the emergence of new medical technologies has vastly increased,
to maintain and improve health care. Development of medicinal devices and systems
undergoes many procedures, including prototyping and ex-vivo trails for appropriate
functionality and maintained safety. This chapter presents the development process of
the microwave-optical hybrid system, undergoes early stage development from off-the-
shelf devices to a standalone prototype system. Figure 5.1 presents the complete system
block diagram which consists of microwave/RF, cooling, NIRS and LDF system. The
system drives all the elements in the applicator, including antenna, temperature sensors,
optical emitter and detector. The developed hybrid system prototype is presented in
Figure 5.2. The operation of microwave and cooling system is dependent on LDF probe
for temperature feedback. This chapter discusses each subsystem in further detail.
Hybrid device
RF coaxial cable
& optical fibres
RF 
O
p
tical 
Near infreared source 
and monitor (NIRS)
Microwave system
Laser doppler flowmetry 
(LDF)
Cooling and 
control system
Thermistor
Tempreature 
control
Figure 5.1: Block diagram of hybrid system.
Figure 5.2: The developed hybrid system prototype.
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5.2 Microwave System
While technology continues to advance, microwave system had been employed in the
medical field for over the last three decades, and until this date more applications have
emerged particularly for hyperthermia, diathermy and radiometry [80–82]. Microwave
systems are often overlooked in contrast to applicator designs, which could further en-
hance safety concerns of the delivered dosage. For the appropriate and safe clinical
operation of microwave applicators, the system must consider numerous safety proto-
col to ensure reliable operation. The basic system operation remains the same to this
date, with additional sophisticated and miniaturized components. For therapeutic appli-
cations, systems often compromises of microwave source (CW or and pulsed), power
meters and power limiter for safety mechanism. In 1938, a magnetic based vacuum tube
known as magnetron was invented for generating microwave energy, but not until 1945
it was utilized as a microwave source, and was used in numerous medical applications,
including microwave diathermy system [1]. The magnetron is capable of producing a
mean power of 3.7 kW [83], and for clinical therapeutic purposes, the reported power
was up to 250 watts [1][84]. The actual power used is dependent on operating frequency
and duration of exposure. The radiation exposure can be either pulsed or continuous
wave (CW), both methods have the same net average power deposition; however, these
techniques have been reported to have a different impact on biological system [85, 86].
In the current wake of technological advancement, a sold-state based oscillators known
as the frequency synthesizers are commonly used in the modern microwave and RF
devices. The key advantage is the miniaturization that allows for complete system to
be constructed on a single PCB. The minor disadvantage is the limited output power of
approximate 1-5 mW, which can be resolved by linear RF power amplifier to attain the
desired output power. Literature shows current microwave systems are capable of con-
trolling and monitoring power levels for interstitial hyperthermia for cancer treatment
at 2.45 GHz [87].
Clinical microwave diathermy system such as RADARMED 2500CP is commer-
cially available with maximum power of 250 watts in continuous mode and 1600 watts
in pulsed mode. The device is microprocessor based with a custom protocol and added
safety mechanism [84]. In contrast to the BSD-500 microwave hyperthermia system,
which consists of 8-output channels, were 60 watts is the maximum delivered power
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per channel[88]. This system is typically used for interstitial hyperthermia in array
configuration, in addition to the non-invasive applicator approach. This system radiates
at 915 MHz using a solid-state microwave generator. Unlike the previous sophisticated
systems, a low-cost and compact alternative offered by Emblation Microwave such
as the ISYS245 is commercially available for scientific research purposes [89]. This
system operates at 2.45 GHz with a frequency synthesizer and high-power microwave
amplifier to achieve an adjustable output of up to 100 Watts. This system is attractive
for the purposes of the hybrid device. Consequently, the delivered power is signifi-
cantly higher than required and additional control is desired for embedding the cooling
system. Developing application-specific system have many more benefits, including
significant cost reduction, embedded system and software customization.
Based on published literature the essential requirement of a clinical microwave
system is the monitoring, controlling and safety mechanism. During the early studies
of the hybrid system, off-the-shelf devices were used such as Rohode&Schwarz signal
generator operating between 0-20GHz in conjunction the 45 dB gain microwave ampli-
fier (ZHL-16W-43, Mini Circuit). Moreover, R&S NRT Power Reflection Meter was
used to monitor transmitted power, reflected power and VSWR during ex-vivo and in-
vivo trial of Applicator I. The system was manually monitored and controlled. This set
up lacks micro-controller and computer interface for automated operation and safety
feedback loop, which is inherited in the developed prototype.
Microwave system in the medical field, rely on real time measurements of forward
and reflected power, which act as fundamental safety features. This mechanism often
detects changes in deposited power caused by impedance miss-match that arises during
improper contact between the applicator and tissue. Changes in impedance produce a
standing wave, where the energy at the load is reflected back to the source and reduce
the overall radiated power. Anatomical composition of the tissue could also alter the
impedance, leading to unpredictable deposited power. Consequently, it is essential to
monitor the reflected power and often is evaluated as the Voltage Standing Wave Ratio
(VSWR) given by Equation 5.2.1. Where Vmax is the sum of amplitudes in constructive
interference, and Vmin is the difference between amplitudes during destructive inter-
ference. It can also be described in terms of the magnitude reflection coefficients |Γ|,
where 1 ≥ Γ ≥ −1. Reflection coefficient at 0 indicating a perfectly matched load,
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while the maximum positive value (1) is an open circuit and minimum negative value (-
1) is a short circuit. In a perfectly matched transmission line the VSWR is 1, indicating
no reflection. However, if the transmission line is open or short circuited, the VSWR
will be infinity and therefore the energy is all reflected back to the source.
VSWR =
Vmax
Vmin
=
1 + |Γ|
1− |Γ| (5.2.1)
For system measurement, the loss in transmission line resulting from the
impedance mismatch is estimated by return loss (RL) given by Equation 5.2.2. Where
the measured input power is Pi, and the corresponding reflected power is Pr. The
return loss is an essential parameter that links the relationship of VSWR and reflection
coefficient as shown in Equation 5.2.3.
RL(dB) = 10log10
Pi
Pr
(5.2.2)
Γ = 10
−RL
20 (5.2.3)
Despite the capability of estimating the VSWR of the applicator during diagnosis
or treatment, the accuracy of the measurement is influenced by any small impedance
and phase changes. The changes are often caused by the physical properties of tissue
and components with respect to temperature. In the meantime, the standing wave is
shifted with respect to phase, resulting in changes of maximum and minimum VSWR
measurement. These inaccuracies can be addressed with the frequency sweep function,
where the peak to peak ripple is apparent and can be mitigated to improve VSWR
measurement accuracy. This feature is essentially used as a self-calibration method to
eliminate the phase uncertainty before and during the diagnosis.
5.2.1 Developed System
The developed microwave system is built upon the essential features gained from litera-
ture with an additional specific functionality for hybrid device purposes. The complete
RF system schematic is shown in Figure 5.3. Signal generator is the start of the chain,
that was achieved with a frequency synthesizer chip (DSN-2700A-1119, Mini Circuit).
The optimal operating frequency is between 2.3 GHz to 2.7 GHz, driven by external
25 MHz crystal local oscillator (LO). Majority of frequency synthesizers are based on
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Figure 5.3: Schematic of microwave system.
phase locked loop (PLL), that produces high level of stability and accuracy, which op-
erates by comparing the phase of the reference signal, and voltage controlled oscillator
(VCO). A digital synthesizer requires a programmable divider (Ncounter block to the
loop for the desired output frequency. The synthesizer chip was soldered on a fabri-
cated PCB with a 50 Ω transmission line for RF output. The fabricated PCB design
with the synthesizer chip is demonstrated in Figure 5.4. The synthesizer was controlled
through a 24-bit serial peripheral interface (SPI) to the micro controller for VCO fre-
quency tuning (fV CO), achieved by adjusting programmable N divider as demonstrated
in Equation 5.2.4. The counter binary relies on the desired fV CO, the fixed R counter
and the reference frequency (REFin). The controller program was further expanded
to accommodate for frequency sweeping of 2.3 to 2.7 GHz. This was achieved with
appropriate logic transformation based on Equation 5.2.4 and with a for loop function
for frequency incrementation by a desired factor. The synthesizer allow minimum fre-
quency step size of 250 KHz during the sweep.
Ncounter = (fV CO ×R)/REFin (5.2.4)
The generated signal passes through an RF digital step attenuator (DSA) ZX76-
15R5-SP, Mini Circuit, with maximum attenuation of 15.5 dB in 0.5 dB steps. The
attenuation level is controlled by the Arduino micro-controller using a 5-bit serial in-
terface. The DSA is essential in controlling the level of output power delivered to the
applicator and used as part of cooling protocol to lower RF power, further discussed in
Section 5.3.3. Generally the generated RF signal has high-frequency harmonics, which
are undesirable and can be rejected with use of band pass filter. The in-line coaxial band
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Figure 5.4: Frequency synthesiser PCB
pass filter (VBFZ-2340+.p, Mini Circuit), has a 3 dB cut-off frequency between 2.0 to
2.7 GHz with 30 dB harmonic rejection. The filtered signal is fed to a 45 dB gain high
power amplifier (HPA), that was used in the early experimental trials. The operating
range of the amplifier is between 1.8 - 4.0 GHz, and maximum saturated output power
of 44 dBm (∼16 watts). A second band pass filter is used after the HPA, to maintain
harmonic rejection and other products may arise from the amplifier. The amplifier DC
power is controlled via a logic relay connected to the Arduino, which serves as a safety
feature during impedance missmatch of applicator to the tisue (high VSWR). The am-
plified signal passes through a high-power Bi-directional coupler (ZABDC20-322H,
Mini Circuit), that is capable of coupling 20.5 dB of input and reflected power between
the frequency range of 1.7 to 3.2 GHz. It is a four port transmission line based with in-
put, output, forward coupled and reversed coupled. The output port is connected to the
applicator via coaxial cable, while any mismatch in the applicator will cause a signal to
reflect back and coupled at the reverse port. The coupled signals at each port are con-
nected to 10 dB fixed attenuator to protect the input of the power detectors. The power
detectors (ZX47-40+, Mini Circuit) converts RF input power to DC output voltage in a
linear relationship. The operating frequency is up to 8 GHz and power level between -
40 to 20 dBm. The output voltage is digitised in the micro-controller with built in 10-bit
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analogue digital conversion (ADC). Then appropriate calculations are done to convert
the voltage level into forward and reflected power, which are essential in estimating
the return loss, reflection coefficient and VSWR. Real time VSWR measurement of the
applicator combined with frequency sweep function, allow for optimal operating fre-
quency detection without the use of external devices such a VNA. The microwave and
cooling system are powered by 28 V, 10 A linear power supply (Calex 32024E/10R);
the voltage is regulated down specifically for all other circuit requirements.
Figure 5.5: Developed microwave, cooling and control system.
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The developed microwave system is embedded in a shielded metallic box to iso-
late any interference or leakage to the surrounding. The system compromises of other
essential hardware including power regulators, switching devices and feedback cir-
cuits. This is demonstrated in Figure 5.5. The power regulation circuit consisted of
multi-stage regulation to step down the 28 V source to 12.5,12, 5 and 3.3 V using
Low-dropout regulators (LDO) to power RF circuits and less demanding circuits. A
high-power regulator (step down DC-DC convertor) was designated for the active cool-
ing modules (Peltier coolers), at maximum power of 40 W. The input voltage is fed
directly from the main power source of 28 V, while the output voltage of the regulator
was manually adjusted to the desired range between 3-5 volt for the suitable cooling
power. However, this process has changed recently by introducing H-bridge MOSFET
replacing the relay switching mechanism, which is capable of automatic power level
adjustment controlled by the Arduino using Pulse Width Modulation (PWM) signals.
The logic controlled relay circuit served as an emergency power off to the RF system.
Additionally for the work conducted in this thesis, it was used as a thermostatic cooling
switch. A Current sensor was recent addition to the system, which is used as a feed-
back circuit to indicate the operation and current level supplied to the active coolers.
The SPI voltage level of frequency synthesizer is 3.3 Volt, whereas the micro-controller
is 5 V. Therefore, a logic level shift was used to shift down the voltage according to the
requirement. LCD display is included to interact with the micro-controller, display-
ing essential information to the user, including temperature, RF power and VSWR. A
manual input control over the system was added as a secondary emergency function.
5.2.2 System Operation
The operation of the microwave system, has been characterized individually using spec-
trum analyser and a VNA. The initial step is studying the RF source, measuring the op-
erating frequency and the output power. Figure 5.6a is the spectrum output from the RF
synthesizer, while the frequency was set at 2.45 GHz. The frequency was with an error
of about ±2-3 MHz, which can be neglected, and the output power was approximately
3.5dB at 2.45 GHz. The measured spectrum over the frequency sweep is shown in Fig-
ure 5.6b, the operating range with in specification between 2.3-2.7 GHz. The output
power of the source was not completely stable, there are peak to peak ripples of about
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Figure 5.6: Measured spectrum at the output of frequency synthesizer at. a) operating
frequency, b) frequency sweep
1.5dB at the lower frequency band below 2.5 GHz. The changes in output power can
be mitigated by the adjustment of in line digital step attenuator to provide a consistent
output power. The characteristic of the remaining elements is analysed and discussed
in Appendix B.
The uniqueness of this system is the ability to measure the VSWR of the appli-
cator over the generated frequency sweep. It’s beneficial to monitor the characteristics
of the applicator when placed on the subject directly, without the use of external spec-
trum analyser or power meter. This is essential part of monitoring, which promptly
allow for dosage control and safety protocol implementation. The measured data can
be obtained real time in any external serial program that has the capability to record
and plot the data in real time. Figure 5.7 presents the measured VSWR of Applicator II
placed on calf and phantom through the microwave system and network analyser. The
system based measurement is limited to the source operating range while VNA often
significantly larger. The VNA based measurement is calibrated to the applicator. Con-
sequently, the baseline VSWR is lower than system measurement; however, the trends
between the two measurement are identical. The optimum operating frequency on calf
is approximately 2.51 GHz measured by the VNA and also calculated by the hybrid
system. Likewise, with phantom measurement, the pattern of VNA and system mea-
surements are consistent at about 2.53 GHz. The system measurement sustains from
large ripples across the frequency sweep, results in a phase shift of the standing wave.
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Figure 5.7: Measured VSWR of Applicator II using microwave system and VNA.
Elimination of system ripples can be achieved by estimating the peak to peak value of
the ripple over the frequency range, were the largest peak-peak ripple was about 0.5 dB.
Furthermore, the system linearity over the operating frequency range must also be con-
sidered as a function of the standing wave, which limits the accuracy of the estimation.
The system was also used to measure the VSWR of CP applicator placed on a
calf, the results presented in Figure 5.8. The CP operating frequency is at the point
where the two degenerate modes are orthogonal, therefore, it is the intersected region
between the two excite modes. The general VSWR trends between the two measure-
ments are identical. The VNA measurement shows the operating frequency is about
2.53 GHz, in contrast, the hybrid system VSWR reading cannot determine the CP op-
erating frequency of the applicator. The system can only determine the best matching
frequency in the linear operating region. The bandwidth of CP applicator is narrow,
which increases the challenge.
Figure 5.9 presents the system measurement with 50Ω termination directly at the
output of Bi-directional coupler in comparison to match loading at the end of the two-
meter coaxial cable. The system VSWR measurement clearly shows the diminished
ripples, when the system, is match terminated at the output of the coupler (before the
coaxial cable). In contrast to the shifting of standing wave as a function of frequency
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Figure 5.8: Measured VSWR of CP applicator using microwave system and VNA.
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Figure 5.9: Match terminated system VSWR.
along the cable length, and cable attenuation contribute to the decreased VSWR. The
mean VSWR value across the frequency sweep for direct termination is approximately
1.3 and 1.15 for cable termination.
The embedded power meter measures the corresponding input and reflected power
of the system; the characteristic with added system attenuation is presented in Figure
5.10. The power coupled at the input of the Bi-directional coupler is approximately
27 dBm when the applicator is placed on the phantom and a leg (impedance matched).
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Figure 5.10: Delivered and reflected power of applicator applied on human calf and phantom.
This indicates the delivered power to the applicator is consistent and regardless of the
test subject. In contrast, the reflected power fluctuates depending on impedance match-
ing of the applicator to the tissue/phantom. At operating frequency approximately of
2.50 GHz, the returned power was 10 dBm lower with a phantom. This signifies the
possible power changes when placed on different anatomical location of tissue, between
subjects and the corresponding age.
5.3 Cooling System
Superficial heating in microwave warming is a typical challenge when deep tissue heat-
ing is desired. Therapeutic devices, including microwave and ultrasound modalities, of-
ten requires surface cooling when the radiation is applied externally in a non-invasive
manner. Consequently, single element applicators may lead to the possibility of skin
burns during hyperthermia treatment [90]. Cooling mechanism have been applied in
the form of water or forced convection (Air cooling). Literature study shows water bo-
lus cooling are used to mitigate the skin heating throughout EM hyperthermia, which
dates back to 1980’s [16, 31]. The bolus contains deionized water to prevent EM losses
and was proved to reduce radiation leakage to surrounding as a result of the high di-
electric properties [16]. Deionized water have a dielectric constant of εr ≈ 80, and acts
as a transmission medium to couple the EM energy into the tissue. It was also used to
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provide the necessary spacing between applicator and tissue, ensuring uniform heating
is applied [14]. The limitation of water cooling is the trapped air bubbles presents be-
tween the bolus and tissue, which shown in a study to have larger SAR in the vicinity
[91]. The bubbles are introduced by the pumping mechanism for the water circulation.
Air cooling have been previously used to lower the risk of skin burn and discomfort
in microwave thermotherapy. This was achieved with use of a waveguide applicator,
with required spacing and perturbation for increase air flow on skin surface [22, 90]. A
microstrip patch antenna based applicators also been reported for the capability to be
used in conjunction with air cooling, assuming a certain spatial arrangement between
applicator and skin [92].
The applicator spacing is a limitation of the current used skin cooling modality,
which is not adequate for this project. The hybrid applicator integrates optical probes
that require direct skin contact for the diagnosis. Consequently, an indirect active cool-
ing approach is an attractive solution; this was implemented with use of Thermoelectric
cooling (TEC). Cooling the skin was achieved by indirectly cooling the applicator from
its ground plane (Copper conductor side) to lower the temperature of the applicator,
hence cooling the skin. The benefits of TEC are small dimensions, no moving parts,
reliability and accurate temperature control. In contrast, air cooling is an alternative
technique. Thermoelectric (TE) modules are found in many industrial applications,
including laser diode cooling [93], infrared detectors and as a heat exchangers. The
literatures of TE modules are limited in the medical sector, particularly as a skin cool-
ing for applicators was not investigated previously. Some literatures were found using
TEC for medical purposes such as liquid heat exchanger [94] and therapeutic used for
reflexotherapy [95].
5.3.1 Thermoelectric Cooling
A thermoelectric module consists of two ceramic plates acting as a junction and semi-
conductor material of p- and n-type in between the plates as shown in Figure 5.11. The
process involved in TEC is commonly known as the Peltier effect. This effect occurs
when electric current passes through two distinct conductors, creating a temperature
difference between the two junctions. This essentially can act as a heat pump, absorb-
ing heat from the cold side of the module and release it to the hot side where it will be
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Figure 5.11: Thermoelectric cooling.
dissipated. The heat generated at the hot side (Qh)can be mathematically estimated by
combining the unit power Pin, and the cooling capacity(Qc). A detailed theory can be
found in the Appendix B Section B.2.
The configuration of the applicator consists of two Peltier coolers, where the cold
side of TE module is attached on the back of the applicator (ground plane) with a double
sided adhesive thermal pad for optimal heat conduction. The hot side of TE module is
attached to a heat sink, which must be sufficient to dissipate the heat at the junction. For
efficient heat dissipation across the heat sink, a dual axial fan was used to reduce ther-
mal resistance of the heat sink by dissipating the heat at a faster rate to maintain a large
temperature difference across the module. The cooling mechanism and configuration
were performed in transient heat transfer simulation in conjunction with the microwave
applicator to examine the effectiveness of skin cooling. The cooling problem was sim-
plified by considering an equivalent thermal circuit is demonstrated in Figure 5.12.
The thermal problem is considered to be in series, beginning with the heat source Qmw
which is induced by the microwave warming as a function of power and time. The junc-
tion temperature (Tj) is the skin temperature and is elevated during microwave warming
from initial temperature of approximately 30 ◦C. The temperature at the skin surface is
always lower than core temperature, which is caused by the high blood regulation at the
skin in conjunction with the air convection. The excess of Tj is dissipated through the
antenna, including superstrate and substrate that have a thermal resistance (RAnt). This
emphasizes the role of substrate thermal properties for effective heat transfer between
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Figure 5.12: Equivalent thermal circuit.
the skin surface and the Peltier cooler. The RAnt−TE of the interface between the cold
side of TE module (Tc) and the antenna ground plane is the thermal adhesive, which is
not considered in the simulation model. The TE module has a large thermal resistance
to maintain high-temperature difference across the Peltier cooler, in a condition where
the heat at the hot side (TH) is effectively dissipated. The circuit is completed with the
added thermal resistance of the heat sink combined with the adhesive (RTE−hs) and
with forced cooling (Rhs−air) The ambient temperature (Tamb) is typically set to 20 ◦C
during the simulation model.
The operation and control of TEC are demonstrated in Figure 5.13. The skin
cooling consist of two TE module and axial fans to lower thermal resistance of the
heat sink. The cooling system operates using the skin temperature; thermistor which
is located at the centre of the applicator. Additional thermistor for monitoring purpose
is placed at the ground plane of the applicator in location of the radiating edge of
antenna, where the maximum temperature is expected. The skin thermistor is integrated
with the LDF optical probe, were the DC output of temperature reading is feed back
to the microwave system Arduino micro-controller. The skin temperature reading is
used to control the cooling system in a thermostatic manner. The Peltier cooler is
activated through a relay switch when the skin temperature exceeds the set point value.
The Forced convection fan is a PWM based switching using a logic MOSFET circuit,
where the speed automatically adjusted by the micro-controller. The axial fan operates
at 17000 RPM, which induces vibration into the applicator, causing an increase in the
baseline of flux measurement and occasional large spikes, which was diminished by
anti-vibration washers along with data post processing.
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5.3.2 Thermometric Techniques
In the 16th and 17th centenary temperature estimation of the body was relied on the
use of hands as a reference point [56]. A thermometer is considered as a device that
measured the output changes with respect to temperature in a repeatable manner. In
clinical thermal therapies, temperature monitoring participates a significant role in var-
ious treatments, and hence feedbacks are necessary to ensure safe delivery of therapy
and minimize any potential risks from high dosage. In microwave warming the heating
response may be likely to vary from one subject to another depending on the anatomical
compost ion of tissue. In hyperthermia, the temperature is controlled at about 42 - 43
◦C [7]. Temperature measurements can also be classified into invasive and non-invasive
techniques. In clinical thermal therapies, an invasive thermometry is required due to
the lack of technological means of non-invasive modalities. Monitoring temperature
invasively require insertion of catheters into the tissue, this approach is used for precise
accurate measurement in the critical location [56]. The three common invasive ther-
mometers are thermistor, thermocouple and fibre optics [7]. These thermometers are
necessarily to be used invasively, they can be used to measure superficial temperature
integrated with other sensors. The benefit of each technique is compared in Table 5.1.
The first section of Table 5.1 presents the common invasive thermometry. Ther-
mistor are thermal sensitive resistors, where the electrical resistance changes with the
changing temperature. There are two types of resistors, first is metal based resis-
tor known as the positive temperature coefficient (PTC) and second is semiconductor
based, which is a negative temperature coefficient (NTC). Typically, thermistor oper-
ates in a smaller temperature range in comparison to other sensors, that allows for an
increase in measurement accuracy (0.1 ◦C) [96]. The limitations of thermistors are
the non-linearity effects with temperature [97], and possible interaction with EM field
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Table 5.1: Thermometric techniques compared.
Modalities Advantages Disadvantages
Thermistor Accurate Non-linearity
Thermocouple Easily integrated with sensors Interaction with EM
Optical No EM interaction Calibration required
IR Thermography Surface imaging Low accuracy
Radiometry Under surface monitoring Limited lateral resolution
Ultrasound Good spatial distribution Interaction with bone and air
with the metallic PTC resistor based. Temperature monitoring in the hybrid system,
achieved non-invasively with three NTC based thermistor measuring temperature of
skin and antenna ground plane. Thermocouples are based on a junction that is created
between two different metals. When applying heat or cold at the junction, a voltage is
generated, which relates to a temperature value. Thermocouples are capable of measur-
ing wide range of temperatures; however, more susceptible to EM field and limits the
accuracy of the measurements (require shielding) [98]. The susceptibility of the EM
energy can be avoided with use of non-inductive optical fibre thermometry. The probe
has a phosphor thermosensor at the tip, which is excited by light-emitting diode (LED).
Recent literature shows optical fibre thermometry also used in non-invasive skin tem-
perature mapping [99]. The downside of the optical probe is the time consumed on
calibrations [7].
The second half of Table 5.1 summarises some of the non-invasive approach of
thermometry. Non-invasive modalities are attractive because it is capable of mapping
thermal distribution of the tissue externally. IR thermography is a commercially avail-
able thermometry, utilises IR photo-detector to measure the emitted IR energy of object
surfaces. The emission of IR is produced by the molecular vibration. For hybrid ap-
plicator, thermal distribution verification in this thesis was achieved using Flir i7 IR
imaging, capturing immediately after 5 minutes of microwave exposure of phantom or
human calf. The used IR imaging have an accuracy of ±2 ◦C, sensitivity of 0.15 ◦C
and a resolution of 60x60 pixels. The modality is simple to use and portable, however,
is limited by surface measurement.
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Unlike IR thermography, microwave radiometry is a non-invasive technique that
is capable of mapping temperature distribution at depth (up to 30 mm). This tech-
nique can detect the elevation of temperature inside the tissue. This modality uses a
specially designed antenna to measure microwave thermal noise emitted by the tis-
sue with temperature above absolute zero [100]. Radiometry was used in clinical
evaluation as a thermometric tool [101], breast cancer screening and blood flow mea-
surement [102, 103]. Typical microwave radiometry operating frequency is around
1.0 - 3.0 GHz. Literature shows radiometry was used in conjunction with microwave
hyperthermia for simultaneous heating and temperature monitoring [104, 105]. The
Reported resolution of radiometry is approximately 0.1 ◦C [101] and signal sensitiv-
ity between 0.3 - 0.8 ◦C [105]. The trade-offs of microwave radiometry is between
depth and lateral resolution which corresponding to operating frequency. For optimum
depth, the lateral resolution is limited and reported at about 5.0 mm [101]. In con-
trast to ultrasound imaging, better lateral resolution can be achieved with the shorter
sound wavelength in the tissue. However, the limitation is the rapid attenuation when
bones or gasses is at the site [56]. Despite the limitation of radiometry, it remains
an attractive future add-on to the hybrid system, which can provide an insight tem-
perature change with respect to measure thermal responses using the optical system.
5.3.3 Control System
The coordination of microwave and cooling system relies on the micro-controller to ex-
ecute the defined program. A brief control system flow chart is shown in Figure 5.14.
The program was designed to operate at different conditions (Mode). The program
consists of three essential modes starting with Mode-1 for VSWR sweep, Mode-2 for
microwave heating with cooling (primary function), and Mode-3 is identical to Mode-2
excluding cooling system. In Mode-1, the output of the microwave system is reduced
by controlling the DSA to increase the RF attenuation, and activates the HPA through
the relay trigger to enable the microwave exposure. Meanwhile, a frequency sweep is
triggered to loop the output frequency of synthesizer, and frequency sample is recorded
with the corresponding transmitted power (TP) and reflected power (RP) measurement
from the inbuilt power meter. The VSWR is then calculated for each frequency, which
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Figure 5.14: Control system flow chart for microwave and skin cooling.
is displayed and recorded through a serial interface. Optimum operating frequency can
be selected manually based on minimum VSWR value; this could be achieved automat-
ically in the future work. Mode-2, uses predefined parameters such as the frequency,
output power, temperature set-point and VSWR limit. The applicator is radiating as
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the microwave HPA is turned on and the system begins monitoring skin temperature,
VSWR and the net delivered power. The cooling system is only activated when the
temperature of skin exceeds the set point value, e.g. 30 ◦C, and at the same time the
RF power is reduced by 3dB until the temperature is below or at the set point value.
Furthermore, set points was added for VSWR and temperature limits as part of safety
mechanism, when exceeded the system will shut off without microwave exposure.
5.4 Optical System
5.4.1 NIRS Monitor
Measuring the changes in blood volume using NIRS can be achieved in numerous meth-
ods depending on the application, these instruments require a minimum of three wave-
lengths to distinguish the absorption spectra of the local tissue. The simplest forms of
spectrophotometry instruments are the commercially available continuous-wave NIRS.
These devices are based on modified Beer-Lamber that capable of continuously measur-
ing the changes in concentration level (∆HbO2/∆HHb/∆HbT) [106]. However those
devices are limited to only measuring changes from a baseline level without an actual
quantitative value[107]. This factor can be resolved if the optical path-length and the
light dispersion for each wavelength is known. Currently, complex devices with appro-
priate algorithms are able to measure the absolute concentration by utilising reflectance
measurements of multiple detectors distributed at different distances; this is known as
the spatially resolved spectroscopy (SRS) [108]. Despite the benefit of acquiring quan-
titative value, the continuous-wave NIRS remains to be advantageous in clinical use for
its cost and practicality [109].
During the initial stage of the study, a commercially available Hamamtsu NIRO
100 was used to measure the changes in oxy and deoxy haemoglobin. The NIRO 100
was used in conjunction with the first proposed applicator to measure the changes in
thermal response. The NIRO 100 equipped with a single source and dual detectors at
different spacing, hence operating in SRS principle. Applicator I was designed spe-
cially to integrate the Hamamtsu Optical source and detectors (Optodes). The SRS
system can measure the light intensity difference between each detector, that provides
additional parameters such as tissue oxidation index (TOI) and the normalized tissue
haemoglobin index (nTHI). The TOI is the ratio of the oxygenated haemoglobin to the
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total tissue haemoglobin and given in Equation 5.4.1.
TOI =
HbO2
HbO2 +HHb
% (5.4.1)
During the development of the hybrid system, in-house built NIRS system was de-
veloped by the UCL BioMedical Physics and Bioengineering department to be used for
hyrbid system. The instrument is based on CW-NIRS with modified beers-lambert for
measuring changes in concentration, and uses single optical emitter and detector. The
new probes are integrated with the more recent antenna designs beginning with Appli-
cator II. The emitter consists of six laser diodes operating at six different wavelengths
(670, 760, 780, 860, 904, and 980 nm). The light from the six laser diodes is coupled
into one flexible optical emitter probe. The avalanche photo diode is used to detect the
spectral response which is connected to a single-channel optical fibre. The separation
between the emitter-detector is set to be 40 mm to ensure desirable light penetration to
the muscle. The system acquires and control data through a DAQ with LabVIEW inter-
face. The captured data requires some necessary conversion to account for the optodes
separation and the Differential path factor (DPF). The DPF value of 4.94 is typically
used for human calf. This value was obtained from the literature [110].
5.4.2 LDF Skin Monitor
The primary objective is to measure thermal responses in deep tissue induced by the mi-
crowave warming. However, skin temperature is also increased in the process, resulted
by the high-water content in the superficial layer. A secondary optical monitoring sys-
tem based on LDF was introduced for applicator II and onward. This instrument is
the moorVMS-LDF1 commercially available by Moors instruments. The device uses
a single 6 mm diameter optical probe with an integrated emitter and detector spaced
at 0.5 mm. The reduced separation limits the measuring depth of up to 1 mm, that is
essentially used to measure the micro-circulation, particularly the capillaries, arterioles
and venules. The skin measurement will be used to evaluate the efficacy of the skin
cooling and to verify if the NIRS measurement from the deeper tissue. Equally, to the
NIRS, the laser Doppler measurement is not an absolute perfusion value. It’s rather
expressed in arbitrary units of perfusion in flux. The LDF monitor also integrates a
thermistor which is used to measure the skin temperature, with accuracy of 0.3 ◦C. The
laser doppler operates at a single wavelength of 785nm that is in the NIRS operating
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band and causes interference to the NIRS measurement when both systems operated
simultaneously. The current method used to mitigate this problem is by repeating the
experiment with each instrument independently. This is further discussed in the proto-
col in Chapter 8.
5.5 Chapter Summary
The full operation of the hybrid system was reviewed in this chapter. The microwave
system was designed and built to adapt any changes in operating frequency caused by
the anatomical aspect of tissue or applicator designs accuracy. The system was built
around the synthesizer as a signal source which undergoes to amplification process for
the required output dosage. The transmitted and reflected power is monitored as part of
a safety mechanism during improper placement of the applicator, where the impedance
miss-match will be detected. Moreover, thermistor was used to monitor skin tempera-
tures and used as part of cooling feedback, to minimize skin heating. Several cooling
methods were investigated including water bolus. However, the limitation was the ap-
plicator to tissue spacing is not appropriate for integrated optical probes. Peltier cool-
ing was implemented as a skin cooling mechanism, which is a new application domain
that has not been investigated previously. The combination of microwave and cooling
systems function accordingly by using a micro-controller for the necessary cooling or
heating protocol and other implemented features to ensure patient safety. The induced
physiological changes are monitored by the two independent optical systems. NIRS
was the primary instrument to measure blood volume in greater depth where as the
LDF to measure the micro circulation in the superficial layers. Both devices use near-
infrared light, which causes cross interference when operated simultaneously, thus the
experiments were done independently for each monitoring instrument.
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Chapter 6
Linearly Polarised Microwave
Applicator
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6.1 Introduction
This section introduces the development and design stages of the hybrid microwave ap-
plicators. The development procedures involved various design investigations, includ-
ing operating frequency, coupling layer and applicator proximity to the skin surface.
Moreover, the study goes over the details of anatomical contribution of tissue to the de-
posited EM energy by the aid of EM and thermal simulation. There are three developed
applicators based on linear polarisation, which have been modelled, fabricated and val-
idated. Each stage of the applicator, evolved upon previous design, primarily to reduce
skin heating and promote deep tissue warming. Applicator I design concentrated on
EM and thermal study of the applicator at different anatomical conditions, while Ap-
plicator II in-cooperated skin cooling and additional optical probe (LDF). Furthermore,
Applicator III was introduced to enhance the cooling efficiency of the predecessor.
6.2 Design Requirements
The operation of antenna in therapeutic or diagnostic application is different to the
standard free space environment. In therapy, applicators typically operate in the near-
field region by interacting with lossy dielectric medium. This arises numerous antenna
design challenges with consideration of penetration depth and uniformity of deposited
EM field. The field distribution, penetration depth and applicator dimension are largely
dependent upon the operation frequency, the proximity of the applicator and the cou-
pling medium. These parameters have been investigated in depth as they form the
essential concept of optimum applicator design. The operating frequency choice was
2.45 GHz for compact applicator size, localised heating, reduce power requirement and
aviliable ISM band.
6.2.1 Applicator proximity
Applicators can be either as non-contact (in free space), or in direct contact to patient
skin. The induced EM energy is assessed with accordance to the distance of the an-
tenna source to the biological tissue, as shown in Figure 6.1. In the far field-region, the
radiating source is approximately 2D2/λ away from the biological tissue in free space.
The incident field is characterised as a plane wave in a cosine distribution, where the
electric and magnetic field are in phase with each other radiated. Moreover, the radi-
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Figure 6.1: Antenna field distribution at different transition zones.
ated energy decreases with the square of the propagating distance. When operating in
free space, the applicator physical dimension becomes larger as it is matched to the
intrinsic impedance (η) of the medium at 120pi. This is derived from the permittivity
and permeability of free space. In therapeutic applications, far-field approach is limited
because of the radiation leakage to the surrounding.
In the reactive near-field the electric and magnetic field are quadrature out of phase
and thee corresponding maximum amplitude varies with respect to the distance in the
medium. Therefore the wave impedance is no longer the same as intrinsic impedance,
and hence also changes from point to point in the tissue. In this configuration it is
expected to observe a standing wave between the applicator and the tissue, due to
operation at high frequency spectrum in a multi-layered dielectric tissue [111]. The
interaction of incident EM energy to the high permittivity of skin surface at the near-
field region is expected to be weaker. Consequently, the deposited EM energy into
biological tissue is a function of antenna current distribution, composition of tissue and
the spacing of source to the skin surface. Applicators in close proximity (near-field /
Fresnel zone) are commonly used in hyperthermia [25, 26, 60, 14] Direct contact ap-
plicators are separated from the tissue by a coupling medium layer such as water bolus.
A close proximity applicator with appropriate design can easily couple the EM energy
into organic medium with uniform field pattern and reduced stray radiation in compari-
son to non-direct contact applicators [112, 1] Additionally, with high permittivity tissue
loading, the induced warming is localised as applicator size is miniaturised.
In this thesis, the radiated field is mostly considered as in near field region and for
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finite size applicator, the field is in the form of spherical waves. For hybrid system,
the optical probes can only operate in contact to the skin along with the active cooling.
Consequently, A direct contact applicator design was adopted with the use of super-
strate layer to introduce some spacing between the radiator and the tissue. In the close
proximity, the antenna operates in near-field and/or Fresnel regions depending on the
chosen superstrate thickness. This layer is of importance in the EM absorption, heating
and cooling mechanism.
The reactive region is an ideal case for the direct contact applicator, defined as the
region directly surrounding the applicator, where the reactive power density is signif-
icant in this region making the EM field sensitive to absorption. As for the radiating
near field also known as Fresnel, is the case considered for the non-direct contact appli-
cators, it can be seen at this region the field is semi radiative with peak power density
at centre which can cause surface heating when interacted with skin [1].
6.2.2 Coupling layer
The impedance of the applicator can be matched to the biological tissue when it is in
direct contact (with appropriate loading) for enhanced EM coupling [113]. In previous
therapeutic studies, direct contact microwave applicators are often spaced by water bo-
lus for skin cooling [114, 31, 91, 115]. Literature also shows wave-guide based applica-
tor have a bolus bag filled within the aperture to effectively improve impedance match
and reduce stray radiation[31, 115]. A skin dielectric equivalent gel was previously
investigated to improve impedance matching to the human skin and heating uniformity
[113]. However, this was achieved at operating frequency under 400 MHz. An alterna-
tive approach was the use of a substrate material suspended over the radiating element,
this is known as a superstrate layer. The first analysis of microstrip antenna covered
with a dielectric medium was investigated back in the 1980, where numerical solution
for effective dielectric constant of two medium was investigated[116]. The primary use
was as a protecting layer of the radiating element. The superstrate material was then
further investigated in term of the operating frequency as a function of thickness and in-
put impedance [117]. The superstrate layer was also known as the " low loss dielectric
cover layer", was initially investigated on a rectangular microstrip radiator in a local
hyperthermia [118]. The dielectric medium was used to improve impedance matching
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and the radiated E-field pattern. In wireless medical telemetry, superstrate layer was
used to optimise the antenna surface area [119]. Superstrate was also discovered to
increase the directivity/Gain and bandwidth of the antenna [120, 121]. In our study,
we focused on a superstrate layer to isolate the antenna element from the tissue. The
superstrate layer used was equivalent to substrate, a low loss dielectric medium. The
study focus on applicator matching with appropriate superstrate thickness, for optimal
heating and cooling pattern.
6.3 Microstrip Antenna Theory
The interests in microstrip antennas are continuously increasing in every day appli-
cations, the attractiveness is led by its low profile, easy to fabricate and low cost.
Printed antennas can be in the form basic shapes to more complex shapes, rectangu-
lar patch are most frequently used in variety of application, due to its simplicity in
design and impedance matching. Microstrip radiators in medical application were re-
ported in 1979 and 1980 [122, 123]. Antenna comes in many different shapes and
applications, such as a spiral [124],an annular ring for hyperthermia [123], slotted
patch antenna for microwave breast imaging [125] and dual concentric conductor in
an array approach[126, 14]. The field distribution impact of contact flexible microstrip
applicators on curved biological tissue have been recently investigated for superficial
hyperthermia [127].
A microstrip antenna consists of a conducting radiating element on a substrate
material with an optimal dielectric constant r, thickness H , and a ground plane at the
bottom side. Figure6.2 shows the schematic of a standard rectangular patch antenna.
Generally, in order for the antenna operates in the fundamental TM01(Transverse Mag-
netic) mode, the patch length L must be at approximately λg/2. Where λg is the guided
wavelength, and can be calculated from λg = λ0/
√
eff . This estimation is required
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Figure 6.2: Microstrip patch antenna theory.
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when the phase velocity in air and dielectric medium are different. The effective di-
electric constant eff is a parameter which considers the propagation of fringing field
between dielectric substrate and air as given in the equation. Typically this value is
lower than r of substrate, due to the spread of wave in air (r = 1). The effective
dielectric constant estimation is a function of r , substrate height H and patch width
W as shown in Equation 6.3.1[128].
εreff =
εr + 1
2
+
εr − 1
2
[1 + 12
H
W
]−
1
2 (6.3.1)
The electric field along the width of the patch is maximum, where the current is mini-
mum due to the high impedance at the ends. Figure 6.2 shows the normal components
of the fringing field are out of phase at the two edges. This caused by the λg/2 patch
length L which causes the field to cancel out at the centre. In contrast, the excited
tangential field between patch edge and ground plane are in phase and therefore field
is radiated normal to the surface of the patch. It can be observed, the fringing field
extends further than the physical patch length L. For improved estimation the effective
length can be estimated from the given Equation 6.3.2.
Leff = L+ 2∆L (6.3.2)
Where L is the physical patch length calculated from Equation 6.3.3 and ∆L is the ex-
tended fringing field length which is a function of eff , W and H as shown in Equation
6.3.4[129, 130].
L =
c
2fo
√
εreff
(6.3.3)
∆L = 0.412h
(εreff + 0.3)(
W
H
+ 0.264)
(εreff − 0.258)(WH + 0.8)
(6.3.4)
The width of the patch W can be estimated with the following expression
W =
c
2fo
√
(εr+1)
2
(6.3.5)
Microstrip patch antennas may have various feeding techniques to couple the EM
energy in or out, such as Inset feed, pin fed and aperture coupled [14, 125, 131]. The
inset feed a transmission line is required at the radiating surface which is not suitable
for this particular application due the near field operation region where the transmission
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line will disturb the field propagation from the radiating element. A common feeding
technique is probe feed shown in Figure 6.2, where a coaxial SMA connector is con-
nected from the ground with isolated 50Ω pin through the substrate and soldered to the
patch element surface. Consequently, mitigating the fringing transmission line to the
superficial tissue [114]. This approach was adopted for the Hybrid probe. The feed
position location can be calculated from radiation conductance, further detail found in
literature [132]. The aperture feeding method compromises of stacked approach where
the transmission line is shielded by conducting plane with gap to transmit energy to
the patch, This method could prove to be more useful than probe fed microstrip, due
to the coaxial soldering at the surface of patch which may cause air gap between an-
tenna and phantom. The design of applicator operating in close proximity to the tissue
relies heavily on numerical calculations, by studying the E-field and SAR distribution.
With microstrip antenna theory it is possible to estimate the optimal geometry for the
desired frequency in free space. Therefore the applicators were designed without tissue
loading (in free space). The is because it is impossible to estimate the eff of hetero-
geneous biological tissue with a dielectric substrate. The applicator is then optimised
appropriately with EM simulation when placed on layered tissue model.
6.4 Modelling and Simulation
6.4.1 Numerical Study
Measuring the EM energy inside a living biological tissue is a major challenge for RF
engineer working in the medical sector. The operation of newly developed RF devices
ranging from daily uses such as mobile phones to therapeutic applicators, they all must
comply with the regulated dosage. Consequently, RF engineers are forced to rely on
computer simulation for design and development of new devices before commencing to
the ex-vivo and eventual in-vivo trials for validations. The method of acquiring the de-
posited EM energy can be achieved analytically or numerically. Analytical techniques
are achieved by solving Maxwell’s equation for simplified geometry such as the ho-
mogeneous canonical models. The rapid development of computing capability, meant
the numerical dosimetry is the dominant method in calculating RF dosimetry in either
simple geometry to vast complex inhomogeneous structures. The numerical methods
allow for near-field studies of an external non-plane wave source [133]. There are few
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numerical techniques have been employed over the last several years in order to solve
bio-electromagnetic problems. Presently, the finite difference time domain (FDTD) is
the most common computer simulation technique, which is based on partial differential
form of time dependent Maxwell’s equations [134–136]. The implementation began by
dividing the simulation problem into cubes. This is known as the Yee space cell or the
grid mesh as we know it today [137]. The field components are approximated at the
centre of each cell at a given time. Alternative technique that been used is based on
finite-element method (FEM), which analyses the field components at the nodes of the
cell [138]. the final technique which was considered during the development of the hy-
brid applicator, based on finite integral technique (FIT) used with Computer Simulation
Technology (CST) microwave studio package[139].
FIT was initially proposed by Wieland in 1977 as frequency-domain solver, by
solving Maxwell’s equations in the integral form [140] However, it has expanded and
now is capable of solving in time and frequency domains among with other techniques.
FIT provides a spatial discretisation scheme, where the domain (3D model) is divided
up into grid (Hexahedral mesh), and field components are solved within each cell. FIT
strength lies with in meshing of three-dimensional models and staircase approximation
for curved structures [140]. Literature study shows both FDTD, and FIT have been
employed in numerous studies of microwave dosimetry on biological tissue [141–144].
The availability of CST studio in the Electronic Engineering department, meant it was
unnecessary to investigate into FDTD method unless additional verification is needed in
the future development. Consequently, CST was used to develop the hybrid applicator
from dosimetry calculations to transient thermal solution of the combination of induced
microwave and skin cooling mechanism.
6.4.2 Simulation Model
In the simulation study, the characteristics of EM deposition in biological tissue have
been previously investigated with a simple homogeneous and heterogeneous models
[145, 146]. Canonical models (multi-layered) are customary approach when time and
computational resources are restricted. It can be modelled in a different form of ge-
ometry, such as the basic superimposed model [147], sphere for simulating the human
head[148, 149] and cylindrical for curved anatomical locations[150]. Planar three lay-
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ered model was proposed with the use of essential tissue composition of skin, fat and
muscle [147, 151]. This approach was taken into account in the design and simulation
study of the hybrid applicator. This was justified by the computational efficiency, and
to be compatible for comparison with the experimental three layered phantom. Recent
studies show greater interest in anatomical models for realistic analysis on deposited
EM energy [142]. Current anatomical models of the individual body, are based on a
voxel (cubic staircase) with a predefined resolution and dielectric properties [65]. The
models were originally obtained from either CT or MRI scans, which both are compli-
cated problems to solve. In this study, simulation with anatomical model was used for
verification of the final design before fabrication. The used voxel model was provided
by CST Microwave Studio with a resolution of 2.08 × 2.08 × 2.00 mm3. To reduce
computational time, only the human calf was extracted, neglecting the remaining of the
biological model.
The developed applicator is designed using the combination of microwave and
thermal co-simulation. The applicator was first adapted from the basic antenna theory,
then transformed into a parametric digital model for optimisation and further study. The
applicator model is combined with a three-layered tissue model consisting of skin, fat
and muscle with the following thickness of 1.0, 7.0 and 50 mm respectively. The thick-
ness of muscle is limited to 50 mm which has sufficient losses and depth to absorb all
the energy, therefore there is no reflection from the simulation boundary. The combined
model undergoes a series of configurations, simulation and analysis as shown in Figure
6.3. The early stage configuration involves mesh optimisation and boundary conditions.
In the CST microwave studio, a Hexahedrial mesh is deployed and refined based on the
upper operating frequency which was 5.0 GHz. The frequency limit is twice larger than
the desired centre frequency, this to ensure adequate meshing employed. Furthermore,
a predefined local mesh size was set manually to ensure sufficient mesh lines inside the
thin layers of skin. The boundary condition is essential in obtaining the desired reading
for the proposed application. In microwave simulation, the boundary condition is set to
open boundary in all directions except for at the negative z-axis, where the applicator
is interfaced to the skin surface. During microwave simulation the scattering parameter
and SAR is evaluated at first, and enhanced accordingly before proceeding to thermal
simulation.
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Figure 6.3: EM and thermal simulation procedure for applicator designs.
Thermal boundary condition is also considered and applied to the model appropri-
ately. Adibatic condition is applied along the x-axis, y-axis and z-max as shown in Fig-
ure 6.4a. This condition ensures no heat flows past the boundary, hence the temperature
distribution is not constant. This is typically used for multi-layered tissue models with
biological heat. Open condition is applied to z-min, to emulate free space where surface
convection can be used. For experimental phantom validation, the thermal boundary is
changed to open space for all directions to match the phantom condition exposed air.
Surface convection is applied, where the convection rate is the standard passive convec-
tion of 7 W/m2. Figure 6.4b shows the temperature of the three-layered tissue phantom
with and without applied surface convection. Thermal boundary condition cannot re-
solve skin convection. Consequently, the skin and deep tissue temperature are identical
to approximate 37 ◦C. The model with skin convection, has a skin temperature of about
34 ◦C. In contrast, when the applicator is placed on the tissue with passive cooling, the
skin temperature drops to 32 ◦C and 29.5 ◦C with added heat-sink on applicator. The
final adjustment would be the excitation signal and microwave power scaling. Con-
tinuous and pulsed excitation signals have been investigated to emulate thermostatic
cooling and heating. The power levels are also adjusted accordingly along with the
active cooling, further discussed in Section 6.6.3.
6.4.3 EM Simulation Procedure
The simulation package was used to establish general understanding of a standard mi-
crostrip patch antenna on the modelled three-layered phantom. The basic simulation
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Figure 6.4: Tissue model with appropriate boundary conditions. (a) three-dimensional model
of applicator and phantom, (b) the simulated tissue temperature as a function of surface
convection
model is shown in Figure 6.5. The simple antenna geometry is presented in Figure 6.5a,
and it is suspended at a proximity of Sa above the three layered phantom as shown in
Figure 6.5b The biological model uses the corresponding electric and thermal proper-
ties for each layer. This study investigates the antenna performance with respect to Sa.
This is an essential parameter for early stage design of the hybrid applicator. The mod-
elled tissue thickness is currently based on 1.0 mm skin, 7.0 mm fat layer and 40.0 mm
muscle. However, the original model thickness of 2.0 mm skin and 10.0 mm fat layer
was used previously during the development of majority of applicators. It was later dis-
covered the values were over estimated for a calf/arm tissue. The modelled rectangular
microstrip antenna was calculated by the given theory to estimate the length (lp) and
the width of the patch (wp). The design is then optimised accordingly to operate with
the phantom and the proximity parametric study. The substrate was based on Rogers
5880, (r = 2.2) and operating frequency was maintained at 2.45 GHz. The simulated
result is evaluated in term SAR at different antenna spacing as demonstrated in Fig-
ure 6.6. The results is evaluated horizontally, where the first column corresponds to
the yz-plane cut (a,b,c,d), and the second column is the xz-plane cut (e,f,g,h). Results
evaluated vertically from the top to bottom. Each row corresponds to the antenna spac-
ing (Sa) in the following order, 5.0 mm and 2.0 mm in free space, direct contact and
1.58 mm of superstate.
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Figure 6.5: General rectangular microstrip patch antenna model. (a) simple antenna
geometry,(b) antenna placement on a modelled phantom
From the simulated SAR plots, it can be observed the absorbed field in the tissue
changes its performance as a function of spacing. In the scenario of Sa = 3.0 mm Fig-
ure 6.6(a and e) the antenna is spaced further away. Therefore, the electrical length of
the antenna becomes longer to maintain the same operating frequency. Consequently,
larger area is radiated at the surface of the skin. This is undesirable effect and will not
be considered. Moreover, the field pattern in the yz-plane is not identical to xz-plane,
caused by the radiating electric field at the antenna edges which can be only seen across
the yz-plane in this current geometry. This can be described with respect to antenna
orientation as the E-plane for yz, while xz is the H-plane. The radiating edges become
more apparent when the antenna proximity is closer to the phantom, hence the reacting
near-field region. Figure 6.6(b and f) have a reduced area absorption when the separa-
tion is 2.0 mm, where as in the direct contact, the SAR is significantly larger at excited
edges as illustrated in Figure 6.6(c and g). The final approach was to load the antenna
by adding a superstrate later, which is an equivalent dielectric material as the substrate,
at thickness of 1.58 mm. The SAR achieved was localised in comparison to the other
studies as presented in Figure 6.6(d and h).
Alternative evaluation of the SAR data by recording the maximum peak values
across tissue depth for each corresponding plane. The optimal measurement is con-
sidered by the muscle to skin ratio, were the skin is at depth of 1.0 mm, and muscle
is anywhere between 8.0 - 50 mm. Figure 6.7a is the peak SAR comparison across
the yz-plane The result clearly shows the direct contact approach has a peak SAR at
the skin surface is more than twice larger to other spatial arrangements. The effect is
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Figure 6.6: SAR distribution of simulated patch antenna at different separations between the
applicator and skin. (a, e) 5.0 mm, (b, f) 2.0 mm, (c, g) direct contact, (d, h) 1.58 mm thickness
superstrate (r = 2.2)
undesirable, particularly where only 13.7% of the EM energy is absorbed in the mus-
cle. Antenna spaced by superstrate is the most efficient, when considering the peak
across both planes. In contrast to the antenna suspended in free space, the fat absorp-
tion is greater, and it further increases as the proximity to tissue gets larger. The result
observed are from the EM field absorption perspective, thermal study will also be ben-
eficial in providing different insight from heat transfer point of view.
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Figure 6.7: Peak SAR at different proximity across (a) yz-plane, (b) xz-plane
6.4.4 Thermal Simulation Procedure
The corresponding thermal simulation of antenna proximity is demonstrated in Figure
6.8. The result was based on transient thermal simulation at 5-minutes of microwave
exposure, using biological heat parameters and a 5 watts of microwave power. The ther-
mal pattern are equivalent to the observed SAR distribution. It can be seen in Figure
6.8(a,e,b,f)the elevated temperature covers larger area under the antenna with muscle
warming at about 42 ◦C. The direct contact approach shows large peak temperature at
skin and almost minimal muscle temperature change in the muscle. Figure 6.8 is the
simulation result using superstrate, were temperatures at the skin surface is lower in
contrast to other studies. The heating pattern is localised due to the increase in permit-
tivity of the superstrate, producing a shorter electrical length. The peak temperatures
are recorded and shown in Figure 6.9. The overall peak temperature is 50 ◦C at the
skin surface in direct contact approach, which is completely unsafe design. The other
parametric study shows as the proximity in free space increases, the temperature rises
in the exposed area, particularly the skin surface at 43 ◦C. In contrast, the applicator
with superstrate decrease in temperature peaking at 40.5 ◦C at the skin-fat interface and
in the muscle. The advantage of the superstrate appears clearly in the xz-plane shown
in Figure 6.9b, where the surface temperature is just about 37.5 ◦C in contrast to 2.0
mm free space of 40 ◦C. That is 2.5 ◦C lower, while the muscle temperatures are nearly
identical to 40.5-41 ◦C.
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Figure 6.8: Thermal distribution of simulated patch antenna after 5 minute of microwave
exposure at different separations between the applicator and skin. (a, e) 5.0 mm, (b, f) 2.0 mm,
(c, g) direct contact, (d, h) 1.58 mm thickness superstrate (r = 2.2)
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Figure 6.9: Peak temperature at different proximity across. (a) yz-plane, (b) xz-plane
6.5 Applicator I
The previous sections introduced the foundation of applicator design from simulation
conditions to antenna configurations. The study clearly indicates that a superstrate layer
enables localised warming and reduced superficial heat on the skin layer in the mean
of passive heat transfer. The other added benefit of the superstrate is the size reduction
and provides electrical isolation between the radiating element and tissue. Based on
those early studies, Applicator I was proposed with integration of optical sensors that
provided by the Hamamtsu NIRO-103 oxygenation monitor. Figure 6.10 is the mod-
eled and developed applicator, the design is based on the previous microstrip antenna
study with use of Rogere 5880 for substrate and superstrate (r = 2.2).The substrate
and superstrate thickness are both 1.58 mm (λo/100), where λ0 is the wavelength in
free space at 2.45 GHz. Figure 6.10a shows the radiating element geometry from an
inherited rectangular patch antenna with patch length is lp and width is wp. The optical
emitter and detector spacing is ls and diameter is ds, and the probes are inserted through
the applicator to make contact to the tissue as presented in Figure 6.10a,b). The full
antenna dimensions and parameters are given in Table C.1.
The applicator was modelled with the same configuration previously mentioned
using a planar three layered phantom, with aim to operate at 2.45 GHz. The perfor-
mance of the applicator is studied by its current distribution, particularly contribution
of the integrated probes. The probes are modelled as common plastic with r = 3.0.
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Figure 6.10: Modelled applicator I. (a) patch antenna parameters, (b) optical probes geometry,
(c) applicator surface
(a) (b)
Figure 6.11: Applicator I surface current distribution. (a) phase=0, (b) phase=180
The current distribution in Figure 6.11a shows the vectors flow towards the positive y-
axis at phase 0 and negative y-axis during phase of 180. This clearly indicates the linear
operation of antenna along the length lp. The current distributes along a longer path at
the lower centre of the patch, caused by the circular emitter cut-out. This essentially
increases the electrical length of the patch, which leads to lowering the operating fre-
quency and consequently, simple applicator minimisation was achieved. The applicator
has been parametrised for further study in the following sections.
6.5.1 Integrated Optical Sensors Study
The optodes spacing (ls) and the emitter diameter (ds) have been further investigated
with a parametric study. The desired optodes separation is 40 mm. However differ-
ent lengths were studied to assess the applicator response. Figure 6.12a shows the
s-parameter study of the (ls), the results indicate the frequency shifts as the separation
6.5. APPLICATOR I 113
2.3 2.4 2.5 2.6 2.7
−40
−30
−20
−10
0
Frequency (GHz)
|S1
1|, 
dB
 
 
38 mm
40 mm
42 mm
(a)
2.4 2.45 2.5 2.55 2.6
−40
−30
−20
−10
0
Frequency (GHz)
|S1
1|, 
dB
 
 
7.0 mm
8.0 mm
9.0 mm
(b)
Figure 6.12: Simulated |S11| for parametric study on. (a) optodes separation, (b) optical
emitter diameter
increase which is explained by the decrease in electrical length as the emitter pertur-
bation is moving away from the radiating element. The optical emitter diameter had a
similar effect during the study shown in Figure 6.12b. The increase in emitter diameter
meant, there is a decrease in frequency, caused by the circulating current around the
emitter perturbation.
6.5.2 Superstrate Analysis
Previously, applicator proximity was studied with free space and compared with super-
strate performance. In this study, the superstrate was investigated at thicknesses that are
approximately equal to that of commercial substrate. The implication of the superstrate
to the applicator design is investigated by analysing the scattering parameter, SAR and
thermal distribution. The simulated |S11| is presented in Figure 6.13, the result clearly
shows an increase shift of in resonance frequency with the thicker superstrate. The in-
crease in superstrate thickness, produces a larger spacing between the antenna element
and the high dielectric tissue properties (lower r). Consequently the radiating fringing
field is engaged in the lower dielectric medium of the superstrate; which leads to shift
in operating frequency. Superstrate has a relatively low dielectric constant r = 2.2 in
comparison to a skin layer which is r = 37. For a greater spacing, larger physical an-
tenna length is required to maintain same operating frequency of the original 1.6 mm.
Thinner superstrate thickness was also investigated. However, the performances are
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Figure 6.13: Simulated |S11| for superstrate parametric study.
undesirable, as it works much like the direct contact study discussed in sections 6.4.3
and 6.4.4.
The study of superstrate thickness, is observed in the form of SAR shown in Figure
6.14. The vertical orientation from top to bottom corresponds to the increase in super-
strate thickness, while horizontally from left to right corresponds to yz-plane and xz-
plane. The result leads to a similar conclusion as to the previous study interfacing free
space. The increased thickness of the superstrate leads to higher deposition of energy
in the centre of the skin and muscle tissue, while the peak absorption is in the muscle.
Decrease in thickness causes the deposited energy at the centre of the superficial layer
to spread apart, resulted by the confined fringing field directly under the radiating edges
of the applicator (reactive near-field). The results are further evaluated with the peak
SAR plots along the tissue, shown in Figure 6.15. The 1.6 mm loaded superstrate has a
maximum SAR peak in the superficial layer at about 23 W/kg, and 21 W/kg in muscle.
In contrast to 5.0 mm thickness, the maximum superficial SAR peak is about 16 W/kg
and 25 W/kg in the muscle. Based on this study, the ideal superstrate thickness is above
3.2 mm, were the applicator is operating in radiative near-field region. Consequently,
surface peak absorption is minimised, and a uniform EM distribution is attained.
The study of the superstrate is expended to transient thermal distribution of 5-
minute microwave exposure at 5 watts RMS power. The simulation result is presented
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Figure 6.14: SAR distribution at of simulated patch antenna at different superstrate thickness.
(a,b,c) yz-plane at 1.6, 3.2, 5.0 mm, (d,e,f) xz-plane at 1.6, 3.2, 5.0 mm
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Figure 6.15: Peak SAR at different superstrate thickness. (a) across yz-plane, (b) across
xz-plane
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in Figure 6.16. Similar characteristics can be observed with SAR distribution, at 1.6
mm thickness the peak temperature is at the skin-fat interface. The increase in spac-
ing, causes a uniform superficial heating distribution at the centre of the phantomn in
a spherical form, which can be observed in the yz and xz planes. Thin superstrate have
lower superficial heating in the non-radiating edges xz-plane, as the maximum tempera-
ture is observed in the yz-plane. The peak temperatures of this study presented in Figure
6.17b. The maximum temperature at the skin is 42.6 ◦C with 1.6 mm superstrate, other
recorded temperatures are 40, 39 ◦C for thickness of 3.2 mm and 5.0 mm respectively.
In contrast, the temperature in the muscle at depth of 12 mm is approximately 41.5
◦C, 42.4 ◦C and 42.6 ◦C in the ascending manor of superstrate thickness. This clearly
shows the 1.6 mm thick superstrate have muscle temperature of approximately 1 ◦C
lower than skin temperature. The peak temperature profile at the non-radiating edges
x-plane in Figure 6.17b, shows the 5.0 mm superstrate have an identical temperature
profile in both planes. Transient thermal graph of 1.6 mm superstrate is shown in Figure
Figure 6.16: Thermal distribution at of simulated patch antenna at different superstrate
thickness. (a,b,c) yz-plane at 1.6, 3.2, 5.0 mm, (d,e,f) xz-plane at 1.6, 3.2, 5.0 mm
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6.18. It can be observed in Figure 6.18a the elevation of temperature at the skin-fat (1.0
mm in z-direction) interface over exposure duration. The point 0.0 mm corresponds to
the centre, 17.5 and 17.5 mm are the points away from the centre in the y-direction un-
der the excited edges, where the peak temperatures are expected. It can be observed the
temperature of two radiating edges are 5-7 ◦C higher than at the centre. Figure 6.18b
are the transient thermal analysis in the centre of tissue along the depth of (z-axis) at
0.0, 1.0, 8.0, and 10.0 mm. The depth of 8.0 mm and over corresponds to elevation
in muscle temperature, where it is approximately 5 ◦C higher than skin at the centre.
However, it is 2 ◦C lower when compared to the superficial hot spots. The transient pat-
tern over 5-minutes have not reached a steady state. Thus further continuation may lead
to high-temperature increase approaching to hyperthermia. Consequently, the duration
is restricted to 5-minutes only.
The study shows 5.0 mm superstrate is the most optimum in terms of distribution
uniformity, and reduced superficial heating. The downside is 5.0 mm is not an available
thickness and stacking multiple of 1.575 may lead to undesirable air pockets in between
each layer. The objective of task 1 was to design an applicator with integrated optical
probes to warm and measure tissue response as a preliminary study of the combined
devices. For that purpose, the 1.575 mm substrate was readily available and inevitably
applicator was developed based on that substrate/superstrate thickness.
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Figure 6.17: Peak temperature at different superstrate thickness after 5-minutes of exposure.
(a) across yz-plane, (b) across xz-plane
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Figure 6.18: Transient thermal simulation at fixed points,(a) along y-axis, with z=1mm,
x=0mm,(b) along z-axis, with y=0 and x=0
6.5.3 Fat Thickness
The anatomical composition of biological tissue can vary from position to another and
from one subject to another. This is a common problem RF engineer face during de-
sign of applicators or implanted communication devices, as the change of tissue thick-
ness had an impact to the impedance and radiation pattern of the device. This study
looked at the effect of changing fat thickness at 4.0, 7.0, and 10 mm, these are the
common thickness in human body. The change in resonant frequency corresponding to
the changes in fat thickness can be observed in the simulated |S11|. It can be observed
from Figure 6.19, the increase in fat thickness leads to a fractional frequency shift to
lower frequency. The dielectric constant (r) of fat at 2.45 GHz was taken as 4.5. When
thickness is increased the radiating fringing field extends longer before being reflected
by the high dielectric of muscle. This further extension lowers the resonance frequency.
The operating bandwidth of the applicator at -10 dB is 85 MHz, which is sufficient to
cover the frequency shift of approximately 20 MHz.
The impact of fat thickness was studied and represented in SAR distribution across
both antenna planes as shown in Figure 6.20. The thickness increases vertically from
each sub-plot. The results clearly show the fat thickness has an impact on the de-
posited EM energy. The maximum SAR observed is deposited in the muscle, while the
absorbed power in the skin-fat interface is minimum. The result illustrates the SAR dis-
tribution between the muscle, and skin is a function of fat thickness for an incident EM
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energy. Larger intermediate layer introduces a standing wave in the layer as the thick-
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Figure 6.19: Simulated |S11| of applicator at different fat thickness.
ness approaches λo/4, consequently introducing a superficial hot spot. This common
limitation of microwave applicators operating at 2.45 GHz, which have been previously
investigated with a plane-wave [152]. Furthermore, SAR in the muscle varies substan-
tially with the fat thickness, which becomes a challenge to estimate the appropriate
level of exposure with patients at different fat thickness. This effect can only be miti-
gated by operating at lower frequency such as 900 MHz or 430 MHz. The first is not
licensed in the UK, while the latter is undesirable due to larger applicator and heating
pattern. Consequently, the most convenient solution is by suppressing the skin heating
with cooling.
The peak absorption rate of tissue in the yz-plane and the xz-plane is illustrated in
Figure 6.21. It can be seen the increase in fat thickness at the yz-plane promotes to an
increase of skin absorption and reduction in muscle absorption. This effectively can be
translated it into heat pattern, where a superficial hotspot is dominant in a subject with
thicker fat. At 10 mm, the peak SAR at fat layer is 25 W/kg, where as in the muscle
at 16 mm depth, it is 15.1 W/kg. In contrast, thinner fat thickness have higher peak
SAR at the same depth of 16 mm. This clearly indicates, the fat thickness have a large
factor on the superficial heating pattern and the penetration depth. Figure 6.21b shows
the superficial layer have lower SAR in the xz-plane when the fat thickness is higher.
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Figure 6.20: SAR distribution at of simulated patch antenna at different fat thickness. (a,b,c)
yz-plane at 4.0, 7.0, 10 mm, (d,e,f) xz-plane at 4.0, 7.0, 10 mm
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Figure 6.21: Peak SAR at different fat thickness. (a) across yz-plane, (b) across xz-plane
This is caused by the spread of the fringing field at the other plane cut (radiating edge)
as seen in the yz-plane.
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6.5.4 Skin Thickness
Having established the contribution of fat thickness in the previous study, the following
investigation is based on skin thickness. This was implemented by varying the thick-
ness from 0.5 mm to 2.0 mm in four equal steps. The current default study is based on
1.0 mm skin thickness. However, the actual design study was based on 2.0 mm skin
thickness. The |S11| simulation in Figure 6.22 shows a frequency shift with respect
to the skin thickness. As the thickness increases the resonant frequency detune down
from 2.53 GHz at 0.5 mm thickness to 2.46 GHz with 2.0 mm skin. The reduction in
frequency as a function of thickness is explained by the proximity of antenna to the
skin, and the extension of fringing field in a high loaded dielectric of skin layer. The
centre frequency shift is about 2.8%, where as the bandwidth of the applicator is about
3.6% at -10 dB. This is just about sufficient bandwidth to adapt for the frequency shift
arises from skin or fat thickness.
The SAR study illustrated in Figure 6.23 shows the contribution of skin thickness
to the SAR distribution. The yz-plane in figures 6.24(a,b,c,d), it can be observed a
marginal increase in superficial absorption with the extended skin thickness, where as
the muscle absorption has decreased. The xz-plane presented in Figure 6.23(e,f,g,h)
shows the effective absorption area has decreased with the increasing skin thickness.
The logical answer is the contribution of higher permitivity of skin (r = 38) which
2.3 2.4 2.5 2.6 2.7
−40
−30
−20
−10
0
Frequency (GHz)
|S1
1|, 
dB
 
 
0.5 mm
1.0 mm
1.5 mm
2.0 mm
Figure 6.22: Simulated |S11| for applicator at various skin thickness.
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confines the field in a localised area. Further details are presented in Figure 6.24b,
demonstrating the peak SAR value in the vertical and horizontal plane. At 0.5 mm skin
thickness, the peak SAR in the muscle is about 5 W/kg greater than the skin absorption.
Meanwhile increasing thickness to 1.0 mm or higher have almost no further impact
on the peak skin absorption. However, notable decrease in muscle can be observed.
The peak SAR in the horizontal plane in Figure 6.24b clearly shows the absorption
dimension for 0.5 mm skin thickness is larger in the fat-muscle area.
Figure 6.23: SAR distribution at of simulated patch antenna at different skin thickness.
(a,b,c,d) across yz-plane at 0.5, 1.0, 1.5 and 2.0 mm respectively, (e,f,g,h) across xz-plane at
0.5, 1.0, 1.5 and 2.0 mm respectively
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Figure 6.24: Peak SAR at different skin thickness. (a) across yz-plane, (b) across xz-plane
6.5.5 Anatomical Model
Study with a male anatomical model (Voxel) have been conducted for verification and
applicator optimisation. The model was localised to only single calf with the placed
applicator, which essentially reduce computational time. The numerical configuration
shown in Figure 6.25. In contrast to the three layered model, it can be seen the added
complexity of model curvature, inconsistency of tissue thickness and also the addition
of bone. The tissue uses the appropriate electrical and thermal properties. The mi-
crowave simulation was carried out, and the SAR distribution is shown in Figure 6.26.
The results illustrate identical features to the planar model in 6.16. The peak SAR in
the anatomical model is 5 W/kg higher than the layered model. This is caused by the
increase of skin and fat thickness, which varies along the model. The average thickness
of the anatomical calf was 1.5 and 10.0 mm for skin and fat thickness respectively. Fig-
ure 6.26 shows the xz-plane of the SAR distribution. It can be seen the non symmetrical
EM absorption in tissue, caused by the lack of consistency in the tissue thickness and
possible reflection from the bone.
The 5-minute thermal distribution was simulated and shown in Figure 6.27. The
peak temperature is in the skin-fat interface approximately 44 ◦C, which is 2.0 ◦C
higher than the layered model. The muscle temperature was elevated from 3.0 ◦C
to 40.0 ◦C. Despite the crucial difference between the two models; the layered model
is more optimal as the corresponding tissue thickness was measured with ultrasound
imaging, discussed further in Chapter 8.
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Figure 6.25: Anatomical leg model used for evaluations study.
Figure 6.26: Simulated SAR distribution with anatomical model. (a)yz-plane cut, (b) xz-plane
cut
Figure 6.27: Simulated thermal distribution with anatomical model. (a) across yz-plane cut, (b)
across xz-plane cut
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6.5.6 Fabrication and Validation
The developed applicator and the ex-vivo setup is illustrated in Figure 6.28. This was
before the implementation of the microwave system. Applicator I experiments was
achieved with external off-the-shelf microwave generator and power meter. The setup
in Figure 6.28b was for chicken breast temperature monitoring with the inserted ther-
mocouple. The initial study was the antenna design, by evaluating performance in clear
air and on biological tissue. The measurement is illustrated in Figure 6.29, where the
return loss (|S11|) in free space shows higher operating frequency at about 2.74 GHz,
as the intended working frequency was 2.45 GHz. This was expected when the an-
tenna operates in air, as it was optimised when loaded by the high dielectric properties
of biological tissue. The purpose of in air measurement was to examine the perfor-
mance of the applicator to the simulation without the liability of tissue composition.
Consequently, the antenna impedance is matched to the tissue, operating in free space
result in high return loss at about -7.9 dB. The measured data also indicates a 50 MHz
increase in operating frequency from the numerical study.
The measured |S11| of the applicator placed on human calf is illustrated in Figure
6.30. The measurement was obtained from two human subjects prior to in-vivo study.
It can be seen the resonance frequency is -24.0 dB at 2.55 GHz, that is discrepancy of
3.9% (100 MHz) from the intended operating frequency at 2.45 GHz. The measured
-10.0 dB bandwidth was about 100 MHz, which is also 3.9%. Therefore, the bandwidth
Optical emitter
Optical detectors
Foam housing
Chicken 
breast
Tempreature
monitor
Microwave
source &
amplifier
Power monitor
(a) (b)
Figure 6.28: Applicator development. (a) fabricated applicator with integrated optical probes,
(b) deployed system for ex-vivo trial
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Figure 6.29: Applicator I measured |S11| on human subjects.
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Figure 6.30: Applicator I measured |S11| on human subjects.
is not sufficient to cover the ISM operating range. The large deviation was caused by the
numerous factors, including the modelled tissue thickness, electrical properties, fabri-
cation errors, including introduced gaps with the stacked superstrate/substrate. Appli-
cator I, II & CP applicators where developed based on the assumption of 2.0 mm skin
and 10.0 mm fat thickness (original model). This was later discovered not accurate
representation of a calf tissue, hence the change in the numerical model to 1.0 mm skin
and 7.0 mm fat thickness (current model). The current model is 40 MHz lower than
measurement, which coincide with the shift in free space result.
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Figure 6.31: Measured transient temperature inside breast phantom.
The ex-vivo trial was implemented on a chicken breast, which is a single layer
equivalent to a muscle. During the trial the applicator was placed on the surface of the
chicken breast . A thermocouple temperature probe was inserted from the bottom to a
fixed position at approximately 5.0 mm under the surface, where the temperature was
recorded over the 5-minute of microwave exposure. The measure data was compared
with the simulation result at equivalent configuration using appropriate dielectric and
thermal properties of chicken breast, which was acquired from literature[153, 154]. The
dielectric constant of chicken breast was 55, that is a 4.3% increase over the properties
of human muscle. The electrical conductivity used was 2.5, which sees an increase
of 43%. The thermal conductivity and heat capacity was 0.53 W/(m*K) and 3.546
kJ/(Kg*K) respectively. The result of a single measurement is presented in Figure
6.31, which shows the measured temperature against the simulation study at different
depths to accommodate the possible region of probe placement. During the 5-minute of
exposure, the recorded temperature was 27.9 ◦C, in contrast to the simulation at 7.0 mm
depth was 28.2 ◦C. The general tendency shows a rapid increase in the first 60 seconds,
after which the gradient was reduced to of the numerical study. The deviation in the
measurement was limited by the number of samples taken at about every 60 seconds.
Regardless early stage study indicated some consistence between the two data set. The
variation was expected and was only marginal difference because of probe accuracy
(1 ◦C) and positioning. Further evaluation and analysis were obtained with the use of
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three layered phantom and IR thermal camera.
The fabricated tissue mimicked phantom was used to evaluate the deposited EM
energy by measuring the thermal distribution for each applicator. The applicator was
placed on the phantom, and kept at room temperature until thermal equilibrium on the
skin surface is met. Figure 6.32 demonstrates the ex-vivo trial setup for Applicator I,
where the tomographic camera clamped above the phantom to capture skin and muscle
distribution after 5-minutes of exposure. The two layers are separated by a cling film,
therefore muscle measurement was captured by removing the superficial layers. The
initial temperature (microwave off) of skin layer varies between 21.5-22.5 ◦C, and the
muscle was typically lower at 19.5-20.0 ◦C. The surface convection on the exposed
surfaces causes the temperature to be equivalent to the surrounding. However, the
muscle phantom is not exposed to air, and hence the temperature inside is preserved
unless exposed for very long duration. This is illustrated in the Appendix C in Figure
C.3. The captured thermographic image on the skin phantom is shown in Figure 6.33a.
It can be seen a typical characteristics of applicator with superficial hot spots at the
radiating edges when the microwave warming was on. The peak temperature at the skin
was 33.0 ◦C, and 24.8 ◦C in the muscle (Figure 6.33b). The measured distribution was
validated with simulation based on equivalent phantom configuration. The simulated
skin temperature was just 1.0 ◦C inferior than measurement, and 0.2 ◦C in the muscle
as shown in Figure 6.34. The variation in the skin layer was caused by the thicker skin
Figure 6.32: Ex-vivo experiment setup with multi-layered tissue mimicked phantom.
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layer at the edge of the phantom, that lead to microwave absorption increase in the
superficial layer. The measured skin thermal distribution shows identical features to
the numerical study. The results in both scenarios conclude that is possible to warm up
the muscle. However, larger increase was observed in the skin layer. This early stage
validation assists in optimising the simulation model for enhanced accuracy of future
applicator development and understanding.
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Figure 6.33: Measured thermal distribution after 5-minutes of microwave exposure. (a)
Phantom Skin surface, (b) Phantom muscle surface
Figure 6.34: Simulated Thermal distribution after 5-minutes of microwave exposure. (a)
phantom skin surface, (b) phantom muscle surface
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6.6 Applicator II
The initial goal of Applicator II, was to reduce skin heating while mantling deeper
tissue warming. This was achieved with use of TEC, and a high thermal conductive
(HTC) substrate and superstrate. The modelled applicator deign is illustrated in Fig-
ure 6.35. It can be seen, a new circular geometry was introduced to accommodate the
changes of the NIRS optodes and the addition of the LDF probe at the centre of the an-
tenna. The diameter of the applicator, including the external casing is 67.5 mm, while
the actual radiating element is only 29.6 mm (λo/4). The substrate and superstrate
material is based on Rogers 6035 HTC, with higher dielectric constant r = 3.5 than
previous applicator design. This was essential in reducing the radiating element dimen-
sion. The substrate and superstrate thickness (h1, h2) are 1.52 mm and about 2.0 mm.
It was previously discovered thicker superstrate was beneficial for uniform heating and
eliminating the warm spots caused by radiating edge. However, increasing thickness
further will raise the thermal resistance and hence reduce cooling efficiency. The su-
perstrate thickness was chosen based on combination study of EM SAR absorption and
thermal analysis with applied active cooling. This section goes through Applicator II
development, fabrication and validation by comparing its warming performance with
and without the use of the cooling system.
The microstrip antenna element was based on annular ring geometry with a non-
conducting concentric centre. This is an attractive solution to embed LDF probe
at the centre of the patch without causing significant EM interaction to the opti-
Figure 6.35: Modeled Applicator II. (a) antenna parameters, (b) optical probes geometry
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cal/temperature sensor. The ring approach had been previously studied in medical
and non-medical applications [144, 123]. The geometry allows the current to flow
around the concentric centre, hence increasing the electrical length and allows for ad-
ditional antenna minimisation. Essentially to meet the requirements of NIRS optodes
spacing at 40 mm from the centre of each probe, without causing any perturbation the
element. The modeled geometry based on theoretical estimation of the wanted oper-
ating frequency, which is adjusted by the inner diameter and outer diameter Di and
Do respectively. The calculations were based on numerous studies from the available
literature [123, 155]. The diameters of the antenna are calculated from the derived
equations 6.6.1 and 6.6.2. Where fr is the desired operating frequency and kn is the
wave number. It can be seen e are typically used based for microstrip antenna de-
signs, however, estimating effective permittivity with loaded biological tissue cannot
be achieved. Therefore, EM simulations are used to optimise the antenna from initial
free space approximation. The wave number is obtained from choosing the antenna
operating mode integer (n), where the fundamental mode is TM11, hence nm = 1. The
annular ring radius’s are a (Di/2) and b (Do/2), which was obtained by selecting the
desired value of one radius in order to solve for the other. However, a condition must
be followed during the calculation, where (b − a)/(b + a) 6 0.35 and nm 6 5. The
complete design parameter is given in the Appendix C Table C.2.
fr =
ckn
2pi
√
εe
(6.6.1)
kn ≈ 2nm
a+ b
(6.6.2)
The three-dimensional model of the applicator is presented in Figure 6.36. This
illustrates all the essential components that compromise the hybrid applicator. It can
be seen the model include all the optical probes, cooling elements and the microwave
antenna. The model was also planned to accommodate magnetically loaded silicone
microwave absorbers to reduce microwave leakage outside the diagnosed site. How-
ever, this was not included in the developed design, but to be incorporated in the future
development.
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Figure 6.36: Three-dimensional model of the complete Applicator II.
6.6.1 Substrate Material
The influence of the substrate/superstrate material to the passive skin cooling was stud-
ied. Applicator II uses HTC substrate material with thermal conductivity of 1.44
W/(m*k), in contrast to 0.2 W/(m*k) of Applicator I. Numerical study comparisons
were made for Applicator II at different superstrate materials. Thermal distribution of
biological tissue with microwave warming using low thermal conductive material is
shown in Figure 6.37(a and c). The result clearly shows a hot spot at the skin surface
Figure 6.37: Simulated thermal distribution as a function of substrate thermal properties.
(a)xz-plane cut, (b) yz-plane cut
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Figure 6.38: Simulated peak SAR as a function of Di. (a) across xz-plane, (b) across yz-plane
at approximately 46.3 ◦C in the xz-plane In contrast to the distribution of the new HTC
material displayed in Figure 6.37(b and d), where peak skin temperature was 42 ◦C. A
difference of 4 ◦C by just passive cooling with the HTC substrate used. Regardless the
muscle temperatures are identical in both scenarios and also in the yz-plane This was
further evaluated with direct peak temperature comparison in Figure 6.38.
6.6.2 Annular Ring Analysis
The design parameter of Applicator II lies within the inner diameter of the concentric
centre (Di). The initial diameter choice was realised from theory before an optimisa-
tion process was applied in the EM simulation. As diameter Di increases so does the
electrical path length. Therefore, the resonant frequency shift down as demonstrated
by the |S11| simulation in Figure 6.39. A Di of 7.0 mm has an external patch diameter
(Do) of 31.0 mm, which is over the 30.0 mm limit set by the NIRS probe spacing. Con-
sequently, a Di = 9mm can achieve Do under 30.0 mm, a reduction of about 2.5 mm.
Further study was conducted, to demonstrate the peak SAR in the tissue as a function
of Di. The results are presented in Figure 6.40a for the xz-plane, and Figure 6.40b is
the yz-plane It can be observed the SAR in the superficial layer is lower for Di = 7.0
mm than the larger concentric diameters. When Di = 9.0 mm the SAR in the mus-
cle is maximum, in comparison to other diameters. Despite high superficial SAR by 3
W/kg, these study leads to the selection of 9.0 mm concentric diameter based on the
dimension limitation and improve SAR in the muscle.
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Figure 6.39: Simulated |S11| for parametric study of Di.
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Figure 6.40: Simulated SAR peak of Applicator II with different substrate thermal material.
(a,c) RO5880, (b) RO6035HTC
6.6.3 Skin Cooling
The skin cooling using TE module, was introduced for Applicator II. The cooling tech-
nique was based on thermostatic cooling. Increase temperature beyond the set point,
triggers the TEC unit and simultaneously lower RF power by 3.0 dB (half power). This
is the typical cooling experimental protocol used, which was difficult to implement to
the simulation model. However, the periodicity of thermostatic triggering was esti-
mated and modelled as an excitation signal, as shown in Figure 6.41. The magnitude is
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Figure 6.41: Applicator microwave excitation signal for the thermal simulation.
a scaling factor for actual RF and cooling power. The first 6.5 seconds, the RF power
is maximum and active cooling is turned off. The following 5.5 seconds (thermostatic
trigger), the RF power is cut to half while the cooling is activated (negative magnitude
to represent cooling power). The mimicked excitation signal was periodic, and hence
repeated for the 5-minute of microwave exposure.
The simulated thermal distribution of Applicator II with and without the active
cooling was studied in further details with the use of the thermostatic excitation signal.
Figure 6.42(a and c) show the cross-section cut of thermal distribution with microwave
warming only. By inspection, the figure clearly shows greater heating in the superficial
and muscle area across the xz-plane. The yz-plane is typically dominated by the muscle
heating. In contrast, Figure 6.42(b and d), the skin cooling was applied and promptly
reduces skin heating in both planes. The thermal distribution data presents the clear
advantage of active cooling, by suppressing the undesired hot spots caused but the
close proximity near-field operation of the applicator. However, warming the fat layer
was not mitigated completely.
The peak temperature of the thermal distribution across the horizontal and vertical
plane is presented in Figure 6.43. The result in the xz-plane clearly shows the skin
temperature is reduced by approximately 3.5 ◦C and 2.0 ◦C in the deeper tissue. Despite
the reduction, superficial heating was still present by about 4.0-5.0 ◦C from the starting
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Figure 6.42: Thermal distribution of simulated Applicator II with different substrate material.
(a,b) across xz-plane using RO5880 and RO6035HTC respectively, 5.0 mm, (c,d) across
yz-plane using RO5880 and RO6035HTC respectively.
skin temperature. Figure 6.43b shows the peak temperature in the yz-plane, where
superficial heating is minimal. The muscle warming reduction can be seen clearly in
both planes. This is caused by the combination of pulsed RF power (when skin cooling
is used) and the applied active cooling through thermal diffusion.
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Figure 6.43: Peak simulated temperature with and without cooling. (a) across xz-plane, (b)
across yz-plane
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The thermal study, was extended to show the transient plot at a predefined points
in the centre of the tissue at different depths, as illustrated in Figure 6.44. The solid
lines correspond to the simulation with no skin cooling (NC), and dashed lines are with
skin cooling (SC). The defined depths are; at the skin surface 0.0 mm, skin-fat interface
1.0 mm, fat-muscle interface is 8.0 mm and 12.0 mm for deep tissue. The results in
the figure clearly show skin heating reduction of 2.5 ◦C over a 5-minute of exposure.
The muscle temperature was also reduced by about 1.75 ◦C, primarily caused by the
pulsing RF power when cooling is active. The actual hot spots are located under the
radiating edges at about ± 17.5 mm on the x-axis. Figure 6.45 shows the transient
thermal profile around the hot spot region (at depth of 1.0 mm) and compared to the
centre of modelled tissue. The rate of temperature elevation is decreased with applied
cooling by about 2 ◦C..However, the peak temperature remains over the actual starting
value by approximately 5 ◦C.
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Figure 6.44: Transient thermal simulation at fixed points along z-axis (depth) for with and
without cooling, where y=0 mm and x=0 mm.
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Figure 6.45: Transient thermal simulation at fixed points along x-axis for with and without
cooling, where y=0 mm and z=1 mm
6.6.4 Fabrication and Validation
The simulation study was sufficient for initial optimisation of applicator; therefore,
anatomical model simulation was also used prior to antenna development. However,
measurement and validation are a necessary step to ensure the reliability of the simula-
tion model. The fabricated applicator is demonstrated in Figure 6.46, where (a) is the
microstrip antenna ground plane with placement of Peltier cooler with heat sink, mi-
crowave coaxial input, a ground plane thermistor and the optical probe. Figure 6.46b
shows the front end of the applicator excluding the superstrate. The annular ring patch
antenna is clearly shown with the soldered feed point. As with the model, the opti-
cal probe placements are demonstrated, LDF in centre and NIRS across the horizontal
plane. The applicator is housed inside a Perspex casing with added straps for secure
placement on human calf/arm. Figure 6.46c shows the back-end of the hybrid probe,
where the axial fans are attached to extract away the excess of heat generated by the
TE modules.
The applicator performance was assessed by the free space |S11| as illustrated in
Figure 6.47. The measured data was compared with the simulation model, to study the
shift in operating frequency and the return loss of the antenna. The measured |S11| was
-3.8 dB at 2.75 GHz. In contrast, the simulated |S11| was -3.6 dB at 2.73 GHz. That
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Figure 6.46: Fabricated applicator II. (a) Back view of ground plane and the included cooling,
(b) Front view of patch antenna, (c) Overall applicator
2.2 2.4 2.6 2.8 3 3.2
−10
−8
−6
−4
−2
0
Frequency (GHz)
|S1
1|, 
dB
 
 
Measured
Simulated
Figure 6.47: Measured s-parameter of Applicator II in free space.
is about 20 MHz (0.73%) difference between the numerical study and measurement.
The results clearly state the antenna is not operable in free space, with high VSWR is
expected when connected to the microwave system. This is the mechanism that was
used to ensure microwave only operates at lower VSWR, were a maximum of 1.5 is set
when applied to human calf.
The hybrid probe was placed on the calf for input reflection measurement. The
data is plotted against the simulation and presented in Figure 6.48. The measured |S11|
agrees with the current updated simulation model (1.0 m skin and 7.0 mm muscle) with
only difference of about 5.0 MHz. The optimum operating frequency was at 2.53 GHz
with low input reflection of -19.0 dB. A discrepancy of 3.3% was observed, which is
outside the ISM band range. The -10.0 dB bandwidth is 160 MHz ranging from 2.45
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Figure 6.48: Measured s-parameter of Applicator II on human calf.
to 2.6 GHz. This is a 6.3% achieved bandwidth, which is 1.0% higher than the nu-
merical study. The improved bandwidth of applicator II was influenced by the antenna
geometry with the use of larger relative permittivity of substrate/superstrate laminate.
Consequently, this allows the antenna to operate at ISM band.
The basic assessment of antenna performance was completed before proceeding
to thermal validation on tissue mimicked phantom. The applicator was placed on the
phantom for duration about 10.0 minutes to ensure skin temperature was stabilised
before applying microwave warming. The duration of warming was the standard 5-
minutes of exposure at 3W RMS power. Figure 6.49 shows the captured heat distri-
bution of skin and muscle phantom surfaces during microwave warming without skin
cooling. The obtained image was compared with an equivalent setup in EM/Thermal
simulation, where the results are presented in Figure 6.50. It can be seen the skin
surface temperature was raised from 22 ◦C to 31.0 ◦C in a dual hot spot produced
by applicator operating in the near-field. This was comparable to the simulated peak
temperature of 31.0 ◦C. The notable difference is the temperature at the centre of the
distribution, where the measurement was about 2.0 ◦C. This was possibly caused by
the inaccurate modelling of the LDF probe (located at the centre of the applicator), and
the limited resolution of the IR camera (140x140 pixels). The muscle surface tempera-
ture was about 27 ◦C after the exposure, that is an elevation 19.5-20.0 ◦C. The muscle
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(a) (b)
Figure 6.49: Measured Thermal distribution after 5-minutes of microwave exposure. (a)
phantom Skin surface, (b) phantom muscle surface
Figure 6.50: Simulated Thermal distribution after 5-minutes of microwave exposure. (a)
phantom skin surface, (b) phantom muscle surface
starting temperature was at least 2.0 degrees lower than skin. Figure 6.51b shows the
simulated muscle phantom with peak temperature of 27.3 ◦C, which is a 0.3 ◦C increase
over the measurement. Overall, skin elevation was only 2 ◦C higher than muscle, which
was also validated by the numerical study.
The tissue mimicked phantom experiment was repeated with the addition of active
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(a) (b)
Figure 6.51: Measured Thermal distribution after 5-minutes of microwave exposure with
active cooling on. (a) phantom Skin surface, (b) phantom muscle surface
Figure 6.52: Simulated Thermal distribution after 5-minutes of microwave exposure with
active cooling on. (a) phantom skin surface, (b) phantom muscle surface
skin cooling. Figure 6.51 and 6.52 are the measured and the simulated thermal surface
profile of skin and muscle respectively. The plots show the peak measured skin tem-
perature was 28.0 ◦C and 26.0 ◦C for the muscle. In contrast to warming only, the skin
temperature was reduced by 3.0 ◦C and 1.0 ◦C in muscle.
Figure 6.51a, clearly illustrates the two warm spots and adjacent cold spots (19.0
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◦C) on the skin surface. These findings were validated with the numerical investi-
gation, which showed marginal difference of up to 0.6 ◦C on the skin surface. The
variation between the measurement and simulation, could be affected by the variation
in room temperature, the non-planar phantom thickness and the dielectric properties of
the phantom. The simulated muscle temperature was 0.4 ◦C lower than the measured
value. This study highlighted the importance of TE module placement on the applica-
tor. In Applicator II, the Peltier coolers are placed on the non-radiating edges (across
the Y-axis). The cooling elements are not capable of uniform distribution. Therefore,
maximum cooling efficiency is directly under TE element as it is demonstrated in the
Appendix C in Section C.2.2. Cooling system relies on the temperature set-point and
the thermistor which is located at the centre of the applicator and hence the thermal
distribution. It can be observed from Figure 6.51a, the temperature at the centre was
22.1 ◦C after 5-minutes of microwave warming and cooling. This temperature was the
actual starting value, and it was maintained by the active cooling because it was the
location of the thermistor reading. Consequently, it is possible to mitigate the hot spots
if the set-point value was lower than starting temperature by over 2 ◦C. The limitation
of this approach is skin over-cooling becomes significant, which will also affect the
physiological measurements.
The transient skin temperature was measured, and compared with the thermistor
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Figure 6.53: Measured skin temperature and ground plane temperature with active cooling.
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reading at the ground plane as it was shown in Figure 6.53. The starting temperature
of both thermistors begins at approximately 22.3 ◦C, which is the typical of the skin
phantom. The result shows the skin measurement fluctuates between 21.5 ◦C to about
22.8 ◦C, which is a standard operation of a thermostatic controller. In contrast, the
ground plane measurement, have large self-fluctuation caused by the cable extension
length which was filtered and smoothed, represented in the red line fit. The temperature
of the ground plane was decreasing in the initial 50 seconds, which follow the similar
pattern to the skin. However, the remnant duration of exposure shows the ground plane
temperature was gradually increasing until after 240 seconds, were it stabilises at 24.0
◦C. This is approximately 1.5 ◦C higher than the skin temperature probe. The results
clearly indicate the set point temperature was not sufficient to cool the area where the
radiating edges, and the ground plane thermistor was located.
In vivo validation of microwave warming on calf skin was measured and presented
in figure 6.54. By inspection Figure 6.54a shows the skin hot spots elevated to 41.0 ◦C
during microwave exposure without cooling. This was validated with the simulation
model using the biological heat equation (unlike phantom validation) as shown in Fig-
ure 6.55a. As previously discovered in the simulation results, the skin warming at the
centre of the distribution is typically lower than measurements by around 2.0-4.0 ◦C
(a) (b)
Figure 6.54: Measured skin thermal distribution after 5-minutes of microwave exposure on
human calf surface. (a) without skin cooling, (b) with skin cooling
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Figure 6.55: Simulated skin Thermal distribution after 5-minutes of microwave exposure with
bio-heat. (a) without skin cooling, (b) with skin cooling
depending on the protocol. The experiment was repeated with inclusion of skin cool-
ing. The measured result is illustrated in Figure 6.54b and compare with the numerical
study in 6.55b. By inspecting the results, it can be observed the active cooling reduced
the peak hot spot temperature by approximately 4.0 ◦C. However, adjacent cold spot
was observed, located under each of TE modules. The minimum temperature was of
the diagnosis site was 29 ◦C. The captured distribution and temperature values were a
match to the equivalent set-up of the simulation presented in Figure 6.55. The same
simulation study also showed the muscle temperature was elevated to 41.25 ◦C.
6.7 Applicator III
The limitation of applicator II was clearly in the geometrical placement of the cool-
ing modules. The coaxial pin feed design approach meant that, the Peltier cooler can
only be placed on the non-radiating edges of the applicator. Therefore, it was diffi-
cult to sufficiently cool the adjacent hot spots produced by the radiating edges. More-
over, Applicator II was over-cooling the adjacent regions to the hot spot, therefore the
thermal distribution showed hot and cold spots. This limiting factor was improved
by the developed applicator III geometry as shown in Figure 6.56. The microstrip
antenna design adopts identical configuration of the previous applicator, using HTC
substrate/superstrate material, thickness and optical probe’s allocation. The primary
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Figure 6.56: Modelled Applicator III. (a) radiating element geometry, (b) wide frame view
change is the antenna feeding approach, using an arced transmission line feed network
with inset feeding to the patch, as illustrated in Figure 6.56a. The transmission line was
feed by the same coaxial pin feed approach. The purpose of this was to shift the back
pin feed away from the radiating element and to allow the placement of Peltier cooler
right above the E-field plane (y-plane). The TE module placement can be seen clearly
in the wide frame view of the modelled Applicator III in Figure 6.56b
6.7.1 Numerical Study
The performance of the applicator was assessed, by studying the current distribution
around radiating patch and the transmission line. An arced transmission line was in-
herited to minimize back reflection from the intersection of feed line and the inset feed.
Applicator III includes a notch at the opposite side of the feed point, which was intro-
duced after SAR study. The purpose of the notch was to balance antenna impedance,
for identical radiated E-field from both edges across the y-plane. The width of arc are
usually calculated from the standard transmission line equation for optimal impedance
at 50Ω. However, in this application theoretical transmission line equation cannot be
relied on, thus EM simulation was used for general impedance optimisation.
The primary focus of this section is about the improvement of skin cooling, and
this was analysed with the transient thermal simulation equivalent protocol to Appli-
cator II. The SAR distribution did not improve upon the previous applicator. In fact,
the numerical investigation shows the SAR of Applicator III was outperformed by the
previous design. This is caused by the introduction of the transmission line, which also
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Figure 6.57: Simulated current distribution of Applicator III.
radiates at the near-field proximity, hence increasing SAR absorption in the skin. For
conciseness, the simulated SAR is summarised in the Chapter 9 Table 9.1. The thermal
simulation study for Applicator III with skin cooling is illustrated in Figure 6.58. The
figure shows xy-plane cuts of the modelled tissue, (a) skin, (b) skin-fat interface and
(c) muscle. The result clearly shows the skin surface is cooled and minimised superfi-
cial hot spots. The peak temperature at the skin was 33.30 ◦C, that is about 1.0 degree
elevation from the starting temperature. This increase was produced by the coaxial
feed-point to the transmission line. In fact, the results also indicate skin over-cooling
at approximately -25 mm of the Y-axis, where the temperature was 31.0 ◦C. In con-
trast to Applicator II, the peak simulated skin temperate with cooling was 37.0 ◦C, that
is a 3.7 ◦C increase over Applicator III. The temperature was elevated in the skin-fat
interface peaking at 35.7 ◦C, that is 1.9 ◦C higher than the surrounding tissue. Figure
6.58c illustrates the muscle warming at about 40.4 ◦C, an increase of 3.4 ◦C. The peak
temperature induced in the tissue of the two applicators are compared in Figure 6.59.
Figure 6.59a is the radiating plane, where Applicator III has reduced the superficial
hot spots but also 1.0 ◦lower in the muscle. In contrast, Figure6.59b shows the non-
radiating plane, where Applicator II has overcooled the superficial layers caused by the
geometrical placement of Peltier cooler.
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Figure 6.58: Simulated thermal distribution of Applicator III with skin cooling. (a) skin (b) fat
(c) muscle
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Figure 6.59: Peak thermal distribution of Applicator II & III. (a) across the radiating plane, (b)
across non-radiating plane
6.7.2 In-vivo Thermal Validation
Applicator III was established on the current updated simulation model using skin
thickness of 1.0 mm and fat layer for 7.0 mm. The fabricated antenna performance
was assessed by a series of |S11| measurement in free space and on biological tissue.
Figure 6.60 shows the measured |S11| plotted against the simulation. It can be seen the
measured return loss is lower over wider frequency range. However, they overlap at
the same frequency of 2.55 GHz at about -7.0 dB. Overall, the impedance of antenna is
mismatched in air, therefore, not operable in this condition. The measurement was re-
peated with applicator placed on human arm and calf. The measured data is contrasted
6.7. APPLICATOR III 149
2.2 2.3 2.4 2.5 2.6 2.7 2.8
−30
−25
−20
−15
−10
−5
0
Frequency (GHz)
|S1
1|, 
dB
 
 
Simulation
Measured
Figure 6.60: Measured s-parameter of Applicator III in free space.
with numerical study as shown in Figure 6.61. The simulation data was similar with
the arm and calf measurement. The arm return loss was -39.0 dB at 2.453 GHz, an 3.0
MHz increase from the simulation and 17 MHz higher than calf measurement. The dif-
ference between the measurement was based on tissue thickness. Healthy human arms
have typically thinner fat layers, which explains the increase in resonant frequency. The
calf measurement had a return loss of -19.0 dB at 2.36 GHz, only drifting by 9.0 MHz
from the simulation. The antenna bandwidth on human calf is 7.1% (168 MHz), which
is 3.1% wider than the numerical study. This is sufficient to cover the ISM band to
cover any circumstances of subjects with dissimilar tissue thickness.
The applicator was placed on human calf for in-vivo thermal measurements. The
operation of the applicator follows the previous protocol of 5-minute microwave expo-
sure with and without skin cooling. Figure 6.62 is the captured IR images of human calf
(under the applicator) directly after the microwave exposure. The skin thermal distri-
bution of tissue warming without skin cooling is shown in Figure 6.62a. The peak mea-
sured temperature was 37.1 ◦C, just about 0.5 ◦C lower than the simulated applicator
shown in Figure 6.63a. The heat distribution shows the warming achieved covers large
area under the applicator with peak temperature located at the feed point. In contrast,
the simulation study shows two distinct hot spots from each radiating edge, a particu-
larly under the feed location at the positive Y-axis. Regardless of closely matched peak
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Figure 6.61: Measured s-parameter of Applicator III on human calf and arm.
temperatures, the distributions at the centre of the applicator are not identical to the
measurement. This was believed to be the modelling approach of the LDF probe at the
centre which was adopted as a single dielectric medium, where in reality it also contains
a metal conductor for temperature measurement. Another possibility is the resolution
and dynamic range of the IR camera, when the temperature values are within a 1.0 ◦C.
The experiment was repeated with active skin cooling, the measured and simulated data
are compared in Figure 6.62b and Figure 6.63b. The measured profile clearly indicates
a cooling pattern at the sides of the thermal distribution. Peak measured skin tempera-
ture was 33.20 ◦C, which is elevated by 1.2 ◦C to the actual skin temperature (32.0 ◦C)
and just 0.1 ◦C lower than the numerical study. Captured thermal distribution illustrates
some identical features to the simulation study. This includes the two cold spots at the
edges, and the feed-point hot spot located in the positive Y-axis. The minimum skin
temperature was 30 ◦C and also equivalent to the simulated distribution. At the centre
of the thermal profiles, the features diverge between the two studies as it was illustrated
in the warming only pattern.
The geometrical changes of active cooling, has proven to be effective in partially
mitigating skin heating. It was possible to eliminate skin heating all together, which
was achieved by lowering the set point temperature by 2.0 ◦C than the initial temper-
ature. This is essentially over-cool the entire region under the applicator uniformly.
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(a) (b)
Figure 6.62: Captured thermal images of human calf after exposure. (a) tissue warming only,
(b) tissue warming with skin cooling
(a) (b)
Figure 6.63: Simulated thermal distribution of human calf after 5-minutes microwave
exposure. (a) tissue warming only, (b) tissue warming with skin cooling
The limitation of this approach was the exterior axial fan was not able to compensate
the heat generated from the TEC when over-cooling and operating at 3 watts RMS.
However, this was achieved by lowering the microwave power to 1.0 watts RMS over
60-minute of exposure. This investigation was carried on to demonstrate the capability
of the skin cooling system, regardless of the physiological data. The in-vivo trial was
conducted after protocol verification with numerical study, ensuring the safety of the
procedure. The thermographic images were captured and presented in Figure 6.64.
Figure 6.64a is the 60-minutes of microwave warming excluding active cooling.
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(a) (b)
Figure 6.64: Captured thermal images of human calf after 60-minutes of microwave exposure
(1W RMS). (a) tissue warming only, (b) tissue warming with skin over-cooling
It can be seen the skin temperature was elevated by just 3.0 ◦C, from initial tempera-
ture of 31.0 ◦C. Based on simulation. The Muscle temperature can reach the thermal
steady state at 39.5 ◦C. In contrast, Figure 6.64b shows the measured heat distribu-
tion of human calf with skin over-cooling. The starting temperature was 29.0 ◦C, and
set point temperature were set to about 27.0 ◦C. The resultant distribution after 60-
minute, clearly indicates the effectiveness of the cooling system, skin temperature was
maintained to the desire value. According to the simulation, the muscle temperature is
elevated to 39 ◦C, which is sufficient for muscle dilation. However, detection of muscle
dilation will be challenging when the skin capillaries are restricted by the over-cooling.
6.8 Chapter Summary
In this chapter, the development of the linear applicators was presented. This was ini-
tiated from simple requirements that include operating frequency, proximity and the
impedance matching layer. Consequently, it was possible to develop applicators with
aid of theoretical and numerical studies. The basic of microstrip antenna was intro-
duced and applied for early stage estimation of antenna dimension. Moreover, EM
simulation was the core aspect of the development and understanding of deposited en-
ergy. Computational technique, including; simulation methods, tissue modelling and
boundary conditions were introduced. Majority of simulation presented were based on
a planar three layered tissue model consisted of skin, fat and muscle layers. Microstrip
antenna was evaluated with the numerical model, to investigate applicator proximity.
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It was found that the superstrate layer was the superior option for optimal in SAR and
thermal pattern. Consequently, Applicator I inherited the design with appropriate mod-
ification to accommodate the NIRS optical probes. The development and performance
of the applicator were extensively evaluated. The study showed the contribution of
different skin or fat thickness to the SAR and thermal distribution. Generally, it was
found the skin was most sensitive to the applicator impedance as it is directly loaded
to the applicator. Therefore, variation in thickness of tissue, particularly of skin leads
to detune of resonance frequency, hence the need for sufficient operating bandwidth.
Anatomical study was also implemented for final evaluation of the applicator prior to
fabrication. The thermal performance of Applicator I was validated with the fabricated
tissue mimicked phantom. The study showed a close match between measurement and
simulation. The limitation of the first design, was the lack of active cooling, real time
skin temperature and an effective way to place on the calf.
Applicator II was introduced to resolve the limitation of the predecessor design.
This was achieved by introducing new geometry, which accommodate NIRS probes,
LDF probe, A thermistor and TEC. Moreover, the applicator uses HTC dielectric medi-
ums for substrate and superstrate layers, which was able to reduce the superficial warm-
ing. The skin temperature was reduced by about 3.5 ◦C with Peltier cooling. However,
despite the cooling the superficial temperature was elevated by about 3-4 ◦C of the
actual skin temperature. The Applicator was then fabricated and validated on tissue
mimicked phantom. The contrast between the numerical study and measured heat dis-
tribution were closely matched. The result showed cold spots were produced, directly
under the TE module. Final evaluation was on human calf, again some agreement
with the numerical and the phantom investigations. The limitation of this applicator
lies within the geometrical placement of Pletier cooler, which was situated on the non
radiating edges. This problem was resolved by the design of Applicator III, which
effectively places the active cooling directly above the hot spot region. The investiga-
tions were repeated accordantly, and the results were conclusive by further mitigating
the skin heating. All the measured and simulated parameters of the Applicators are
placed in tables for quick comparison. This can be found in Chapter 9 Table 9.1 and
9.2. Applicator III was efficient in cooling. However, the SAR in the skin-fat inter-
face was higher compared to the predecessor. In the next section, we investigate SAR
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reduction in the superficial layers, using CP Applicator design.
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Chapter 7
Circularly Polarised Microwave
Applicator
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7.1 Overview
The vast majority of applicators in the medical domain are based on linear polarisation,
where the electric and magnetic fields are orthogonal to each other and travelling in a
single direction in the far field region. Therefore, the field vector is always at a fixed
point, and the radiated EM energy occurs in one particular plane producing large peak
absorption. Circular polarisation radiates the electric field in all planes in a rotating
manner with respect to time. In medical applications, CP applicators for therapy have
not been investigated in great depth, particularity numerical study of SAR absorption
comparison against linear applicators in the near-field region. Some literature study
suggests CP applicator was a technique to reduce the stray radiation during clinical
diathermy treatments operating at 2.45 GHz [156]. In another literature study, a di-
rect contact circular waveguide applicator for microwave diathermy was developed to
excite CP at far-field with uniform distribution, which reduces the steep temperature
gradient [25]. Moreover, a single-fed microstrip CP antenna was investigated recently
for wearable technology. The study focuses on antenna matching on rectangular and
curved structures at close proximity to tissue [157]. The results from the study sug-
gested, the CP antenna impedance match was best achieved at twice the spacing of a
linear polarised antenna[157]. A dosimetry study on rats inside a CP waveguide was
previously conducted. The investigation focuses on measuring of average SAR as a
function specimen size and exposure orientation [158]. However, no real comparisons
were made between CP and linear applicator. In this chapter, we introduce detailed EM
study of CP applicator based on SAR and compared with the already developed linear
applicator. The thermal profiles will then be validated on tissue mimicked phantom and
on human calf.
7.2 Multi-Fed Circularly PolarisedMicrostrip Antenna
The initial investigation of CP applicators commenced by employing the multi-feed
approach to demonstrate the effectiveness of circular polarisation concept in reducing
peak SAR. This is a common direct method to excite circular polarisation. The study
focuses on the peak SAR distribution ratio between the superficial layer skin/fat and
deeper tissue in the muscle. The antenna design was based on the previous annular ring
design of Applicator II, maintaining all the core features including substrate, superstrate
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Figure 7.1: Modified Applicator II for CP operation in the following configuration. (a) dual
input ports, (b) quad input ports
thickness and the dielectric properties. The change was implemented in the model, with
the addition of feed ports. The placements of input ports are orthogonal to each other
with a 90 ◦phase difference between each port, as demonstrated in Figure 7.1. The EM
simulation solves each port independently before combining the data with appropriate
amplitude weighting and phase shift. A dual feed geometry was initially adopted as
demonstrated in Figure 7.1a. The addition of feed point, introduces a change in patch
impedance (increase in inductance), thus the feed position is adjusted accordingly for
50Ω match. The study was compared with a four feed port scenario in Figure 7.1b. The
assessment of CP antenna performance is achieved by evaluating the ratio of vertical
to horizontal field components, which is known as the axial ratio. This is a common
method used to predict the operation of circular polarisation in free space. However, the
applicators are designed to operate in contact with biological tissue. Consequently, far-
field axial ratio assessment cannot be considered for this study. Surface current, is an
alternative method that was used to study the current distribution and the corresponding
operating mode of the antenna.
7.2.1 Dual Feed CP
The simulated SAR distribution of dual feed CP applicator using the original three
layered model is presented in Figure 7.2. It can be seen a circular SAR distribution in
the skin layer with a minimum absorption of 28.0 W/kg and maximum of 40.0 W/kg.
The non-uniform absorption level is caused by the asymmetrical composition of the
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Figure 7.2: Simulated SAR distribution of dual-fed CP excitation on biological model. (a) skin
surface , (b)fat surface, (c) muscle surface
applicator (Optical probes) and the operation in the reactive near-field. Figure 7.2b
shows the highest SAR in the fat layer at 3.5 mm depth, where peak absorption is 55.0
W/kg. In contrast, the absorption in the muscle was 26 W/kg at a depth of 16.0 mm from
the skin surface. The initial impact of this study, shows EM energy is distributed over
the applicator area to reduce peak absorption spots produced by the linear applicators.
The deposited energy in muscle remains the same as with linear polarisation. A full
comparison of CP applicator is presented in the next section. The reflection coefficient
of each port was simulated and demonstrated in Figure 7.3. By inspection, |S11| is the
primary port at phase 0◦set at operating frequency of 2.45 GHz. However, |S22| is the
orthogonal port added for CP operation, where the resonance frequency shifted down
by about 30.0 MHz it is also desirable, as the two orthogonal modes should not be as
the same frequency for wideband CP operation . The change in frequency is caused by
the asymmetry of the applicator. The low dielectric optical probes are not used in the
y-plane, hence change in electrical length with respect of port position.
7.2.2 Quad Feed CP
The dual-port study, showed non-uniform circular distribution, which was expected to
be caused by the reactive near-field operation. A more uniform distribution on the skin
surface can be achieved with four orthogonal ports as it was illustrated in Figure 7.1b.
Each port is incremented with 90 ◦phase difference in clockwise. The orientation of
phase can define the direction of current circulation. In the given configuration, the
applicator operates in right hand circular polarisation (RHCP). The numerical study in
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Figure 7.3: Simulated S-parameter of dual-fed circular polarised applicator.
Figure 7.4 shows uniform SAR distribution can be achieved with four ports. The peak
SAR in fat layer is 40.0 W/kg, while 21.5 W/kg in the muscle. The overall SAR is
generally lower than the dual-fed. This is caused by the unoptimised impedance of the
design, it was only for distribution demonstration. The multi-feed study demonstrated
the potential of CP applicators. However, it was not feasible with the current spatial
limitation at the back of the antenna, where the feed ports occupy the majority of ground
plane space. An external power divider and phase shifter will also be required for
dual/quad feed operation. These limitations can be solved with the single feed CP
radiator.
Figure 7.4: Simulated SAR distribution of quad-fed CP excitation on biological model. (a)
Skin surface, (b) Fat surface, (c) Muscle surface
7.3. SINGLE-FED CIRCULARLY POLARISED MICROSTRIP ANTENNA160
7.3 Single-fed Circularly PolarisedMicrostrip Antenna
Single fed CP radiators are commonly known for its simplicity, compactness and ease
of fabrication[159]. It eliminates the requirement of additional feed point and network
divider [160]. This approach maintains the same spacing arrangement of linear po-
larised applicators for effective placement of TEC. This can be accomplished by intro-
ducing a perturbation to the radiating element, which is a pair of symmetrical notches
in the 45◦diagonal plane of the vertical axis as shown in Figure 7.5a. This essentially
splits the degenerate mode into two orthogonal modes (TM11) at 90 ◦phase difference
and equal magnitude. The introduced modes resonate at two frequencies, which is
about 150-200 MHz apart for 2.45 GHz. Therefore, CP excitation and is the frequency
between the two degenerate modes. There are other techniques for a single probe-fed
CP found in literature, such as, crossed slot at the centre of the patch, truncated ellip-
tical geometry and strip-line inside the inner ring [161–163]. The development of CP
applicator, was based on the described perturbation method. The notch size was calcu-
lated using the following Equation 7.3.1 and 7.3.2 obtained from the literature [164].
∣∣∣∣∆sSa = 11.841Qo
∣∣∣∣ (7.3.1)
∣∣∣∣∆s = pia21.841Qo
∣∣∣∣ (7.3.2)
Where ∆s is the area of the total perturbation segments on the patch, Sa is the area
of the original circular patch and Qo is the quality factor of the unmodified antenna.
These approximations are based on the assumption of antenna operating in free space
and based on circular patch antenna. The developed applicator is an annular ring design,
which was not investigated previously with perturbation. Therefore, the effective area
was of the concentric centre subtracted from the area of the circular microstrip antenna.
As the applicator placed on the biological tissue model, the impedance characteristic
of the antenna is altered including the notch size. For optimal CP operation, EM sim-
ulations were required to tweak the perturbation size. The characteristic of antenna
was evaluated by current and SAR distribution. The CP antenna design was further
improved by the addition of a pair of symmetrical stubs on the mirrored diagonal axis,
demonstrated in Figure 7.5b This modification allowed for improved impedance band-
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Figure 7.5: Single-fed CP applicator. (a) original basic model / Model I, (b) improved new
model / Model II
width and optimised SAR distribution. The dimensions of both designs are presented
in Appendix C Table C.3.
7.3.1 Perturbation Study
The optimisation process of the perturbation size was studied using EM simulation.
The investigation established with a simple design using a pair of symmetrical notches
to excite CP. Applicator parametric study was realised for the notch length (ln) and
width (wn) . The performance of CP was evaluated with the simulated |S11|, where the
two orthogonal modes can be distinguished. The result of the study is presented in Fig-
ure 7.6. By inspecting Figure 7.6a, variation in ln causes the two degenerate modes to
shift, where the modes either combine into a fundamental mode or spread further apart
at larger frequency difference. The optimal condition is when the two modes are or-
thogonal, where the centre frequency for CP is represented by the flat region in the |S11|
This is the case when ln = 3.4 mm, as the impedance bandwidth of CP is enhanced.
Decreasing the length of perturbation further causes the two modes to spread apart, and
the return loss at centre frequency is increased. Moreover, increasing ln causes the two
modes to combine into a single fundamental mode, therefore, operating as a linear po-
larisation applicator. Figure 7.6b illustrates changes in CP impedance bandwidth with
the width of the perturbation. Consequently, both parameters are optimised accordingly
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Figure 7.6: CP Model I |S11| parametric study/ (a) perturbation length ln (b) perturbation
width wn
to obtain optimal CP excitation with sufficient bandwidth. The final values were 3.4
and 5.1 for ln and wn respectively.
7.3.2 CP Applicator Performance
The CP Model II, consists of four parameters which all required to be optimised si-
multaneously. This added complexity was beneficial for lowering the return loss by
about 3.2 dB. The simulated |S11| of the two models is illustrated in Figure 7.7. The
operating bandwidth is only 20 MHz between 2.38 and 2.40 GHz. The performance of
the excited CP was evaluated by the numerical current SAR distribution. The current
distribution (in Amps/m) of the improved CP applicator design (Model II) is presented
in Figure 7.8. It can be observed the surface current vector is a function of phase. By
considering over the four shown phase steps, a circular rotation of the current vectors
is generated in an RHCP manner. The CP bandwidth was evaluated by analysing the
SAR on the superficial tissue at different operating frequency, typically this was found
to be about 20 MHz. Exceeding operating frequency by over±10 MHz of the centre
frequency, the SAR and current distribution will deteriorate.
The numerical study of CP applicator was extended to assess the SAR distribu-
tion in the skin, fat and muscle at a depth of 1.0, 4.0 and 16.0 mm respectively. The
assumption made during the CP simulation (before fabrication), the biological medium
was based on the original model of 2.0 mm skin and 10.0 mm fat layer. Using Model II
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Figure 7.7: Simulated |S11| of circular polarised applicator with single-fed CP Model I&II.
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Figure 7.8: Single-fed CP Applicator current distribution at the following phases. (a) 0◦, (b)
90◦,(c) 180◦, (d) 270◦
may deteriorate the CP analysis, as it was very sensitive to tissue composition. There-
fore, Applicator II was simulated on similar condition for comparison with CP designs.
The SAR distribution induced by the linear and circular polarised applicators is illus-
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Figure 7.9: Simulated SAR distribution in biological medium on skin, fat and muscle. (a,b,c)
Linear Applicator II, (b,e,h) CP Applicator I, (c,f,j) CP Applicator II
trated in Figure 7.9. The results demonstrate SAR distribution in each consecutive layer
horizontally with respect to depth inside the tissue. The evaluated types of applicators
are compared vertically from a linear applicator (a,b,c), CP Model I (d,e,f) and the
updated CP Model II (g,h,j) of Figure 7.9. The absorption on the skin surface is 65
W/kg for linear applicator, which is about 20 W/kg higher than CP applicator (30.7%
decrease). The Model II shows an improved circular deposition with skin SAR is 4.7%
lower than the original designed CP applicator. Figure 7.9(b,e,h) shows the SAR distri-
bution on the fat layer deposited by the various applicators. It can be seen the peak SAR
is in the fat, which is produced by the standing wave between the skin and the muscle
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when operating at 2.45 GHz. Applicator II has the greatest SAR at approximately 70
W/kg in the fat layer, this also about 28.8% higher than with CP applicators. The mus-
cle absorption in Figure 7.9(c,f,j), indicates all three applicators have equal absorption
magnitude at about 27 W/kg.
The finding was further evaluated with peak SAR plots across the depth (z-axis)
inside the biological tissue at the horizontal and vertical plane cuts as shown in Figure
7.10. The study across the horizontal plane is shown in Figure 7.10a, were the linear
polarised applicator has the maximum peak absorption in the fat layer. In contrast, the
muscle absorption was the same for both applicators. In the vertical plane shown by
Figure 7.10b, the linear applicator is at the non-radiating edge. The peak SAR in the
fat layer was induced by CP applicator at about 50 W/kg equivalent to the horizontal
plane. This clearly indicates the spread of the deposited energy over the two planes,
minimizing the large peak absorption in one plane. The applicator performance was
characterised by SAR ratio of peak muscle absorption to superficial peak absorption.
The current study shows SAR ratio of 38.7%, 41.2% and 54.56% for Applicator II, CP
model, I and CP model II respectively. Consequently, CP model II is the primary CP
applicator which was later developed.
The bandwidth of single fed CP microstrip antennas is always a challenging prob-
lem in many applications. By studying the SAR distribution the optimal applicator
bandwidth was 20 MHz. Moving operating frequency by± 10 MHz of the given band-
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Figure 7.10: Simulated Peak SAR in phantom with linear and CP applicator. (a) xz-plane (b)
yz-plane
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Figure 7.11: Simulated SAR distribution of CP applicator on skin,fat and muscle at the
following operating frequencies. (a) 2.39 GHz, (b) 2.4 GHz, (c) 2.42 GHz
width will start to deteriorate current distribution and therefore, the emitted radiated
electric field. Figure 7.11 illustrates the layered SAR distribution of optimised CP ap-
plicator at 2.38 GHz, 2.4 GHz and 4.2 GHz. The simulation study presented in Figure
7.11)a,b,c) is the SAR distribution on the surface of skin, fat and muscle respectively
at 2.38 GHz. The absorbed EM energy is deviating to elliptical polarisation and ap-
proaching to linear operation when the frequency is lowered further. The two peaks
are apparent in a positive gradient diagonal line, indicating the degenerate mode at the
lower frequency. This is contrasted with the CP operating region at centre frequency of
2.4 GHz shown in Figure 7.11(d,e,f), where the peaks are distributed in a circular man-
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ner. The peak SAR in the fat layer is 17 % increase at the lower and upper frequency
bands, while the muscle remains the same. This is about 14.3% decrease than of the
full linear applicator. Figure 7.11(g,h,j) is the absorption rate at the upper frequency
of 2.42 GHz. It can be seen the distribution is mirrored of the lower frequency band
(a,b,c) at the y-axis. The two radiating peaks are in the negative gradient line, which
is the second degenerate mode. The combination of those two modes will produce the
observed CP distribution of the centre frequency, which agrees with the theory.
The significance of wide operating bandwidth is emphasized in the tissue compo-
sition study. Figure 7.12a shows the simulated |S11| of CP applicator at different skin
thickness of 1.5, 2.0 and 2.5 mm. It can be observed, as the thickness increases to 2.5
mm, the two degenerate modes add up into a single fundamental mode operating in
linear polarisation. Lower skin thickness with also deteriorate CP operation, where the
two modes are no longer orthogonal. The applicator is clearly very sensitive to skin
thickness, and thus improving impedance bandwidth will not enhance this operation.
However, this problem can be resolved by increasing the spacing of the applicator to
tissue, from reactive near field to radiating near-field. Therefore, reduce the applicator
sensitivity to the change in tissue composition. Figure 7.12b shows the simulated |S11|
of the applicator at different fat thickness. By inspection, the performance deteriorates
less by the fat thickness or deeper tissue composition. In this study, improving the
impedance bandwidth is of benefit, as it can be seen the bandwidth deteriorates further
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Figure 7.12: Simulated |S11| of CP applicator for various tissue thickness. (a) skin thickness
(b) fat thickness
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as the thickness increases to 12.5 mm.
7.4 CP Applicator Development
The simulated and optimised CP model was fabricated on an identical substrate ma-
terial of Applicator II&III, and same optical probe’s geometry. The overall substrate
dimension is fixed for quick integration to the exterior housing. This fabricated CP ap-
plicator is demonstrated in Figure 7.13. The critical feature in the fabrication process is
the feed point soldering to the radiating element surface. The surface of the microstrip
patch antenna with the soldered feed point must be flat surface to eliminate any air gap
introduced when it is loaded by the superstrate. A lumped soldering at the feed point
could introduce large surface current at the location, and therefore, imitation to the skin
layer.
The return loss of the developed CP applicator was measured in free space and
on human calf using VNA. The measurement in air was compared with the simulation
study as shown in Figure 7.14a. The resonating frequency is 2.68 GHz, which agrees
with the numerical results. However, the return loss of the measurement was about 5.0
dB higher, which it may have been caused by the approximated values of dielectric
material of the optical probes and the exterior housing. The applicator was placed on a
human calf, and the |S11| was measured accordingly. The measurement was compared
with the current updated simulation model presented in Figure 7.19. The operating CP
Figure 7.13: Fabricated CP applicator.
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Figure 7.14: Measured and simulated |S11| of CP applicator. (a) free space (b) on human calf
and phantom
frequency in agreement with the simulation at 2.53 GHz. The measurement was re-
peated on the phantom with identical center frequency. The bandwidth was narrower
because of thicker fat layer in the fabricated phantom. This analysis was based on
previous observation of the simulated tissue composition, if skin thickness is varying,
then the change in resonance frequency will be noticeable. Therefore, this change is
mostly influenced by the fat thickness. The measurement on calf had the largest return
loss at -13.0 dB, which is 4.0 dB higher than phantom measurement and simulation.
The |S11| assessment authenticates CP operation frequency, by observing the two de-
generate modes. This measurement was repeated each time the applicator position was
changed, to ensure where about the operating frequency.
7.5 CP Applicator Validation
The performance of developed CP applicator was assessed on mimicked phantom and
human calf. The result compromise of measured thermal distribution and correspond-
ing simulation with equivalent tissue model thickness for each scenario.
7.5.1 Phantom Validation - Warming Only
The applicator was placed on the phantom, and |S11|was measured to attain the optimal
operating frequency for CP. The experimental protocol is identical to the Applicator
II with input microwave power of 3.0 watts RMS over 5-minutes of exposure. The
obtained thermographic images of skin and muscle surfaces are presented in Figure
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7.15. The measured skin profile agrees with the corresponding setup in the simulation
as shown in Figure 7.16. The peak skin temperature was comparable to the Applicator
II at about 31-31.5 ◦C. However, the CP applicator measurements were affected by the
phantom starting temperature, which was about 1.5 ◦C higher than previous studies.
The captured muscle surface had a thermal distribution with peak temperature of
29.1 ◦C is shown in Figure 7.15b. The temperature is also greater at approximately 2.0
(a) (b)
Figure 7.15: Measured thermal distribution after 5-minutes of microwave exposure. (a)
phantom skin surface, (b) phantom muscle surface
Figure 7.16: Simulated thermal distribution after 5-minutes of microwave exposure. (a)
phantom skin surface, (b) phantom muscle surface
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◦C than the measurement of linear applicator II. Therefore, these set of measurement
were influenced by the background temperature. Taking this condition to account, the
corresponding result actually indicated skin temperature is reduced with CP antenna,
while muscle elevation is maintained the same for both polarisation. The simulated
muscle distribution in Figure 7.15b, shows peak muscle temperature is 1.0 ◦C lower
than the measurement. This clearly indicates the influence of room temperature to the
measurement.
7.5.2 Phantom Validation - Skin Cooling
The experiment was repeated with applied skin cooling, the recorded IR images are
presented in Figure 7.17. The skin thermal distribution shows an identical pattern to
the SAR study. The peak skin temperature was 26 ◦C with skin cooling, which is
about 4 ◦C lower. Moreover, Figure 7.17b is the measured muscle distribution with
identical peak surface temperature of 26 ◦C. In contrast, the reciprocal simulation result
is illustrated in Figure 7.18. The phantom simulation with skin cooling was 1.0 ◦C
higher than the measurement of the skin and muscle surfaces. The peak temperature of
both layers is consistent with the measurement. Therefore, the possible difference was
the background temperature. The performance of CP applicator is compared against
measurement of the linear Applicator II that was presented in Chapter 6 Section 6.6.4.
The results demonstrate the CP applicator can reduce the skin temperature by 2 ◦C,
while the muscle temperature was maintained the same for both polarisation technique.
This measurement conforms with the SAR simulation, where peal skin absorption is
reduced with CP applicator.
7.5.3 In-vivo Validation
The final study of CP applicator was based on thermal measurement on human calf.
The return loss of the applicator on the calf was repeated for each measurement, to en-
sure appropriate operating frequency for exciting CP. The first acquired thermographic
measurement in Figure 7.19a was without active cooling. The distribution on human
calf is not as clear with phantom measurement, due to the inclusion of blood perfusion
where the heat is regulated and diffused at a faster rate. Regardless, arc shaped warm-
ing profile is observed, which share equivalent features of the corresponding simulation
in Figure 7.20a. The modelled thermal distribution is based on the current tissue con-
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(a) (b)
Figure 7.17: Measured thermal distribution of CP applicator after 5-minutes of microwave
exposure. (a) phantom Skin surface, (b) phantom muscle surface
Figure 7.18: Simulated Thermal distribution of CP applicator after 5-minutes of microwave
exposure. (a) phantom skin surface, (b) phantom muscle surface
figuration of 1.0 mm skin and 7.0 mm fat layer. The peak skin temperature is 37.2 ◦C,
in contrast to 28 ◦C of the simulated skin model. According to the simulation model
to estimate the muscle temperature, which was 43.4 ◦C. Therefore, the total elevation
in the superficial layer is 6.9 ◦C assuming average skin temperature of calf is 30.3 ◦C
(see Figure C.5 for details). In contrast, the absolute elevation in the muscle is 6.4 ◦C
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(a) (b)
Figure 7.19: Measured Thermal distribution of CP applicator after 5-minutes of microwave
exposure on skin surface. (a) without active cooling, (b) with active cooling
(a) (b)
Figure 7.20: Simulated thermal distribution of CP applicator after 5-minutes of microwave
exposure on skin surface. (a) without active cooling, (b) with active cooling
assuming deep tissue temperature is 37.0 ◦C. This study is compared with the thermal
measurement of linear Applicator II, were peak skin temperature was 41 ◦C. This is an
increase of 3.8 ◦C over CP measurement and 0.4 ◦C lower in the muscle according to
the simulation.
The in-vivo measurement was repeated to incorporate active cooling. The captured
thermal distribution of human calf after 5-minutes of microwave exposure is presented
in Figure 7.19b, and the corresponding simulation in Figure 7.20b. By inspection, the
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measured thermal distribution shows an identical pattern of previous Applicator II with
two horizontal hotspots and two vertical cold spots. The peak temperature was 32.3
◦C that is only raised by approximately 2.0 ◦C of initial skin temperature. This is also
a reduction of 4.5 ◦C from the previously assessed Applicator II with active cooling.
The thermal distribution was validated with the numerical study, illustrating identical
thermal patterns. However, the peak temperature value is about 2.7 ◦C higher than
measurement. This was believed to be an anomaly in the measurement, which was
repeated and equivalent results were achieved again. Therefore, this large indifference
could be based on the optimal CP operation as a function of tissue composition. The
simulation model is based on fixed thickness, where the measurement can vary from
position to another, which may have enhanced the excited CP.
7.6 Chapter Summary
This chapter introduced alternative solution to reduce peak energy absorbed in the su-
perficial using the circularly polarised applicator. This approach promotes the electric
field vector to circulate at a given point in space as a function of time, which radiates
the EM energy in the diagnosed area. We have studied the techniques of achieving
CP by the use of either multi-fed or single-fed microstrip patch antenna. Specific ab-
sorption rate simulation of dual-fed and quad-fed applicators was investigated for early
stage performance assessment of CP. The observed result shows clearly the energy can
be distributed and effectively reducing peak SAR on the superficial layer. However, th
multi-feed approach was not desired for it sheer space limitation and additional require-
ment of a network divider. Consequently, single-fed design was adopted by introducing
perturbation and stubs to the original linear Applicator II model. The performance of
CP microstrip antenna was analysed by observing the S-parameter and surface current
distribution. The simulated SAR showed the CP applicator reduces the peak absorption
in the fat layer by about 28.8%, while muscle absorption was kept the same. The nar-
row impedance bandwidth and near-field operation were one of the major limitations
of CP applicator. Changes in tissue composition thickness, can result in deteriorating
the performance of CP. The design was developed, improved and fabricated for ther-
mal validation. The operating frequency of the applicator was in agreement with the
current simulation model in free space, on human calf and on phantom. The ex-vivo
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thermal distribution was in agreement with the EM model for with and without cooling.
The general trend was the skin temperature was reduced by around 1-2 ◦C when using
CP applicator. The experiment was repeated on human calf, and the results were con-
clusive showing a significant temperature decrease in either with or without cooling.
The reduction was about 3-4 ◦C in the skin, while simulation shows equivalent muscle
temperature. The overall trend the thermal distribution of simulation and measurement
are comparable with a certain degree of accuracy. However, with circularly polarised
applicator, the simulation was usually about 1 ◦C higher than measurement. This was
believed to be by the unpredictable CP performance as a function of tissue thickness.
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Chapter 8
Results and Discussion
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8.1 In-vivoMeasurement Preparation
This chapter integrates the microwave applicator with the hybrid system for in-vivo
thermoregulation monitoring. The developed microwave applicators was proven to be
capable of inducing localised heat in the muscle and superficial layers. The elevated
heat causes the blood vessels to dilate and therefore, change in tissue oxygenation.
These changes are measured with the integrated optical probes based on NIRS, which
is used for all physiological assessments. The study with Applicator I was based on
general tissue warming and was limited to only blood volume measurement with the
NIRS. Applicator II was then introduced to included numerous sensors for skin temper-
ature, blood flow and active cooling element. Therefore, comprehensive measurements
were obtained. This includes tissue oxygenation and blood flow during microwave
warming with and without active cooling. Each applicator has a distinguished protocol
which is essential to the result analysis. This will provide information regarding the
efficacy of the hybrid system in terms of superficial and deep tissue monitoring.
8.1.1 Safety and Ethics
The subject safety is always top priority during all in-vivo experiments. The main risk
factor arises from tissue heating over long exposure duration. Human experiments were
conducted only after simulation, and phantom validation was done. This ensures the
level of induced heat is within the estimation and under the safety margins. Typically
non-invasive microwave hyperthermia induces heat of about 42 to 45 ◦C over a duration
of 30 minutes. This is when cell death occurs over constant high temperature and long
period of time. The intention of the hybrid system, is to induce heat for sufficient
vessel dilation. This can be achieved over lower induced temperature at about 40-41
◦C in muscle and duration of just 5-minutes. The study acquired approval by the UCL
Ethics Committee for up to 5 human subjects. During the experiments, three male
subjects were recruited to participate in the study. The operator closely monitors the
power levels, skin temperature and the change in oxygenation levels.
Microwave exposure to surrounding is another factor that was considered for the
safety of operator and the subject. Measuring the leakage is a standard procedure for all
therapeutic applicators. When operating at microwave region of 2.45 GHz; the max-
imum power density must be less than 10 mW/cm2 at 5.0 cm away from applicator
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[58]. The power density in space equates to S = E2/377, where S is the power density
in W/cm2 and E corresponds to the electric field strength in (V/m). The 377Ω corre-
sponds to the intrinsic impedance of free space. The measurement in most scenarios
are achieved with use of external horn antenna operates at same frequency. This was
achieved using a wide-band horn antenna with Gain of approximately 11.0 dBi at 2.45
GHz and placed 5.0 cm away from the applicator. The horn is connected to a spectrum
analyser to measure the power leakage. The measured power for applicator II was -8.0
dBm (0.16 mW) when the horn antenna positioned along the radiating edge, which was
the maximum leakage. The obtained parameters are used in Equation 8.1.1, where Pr
is the received power and Aeff is the affective area of the receiver horn antenna.
Pr = AeffS (8.1.1)
The antenna effective area in Equation 8.1.2 describes the amount of EM power cap-
tured by the receiver antenna. Where G is the antenna power gain (unit less), hence
the horn antenna gain is converted to the power gain for the necessary calculation to
take place. The estimated leakage power density of applicator I was 4.0 µW/cm2, when
the applicator was operating at 5 watts. The calculated power density of applicator II
operating at 3 W RMS was 1.06 µW/cm2, and the operating power was 3 watts. In both
cases, the exposed microwave is lower than the standard limit of 10 mW/cm2.
Aeff = G
λ2o
4pi
(8.1.2)
8.1.2 Tissue Thickness
The fat thickness of two subjects was measured using an ultrasound scanner. From the
real time images, the thickness was estimated to be 6.8 mm and 5.0 mm for subject one
and two respectively. The measurement is combined with the physiological study listed
in Table 8.1. The estimation of tissue thickness was based on the contraction of muscle
calf. An example of subject one calf image is presented in Figure 8.1. Figure 8.1a is
the captured image when the muscle calf was relaxed. During contraction, the muscle
pushes outward with a dominant tissue movement apart from the superficial layers of
fat and skin as observed in Figure 8.1b. Consequently, it was possible to predict the fat
thickness of the tissue. The skin layer was not estimated, as it was difficult to measure
in this approach. The measured thickness contributed to the evaluation of the modelled
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fat thickness, which in turn the model was changed from 10.0 mm thickness to 7.0 mm
thickness.
(a) (b)
Figure 8.1: Measured fat thickness on subject calf using ultrasound imaging at different states.
(a) relaxed muscle, (b) contracted muscle
8.2 in-vivo Applicator I
Applicator I with the integrated optodes are housed in a rectangular foam as observed
in Figure 8.2a. Figure 8.2b shows how the device was securely placed on a calf with
elastic warping to ensure secure positioning and to eliminate external light to the optical
detector. The foam has typically an r approximately equivalent to free space, which
has negligible influence upon the antenna performance. The scattering parameter of
the applicator while placed on calf was initially measured for each subject to ensure
appropriate operating frequency. Figure 8.3 demonstrates the in in-vivo protocol for
Applicator I. The experiment procedure consists (i) Placement of applicator and ini-
tialisation of NIRS probes, (ii) begin NIRS measurement at rest for 180 seconds, (iii)
followed by microwave warming for duration of 5-minutes and (iv) stop microwave
warming and maintain rest duration for additional 5-minutes.
Figure 8.4 illustrates the time versus measured haemoglobin concentration of sub-
ject (a) one, (b) two. For both subjects, the concentration remained at a stable level
during the initial 1-minute of rest, which is expected as no temperature difference in-
troduced. During the 5-minute microwave exposure period, the ∆HbO2 and ∆HbT
increased, caused by the temperature elevated in the tissue. In contrast, no distinct
changes in the measured deoxy-heamoglobin concentration (∆HHb) during microwave
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(a) (b)
Figure 8.2: Measured fat thickness on subject calf using ultrasound imaging. (a) relaxed
muscle, (b) contracted muscle
 applicator 
placed on calf
Initilise NIRS 
monitor
 Start at rest
for180 sec
Microwave
on for 300 sec
End at rest
 for 300 sec
Figure 8.3: in-vivo Applicator I protocol
exposure, indicating, the vasodilation occurs in the arterial blood vessels. The thermal
response of the subject was estimated from the ratio between concentration increase
and the time duration of microwave exposure (5-minutes), hence the gradient of the
best-fit line fit for ∆HbT The response value (7.7×10−3 µ M/s)can be used to compare
the physiological changes between different subjects. After the microwave was turned
off, the ∆HbO2 concentration further increase for approximately 70 seconds, at which
thermal equilibrium is reached. This observed delay is defined as "latency". The heat
stored in the tissue from the exposure, takes longer time to dissipate before reaching
the original state, therefore, the blood vessels remained dilated. The subject blood per-
fusion continues to take the local heat away until the temperature approaches to normal
state. Consequently, ∆HbT began to drop as a result of the constricted blood vessel.
The latency can be defined a function of perfusion and thermoregulation process. The
estimated data for both subjects are listed in Table 8.1.
The measurement were repeated for subject two as depicted in Figure 8.4b. The
measurement have identical general response to the first subject, were∆HbO2 and
∆HbT both increases during microwave exposure. Moreover, ∆HHb decreases dur-
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Figure 8.4: Measured haemoglobin concentration during 5-minutes of Applicator I microwave
warming on human calf. (a) subject one (b) subject two
ing the exposure, which also indicate arterial dilation. The estimated thermal response
of subject two is larger than that of subject one, by almost about twice the difference
between the two measurements. This can be the explained by the different physiology
between the subjects. The other factor is the fat thickness difference, subject two has
fat thickness of 5.0 mm, in contrast to 6.8 mm to the subject one. This can be explained
by the fat thickness study of microwave applicator in Chapter 6, were larger EM energy
is deposited in the deep tissue as the thickness decreases. Therefore, this is a possible
influence of deep tissue warming combined with the already measured microcirculation
of the skin layer. The estimated latency of ∆HbT for subject two was about 69.5 sec-
onds before the response has dropped, which was approximately equivalent to subject
one.
The NIRS system used for Applicator I utilises SRS. Therefore, additional mea-
surements were obtained, and they are TOI illustrated in Figure 8.5a and nTHI in Figure
8.5b of both subjects. Tissue Oxygenation index of both subjects shows, various oscil-
lations which are random even during microwave warming. In contrast, the measured
nTHI of both subjects decreases with the applied microwave warming. This suggests
a reduction in blood volume, which contradicts the haemoglobin concentration mea-
surement. The normalised haemoglobin index is calculated based on attenuation slope
measured by the two spaced detectors. Therefore, decrease in nTHI means high op-
tical attenuation in the first detector(shorter spacing to the emitter). This only occurs
8.3. IN-VIVO APPLICATOR II 182
0 100 200 300 400 500 600
55
60
65
70
75
Time (sec)
T
O
I
(%
)
Subject one
Subject two
Microwave warming Rest
(a)
0 100 200 300 400 500 600
0.95
0.975
1
1.025
1.05
Time (sec)
n
T
H
I
Subject one
Subject two
RestMicrowave warming
(b)
Figure 8.5: Measured TOI and nTHI of two subjects during 5 minute of microwave warming
on human calf. (a) TOI % (b) nTHI
Table 8.1: Measured results for subject one using Applicator I
Subject
Fat layer
thickness (mm)
Thermal
response ∆HbT
(µM/s)
Latency (sec)
1 6.8 7.7 ×10−3 70
2 5.0 18.0×10−3 69.5
when the local blood volume dilation is closer to the detector„ which is dominated by
the superficial heating. The nTHI calculation also indicates; subject one had the larger
decrease. This can be explained by the increased fat thickness, which promotes super-
ficial heating, this was previously evaluated in the EM simulation study of fat thickness
in Chapter 5 Section 6.5.3.
8.3 In-vivo Applicator II
The protocol procedure for Applicator II was altered by introduction of LDF monitor,
which was not used simultaneously with NIRS measurement. Figure 8.6 shows the
protocol used for the study of Applicator II on three participated human subjects. Ini-
tially, the hybrid applicator was first placed on a subject’s calf shown in Figure 8.7.
The microwave applicator was switched off while the monitoring systems, including
the NIRS/laser Doppler and skin temperature sensors, were on for just monitoring pur-
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pose. The skin temperature decreased from approximately 32.5 ◦C to about 29.7 ◦C
depending on room temperature. This was another evident demonstration of the ap-
plicator passive cooling, which was illustrated in Appendix C Figure C.5. There were
also fluctuations of the tissue oxygenation signals (∆HbO2/∆HHb/∆HbT) at the start
of rest duration caused by the unsettled haemodynamics in the tissue. After both the
skin temperature and the tissue oxygenation signals became stable, the experiment then
began. The measurement for each subjects is classified into microwave warming with
and without skin cooling. Therefore, for each set of result the experiment was repeated
with different optical monitoring system. In the first experiment, LDF monitor was
used to measured the skin blood flow as the NIRS system was turned off to avoid op-
tical light interference between the two systems. The experiment is the repeated again
with the NIRS system to measure tissue oxygenation signals. The result is bases on the
following protocol: (i) 3 minutes of rest time is recorded and the skin temperature at
this point was used as a reference for cooling experiment, followed by (ii) 5-minutes of
microwave warming, and (iii) 4 minutes of rest duration with microwave warming off.
 applicator 
Placed on calf
Skin tempreature
 stablisation
Start at rest
for 180 sec
Microwave
on for 300 sec
Rest
on for 300 sec
Experiment repeated with the other optical modality
Using either NIRS or LDF
Figure 8.6: in-vivo Applicator II protocol.
Figure 8.7: Applicator II placement on human calf for in-vivo measurement.
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8.3.1 Subject One
Figure 8.8 shows the results of two independent experiments for subject one in terms
of flux, which is a relative measure of the skin blood flow in an arbitrary unit obtained
by the laser Doppler flowmeter. Figure 8.8a shows LDF measurement without skin
cooling, while Figure 8.8b is the result for the same experiment with active cooling.
In both measurements, the baseline skin perfusion was stabilised during rest duration,
with marginal decreases over time caused by the minor reduction in skin temperature.
The starting skin temperatures of both experiments at around 30.0 ◦C. During the mi-
crowave exposure, the result without skin cooling shows rapid change flux caused by
the dilation in capillaries, and hence skin microcirculation. After 5-minute of expo-
sure, the peak temperature approached 34.2 ◦C. When the microwave was turned off,
the perfusion and skin temperature began to drop rapidly as the heat being regulated
until approaching to original state over 5-minutes of rest duration. This result indi-
cates any measurement obtained by NIRS without cooling is expected to be influenced
by skin perfusion. The experiment was repeated with same subject with use of active
shown cooling in 8.8b. During the microwave exposure the skin temperature varied
within 1.0 ◦C over time, showing the effectiveness of the skin cooling system when the
skin temperature exceeded the preset threshold temperature. The flux signals during
microwave warming were also stable. The stability of flux signals and skin tempera-
ture suggests that the active cooling system has partially mitigated the hot spots on the
skin caused by the microwave applicator and subsequently prevented the skin blood
flow from significant changes. The peak temperature was maintained at around 30.0 ◦C
during warming, where the starting temperature was 29.8 ◦C. This was an increase of
just 0.2 ◦C. In contrast, without cooling the skin temperature was raised by about 4.1
◦C. The following step is to repeat the experiment with use of NIRS monitor.
Figure 8.9 shows tissue oxygenation changes in the tissue in terms of
∆HbO2/∆HHb/∆HbT, for two repeated experiment (a) without active cooling (b)
with cooling. The measurement without cooling in Figure 8.9a shows ∆HbO2 and
∆HbT gradually increases while ∆HHb decreases during microwave exposure, indi-
cating arterial warming. After the 5-minute exposure, the haemoglobin concentration
rapidly decreases as the temperature return to original state. The latency was just under
10 seconds, in contrast to 70 seconds of the previous applicator. This big difference
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Figure 8.8: Measured flux and skin temperature with 5-minutes of Applicator II microwave
warming for subject one. (a) without active cooling (b) with active cooling
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Figure 8.9: Measured haemoglobin concentration during a 5-minutes of Applicator II
microwave warming for subject one. (a) without active cooling (b) with Active cooling
was caused by the foam housing and warping of the Applicator I, which keeps tissue
temperature warm for longer duration. Applicator II uses HTC superstrate, which
increases heat dissipation. The experiment results with active cooling is depicted
in Figure 8.9b, showing unchanged characteristics in haemoglobin concentration for
about 4 minutes of microwave exposure. The microwave exposure was extended for an
additional 1-minute to some physiological changes, which was just about 0.25 µM/s
The thermal responses were obtained and listed in Table 8.2. This marginal increase
is resulted by the skin cooling which constricts the blood vessels and muscle dilation
in deep tissue. The physiology overcomplicates when the accumulation of cooling
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Table 8.2: Measured results for subject one using Applicator II.
Condition
Initial
temperature
(◦C)
Peak
temperature
(◦C)
Thermal
response ∆HbT
(µM/s)
Latency (sec)
NC 30.1 34.2 1.67×10−3 30.0
SC 29.8 30.0 0.78×10−3 10.0
and heating introduces. It is difficult to predict if the marginal increase was caused by
muscle dilation and therefore, further measurements are required.
8.3.2 Subject Two
The protocol was repeated for Subject two, and LDF results are shown in Figure 8.10.
During the 5-minutes of microwave warming the skin temperature peaked at 34.0 ◦C,
and the measured flux were fluctuating from baseline of 7.0 (A.U) to 22.0 (A.U). The
fluctuation was caused by unknown physiological reasons, which require further study.
After the microwave, warming was switched off, the temperature and flux gradually
decreased to original state. The second experiment based on same subject, but with
active cooling is demonstrated in Figure 8.10b. The protocol and applicator placement
remained the same. The starting skin temperature was at the steady state of 29.8 ◦C,
and during microwave, warming it was fluctuating (±0.4 ◦C) under the set point tem-
perature. The temperature oscillation is a resultant of thermostatic temperature control.
The flux result shows a small increase in skin perfusion after 3 minutes of warming.
This could mean the skin cooling was not sufficient to mitigate skin heating. However,
the flux seemed to decrease just before microwave was switched off.
Figure 8.11 shows the corresponding experiment with use of NIRS monitor pre-
sented for (a) without cooling and (b) with active cooling. The measured ∆HbO2 and
∆HbT increases during tissue warming and approaching steady state at about 4 min-
utes of exposure. The changes in ∆Hbb is of similar response but at minimal scale.
This contribution of response is from venous dilation; however, the increase in oxy-
hameoglobin was greater which, indicates the largest portion is from arterial warming.
The thermal response of subject two was higher than subject one as it did with Ap-
plicator I study, which was explained by the difference of fat thickness. Moreover,
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Figure 8.10: Measured flux and skin temperature with 5-minutes of Applicator II microwave
warming for subject one. (a) without active cooling (b) with active cooling
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Figure 8.11: Measured Haemoglobin concentration during a 5-minutes of Applicator II
microwave warming for subject two. (a) without active cooling (b) active cooling
when the microwave is off the temperature rapidly drops, with short latency, and again
consistent with subject one measurement. The results are listed in Table 8.3. The sec-
ond tissue oxygenation measurement with subject two using active cooling is shown
in Figure 8.11b. In the first 3 minutes of baseline recording before the microwave was
switched on, there were some natural, spontaneous variations in the tissue oxygenation
signals which were typical of NIRS muscle measurement. When the microwave was
switched on, both the ∆HbO2 and ∆HbT signals, and to a lesser degree the ∆Hbb sig-
nal, went up. This increment shows that the microwave applicator successfully induced
warming in the muscle, initiating vasodilation in the arterial blood vessels which carry
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Table 8.3: Measured results for subject two using Applicator II.
Condition
Initial
temperature
(◦C)
Peak
temperature
(◦C)
Thermal
response ∆HbT
(µM/s)
Latency (sec)
NC 29.7 34.0 6.67×10−3 10
SC 29.5 29.7 6.8×10−3 50
more oxygenated blood than de-oxygenated blood. After the microwave was switched
off, the ∆HbO2/∆HHb/∆HbT signals continued to increase for another 50 seconds
before they began to decrease. It should be noted that even after the microwave was
switched off, the skin temperature can increase above the preset threshold due to heat
diffusion from the muscle to the skin surface. The skin cooling system was therefore
operating during the rest duration for consistent measurement. The thermal responses
of both experiments were identical, indicating the cooling was not effective in reducing
skin perfusion. This was validated by the thermographic images in Chapter 6 Section
6.6, showing the introduced hot spots was under the NIRS optodes. Consequently, The
results for both experiments correspond to complete tissue heating from skin to muscle.
8.3.3 Subject Three
The experiment was repeated with the third participated subject, to verify if the mea-
surement were consistent. Figure 8.12 shows the LDF experiment for with and without
cooling as implemented previously. The initial temperature was 29.7 ◦C and was ele-
vated to 34.0 ◦C, a difference of 4.3 ◦C equivalent of other tested subjects. The changes
in flux were small in contrast to previous subjects. However, it is observed just to-
ward the end of 5-minutes of microwave exposure. The subject skin perfusion was less
sensitive to skin temperature change. During the rest period, the flux and temperature
reduced accordingly as expected. The study was repeated with active cooling, where
the temperature was held at about 29.8 ◦C. The measured perfusion shows a general
decline of baseline during the microwave warming, and larger flux attenuation was ob-
served only during the warming. This is believed caused by the instantaneous cooling
and the warming mechanism producing ripples in flux. When the microwave turned
off, the flux increases slenderly to normal state. This result concludes the skin was
8.3. IN-VIVO APPLICATOR II 189
constricted, hence the reduction in blood perfusion.
Figure 8.13 shows the tissue oxygenation changes in the localised tissue in terms
of ∆HbO2/∆HHb/∆HbT signals. Without cooling, the blood volume increases rapidly
with microwave warming, and peaking at the end of the 5-minute exposure identical
to the LDF measurement. When RF is off, the decline in ∆HbO2 and ∆HbT was also
rapid, with latency of only 5.0 seconds. The result is identical to previous subject,
where the haemoglobin signals are dominated by superficial dilation. The repeated ex-
periment with active cooling in Figure 8.13b shows an increase in concentration signals
after 40 seconds of tissue warming. After 18 seconds of switched off microwave, the
blood volume immediately began to contract corresponding to the temperature drop
in tissue, where the cooling was not influenced by. The thermal response with active
cooling was surprisingly larger by 1.4 ×10−3 µM/s than the measurement with just
tissue warming. It was expected with skin cooling the dilation in superficial layer is re-
duced and therefore, the measured signals are dominated by the muscle haemodynam-
ics. However, as previously mentioned Applicator II thermographic results indicate hot
spots are apparent directly under the NIRS optodes, which has influence to the deep
tissue measurement. The thermal response and temperature measurement of subject
three is listed in Table 8.4
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Figure 8.12: Measured flux and skin temperature with 5-minutes of Applicator II microwave
warming for subject one. (a) without active cooling (b) with active cooling
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Figure 8.13: Measured haemoglobin concentration during a 5-minutes of Applicator II
microwave warming for subject thre. (a) without active cooling (b) active cooling
Table 8.4: Measured results for subject three using Applicator II.
Condition
Initial
temperature
(◦C)
Peak
temperature
(◦C)
Thermal
response ∆HbT
(µM/s)
Latency (sec)
NC 29.7 34.0 4.6×10−3 5
SC 29.8 30.1 6.0×10−3 18.0
8.4 in-vivo Applicator III
Applicator III was developed to minimise the superficial heating caused by the mis-
placement of the active coolers. Consequently, the NIRS and LDF signal are expected
to be reduced due to the deficiency of skin dilation. The measurement was limited
to a single subject with interchanging protocol. The procedure begins with applica-
tor placed on a human calf for about 10-minutes until the skin temperature is sta-
bilised. Monitoring devices starts recording blood flow and skin temperature during
the 5-minutes of rest duration. Then microwave is turned on for 60-minutes at 30 dBm
(1 watt RMS) RF power for the first set of experiment without active cooling. In the
second case the experiment is then repeated with skin over-cooling. The final sce-
nario was based on 15-minutes of exposure at 34.8 dBm (3 watts RMS) with moderate
skin cooling (maintaining temperature). After microwave warming is switched off, the
monitoring system records the remaining rest duration.
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Figure 8.14a, shows the LDF measurement of the subject without skin cooling.
The graph shows some fluctuation in flux for the initial 5-minute of rest duration, which
may have led by various physiological changes. The skin temperature was stabilised at
29.6 ◦C during the rest duration. When the microwave warming is activated, the skin
perfusion immediately increased with the temperature simultaneously, which could be
part of the natural variation. However, after 15-minutes of microwave exposure the flux
continues to increase with the elevating temperature until approaching steady state after
55-minutes. The temperature peaked at 33.2 ◦C. This finding clearly indicates the skin
is vasodilated. The microwave was switched off, and it can be seen the temperature and
skin blood flow decreases over the time. The experiment was then repeated with skin
over-cooling as demonstrated in Figure 8.14b. The set point temperature was 1.0 ◦C
lower than initial temperature. During the rest duration, the flux was sustained and the
average skin temperature was maintained during the microwave warming. This indi-
cates the skin cooling mitigated the skin warming, and therefore, skin was not dilated.
The temperature was decreased during the exposure as it was expected by 1.0 ◦C. The
microwave and cooling system were then turned off, which caused the temperature to
rapidly increases by 3 ◦C (at 4,000 seconds). This was caused by the Peltier cooler hot
junction diffused to the cold junction when the cooling system are disabled after long
operation. Incidentally during this external resistive heating in rest time, it can be seen
the skin blood flow has increased with the respect to the change in temperature. This
result is significant as it can verify during the 60-minute of microwave warming the
skin was not dilated, and therefore, the muscle warming will be more effective.
The experiments were repeated on the same subject but with use of NIRS, the mea-
sured results are illustrated in Figure 8.15. In the first case illustrated in Figure 8.15a
was without skin cooling. The temperature and the haemoglobin concentration signals
were stabilised in the initial 5-minute (rest time) followed by microwave warming. The
skin temperature noticeably increases from the initiation as it was demonstrated pre-
viously in Figure 8.14a. However, ∆HbO2 and ∆HbT concentration increased only
after the 12-minutes of microwave exposure at which the temperature was elevated by
about 2.5 ◦C. In contrast, the previous LDF measurement had a large natural varia-
tion at the start, and only 12-minute of exposure, the increase was rapid and identical
to the NIRS measurement. Both results are in agreement and clearly demonstrating
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Figure 8.14: Measured flux and skin temperature with 60-minutes of microwave warming
using Applicator III (1 watt). (a) without active cooling (b) with active cooling
the NIRS response was primarily from skin vasodilation. The ∆HHb concentration
decreases during the microwave warming indicating an increased blood flow in the
tissue. The blood volume gradually returned to initial state during the final rest du-
ration when tissue warming was turned off. The measured thermal response in Table
8.5 is 0.83 ×10−3 µ M/s, which is lower than previous measurement by the factor of
six to nine times due to the low RF power. The latency was not applicable for these
experiments, because the temperature and the NIRS measurements have reached the
steady state before turning microwave off. The procedure was repeated with active
skin cooling. Figure 8.15b illustrates the NIRS signals for microwave exposure on the
subject calf with skin over-cooling by approximately 1◦C below the initial temperature.
The corresponding ∆HbO2 and ∆HbT concentration has decreased with respect to the
microwave warming while deoxy-haemoglobin was relatively stable. The estimated
thermal response as shown in Table 8.5 was -0.08 ×10−3 µ M/s, which is unlike the
previous NIRS responses, were the blood volume generally increase even with skin
cooling. This behaviour is known when the arterial vessels are vasoconstricted, which
can be expected when tissue is cooled. This physiological effect is masking the haemo-
dynamics changes from deeper tissue, and therefore, it is unknown if the muscle was
dilated. In Chapter 6 Section 6.7, it was illustrated in the simulation studies, the muscle
temperature was increased despite skin over-cooling, and it was verified with thermal
images of the skin. After microwave warming is turned off, ∆HbO2 and ∆HbT stopped
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decreasing but rather began to fluctuate. In contrast, ∆HHb remained fairly stable.
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Figure 8.15: Measured haemoglobin concentration during a 60-minutes of Applicator III
microwave warming (1 watt). (a) without active cooling (b) active cooling
Table 8.5: Measured results for subject one using Applicator III.
Condition
Initial
temperature
(◦C)
Peak
temperature
(◦C)
Thermal
response ∆HbT
(µM/s)
Latency (sec)
NC 29.6 33.2 0.83×10−3 NA
SC 28.8 30.8* -0.08×10−3 NA
* Peak temperature after microwave was switched off.
Figure 8.16 shows the NIRS measurement with moderate skin cooling set at 0.2 ◦C
below starting temperature. The output microwave power was increased to 3 watts for
shorter exposure duration to minimise excessive muscle heating. The initial 3-minutes
of microwave warming shows a decrease in haemoglobin concentration, which was
caused by the initial triggering of the skin cooling. For the remaining 12-minutes of
microwave warming, ∆HbO2 and ∆HbT concentrations have increased steadily above
the baseline opposing to decreasing ∆HHb The change in blood volume was about 0.5
×10−3 µ M/s, which is about three to four times smaller than the previous measure-
ment (Applicator II) with skin-cooling. Subsequently, The new cooling geometry in
Applicator III is effectively minimising skin dilation. This also implies, that the blood
volume changes in deeper tissue was possibly the dominant factor in this measurement,
where the skin was not over-cooler or warmed up as previously. After microwave is
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Figure 8.16: Measured haemoglobin concentration during a 15-minutes of Applicator III
microwave warming (3 watt) with moderate skin cooling
switched off, ∆HbO2 concentration decreases and returns to original state, where as
∆HbT ∆HHb continues to decrease. This effect might be the response to the resistive
heating produced when the cooling system is switched off, by which the skin is warmed.
The duration is about 5-minute at which temperature rise and return to original state.
8.5 Chapter Summary
This chapter introduced the procedure and the results of the in-vivo study. The results
were presented and discussed accordingly for the first two introduced applicators. As
part of aim of this project, detecting thermal response induced by microwave warming
was achieved in Applicator I measurement The result clearly shows a rapid increase
in the local blood volume when microwave warming was on, and hence dilating the
blood vessel. The study on two human subjects was analysed based on identical proto-
col, at different fat thickness. The result illustrated an increase oxy/total-hameoglobin
concentration for the subject with thinner fat thickness. This study coincides with the
preliminary EM simulation result, indicating larger muscle warming is achieved with
thinner superficial tissue layers. This was an early indication of deep tissue warming,
and thermal responses were measured and presented for each subject.
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Applicator II was introduced for additional in-vivo investigation on three human
subjects. The thermal responses of the first two subjects were conclusive with the
results of Applicator I. The measurement showed subject two with thinner fat thickness
had a larger thermal response in both scenarios with and without cooling. Subject three
NIRS signals also responded to the microwave warming, particularly when cooling
was used. The addition of LDF monitor indicates the cooling system was sufficient in
reducing local superficial dilation. However, the thermal measurement from previous
chapters shows that the NIRS signals are still likely to be dominated by skin heating
introduced under the optodes of NIRS.
Applicator III was introduced for brief study using alternative protocol, to investi-
gate the hybrid system operation over longer duration and with efficient skin cooling.
The results indicates, the tissue can still dilate under lower microwave power. Mi-
crowave exposure over longer duration allowed the temperature and the haemoglobin
concentration to reach the steady state before turning it off. The measurement with
skin over-cooling causes the blood flow in the superficial layer to constrict and there-
fore ∆HbT concentration was decreasing during microwave warming. The muscle
response was masked by this effect. The final experiment with standard cooling proto-
col, proved to be an essential result. This measurement indicates the skin dilation was
reduced by four times of the previous applicator design, and demonstrating the muscle
response is considerably smaller than the superficial layers. These results demonstrate
different approaches and methods to minimise skin perfusion. Consequently, this also
agrees with the theory, were the skin perfusion is significantly larger than deeper tissue
and possibly faster response to environmental changes.
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Chapter 9
Conclusion and Future Work
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9.1 Summary of Findings
The work presented in this thesis involves multi-disciplinary prospective of RF en-
gineering in the medical field. The aim during the PhD, was to develop a novel non-
invasive probe to investigate the human thermoregulation, with particular interest in the
muscle responses. An effective heater is one crucial component of a thermoregulation
monitor. The current commercial solution is a simple resistive skin heater which has
limited penetration. In this work, a tissue warming has been proposed by exploiting mi-
crowaves to induce heat in the tissue, including superficial and deep tissue. An optical
NIRS probe has also been integrated with the microwave applicator to monitor tissue
oxygenation changes in the tissue in response to local warming. All developed applica-
tors were based on microstrip antenna design, for ease of fabrication and compactness.
Various microstrip applicator designs were developed in this thesis, primarily aimed at
improved coupling and skin heating reduction by specific applicator design and the use
of active cooling. Each applicator was modelled and fabricated for thermal validation
and in-vivo study. The probe was controlled by the developed hybrid system, which
included microwave, cooling and NIRS system. The microwave system was fully func-
tional, delivering the desired power to the applicator, while monitoring the operation
for predefined safety mechanism. In later stages, LDF probe was introduced for addi-
tional monitoring of skin perfusion alone. This served as a validation tool to confirm
the blood volume increase in NIRS signals were dominated by superficial or deeper
tissue.
In the development stage, the interaction of EM fields in the biological tissue has
been modelled to optimize the applicator coupling to the skin, which directly affects
the penetration depth of EM energy and reduction of superficial heating introduced by
the standing waves. The simulation study showed that the superstrate thickness can
significantly alter the SAR pattern and particularly coupling the energy into the tissue.
For a deep and uniform SAR deposition, the simulations suggested a superstrate thick-
ness of 5.0 mm, the absorption spreads across the tissue, rather than localized spots
at the fat / skin interface. Thicker superstrate, meant the applicator operating at the
radiative near-field region, where the E-field components are tangential to the tissue,
and hence enhancing penetration depth. In contrast, thinner superstrate causes the in-
teraction with the tissue at the reactive region, where the fringing fields at the radiating
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edges are perpendicular components to the tissue, and therefore, producing hot spots in
the superficial layer. Regardless, Applicator I was used for preliminary study of gen-
eral tissue heating. Therefore, a superstrate of 1.58 mm was opted for the developed
applicator with appropriate output power to ensure the warm spots are controlled. The
thermal simulation result shows that the temperature in the muscle can be elevated by
about 4 ◦C, also the skin and fat layers were warmed up as well, causing blood volume
to increase in all layers. The applicator was fabricated, and the measured S-parameter
indicates that a 100 MHz shift in resonance frequency, the discrepancy was due to the
composition of patient tissue thickness with respect to the simulation modelled. With
applicator was developed, a validation medium was required. This was achieved with
the fabricated tissue phantom, which mimics the electric properties of biological tissue
at 2.45 GHz. The developed phantom consisted of multi layers, including, skin, fat
and muscle. The dielectric properties of each layer were verified against the paramet-
ric model developed in the literature. The phantom electrical properties were nearly
identical to the biological tissue. However, the thermal characteristics remained undis-
covered. The mimicked tissue was then used to validate and calibrate the thermal simu-
lation model for the developed applicators. The ex-vivo thermographic images showed
identical thermal distribution to the numerical study. Moreover, muscle warming was
demonstrated as well as to skin hot spots.
The developed Applicator II, was based on annular ring microstrip antenna with
increased bandwidth and reduced radiating element size. The new design uses HTC
substrate material, active cooling elements and LDF monitor. The thermal simulation
and measurement on human phantom both indicate reduction of superficial warming by
about 4.0 ◦C of the Applicator I. The thermographic measurement showed the cooling
was not efficiently reducing skin hot spots due to the geometrical placement of Peltier
cooler. The superficial hot spots are located under the optodes. Consequently, Applica-
tor III was introduced to enhance cooling efficiency by placing TE cooler on the same
axis as the radiating edges. The thermal measurement showed skin temperature with
active cooling was reduced from 36.8 ◦C of Applicator II to 33.2 ◦C with the updated
design. While the cooling effectively reduced skin heating, the muscle temperature
was sufficiently higher for deep tissue dilation. All linear polarised applicators showed
a consistent validation with the numerical study, often there are fluctuation at about
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1.0 ◦C caused by the room-temperature change during each experiment. Applicator III
operation was also verified with the in-vivo study. The measured results showed the
skin dilation was eliminated with the use of skin over-cooling. In contrast, it the tem-
perature was only minimised when using standard cooling protocol. The analysis have
showed the skin dilation dominates all other responses particularly from deeper tissue
due to the increased blood perfusion in the superficial layer. Therefore, the changes
in haemoglobin concentration in the final measurement was marginal, indicating the
response could have been dominated by the arterial vessels within the muscle. Despite
the effective cooling, we still believe superficial warming was not completely elimi-
nated (in a cooling standard protocol), thus a large-scale investigation is required to
verify these studies.
While the focus was on active cooling to reduce skin hot spots, an alternative ap-
proach was introduced using circular polarisation. CP Applicator was developed for
distributing the EM field in all directions, therefore, reducing peak absorption in a par-
ticular region. The developed applicator was based on single-fed CP microstrip design.
The early numerical analysis indicated the superficial peak SAR was reduced by ap-
proximate 28.8 % when using CP applicator. As with previous design the antenna
was validated on phantom, and human subjects. The measured skin temperature was
32.30 with active cooling, which was an indication of superficial heat reduction. On
the contrary, the major restriction of single fed-CP was the limited impedance band-
width. For optimal operation, the input reflection coefficient was measured before each
experiment, to spot the intersection between the two modes (CP excitation). The per-
formances of all developed applicators are listed in Table 9.1 for in-vivo experiment
and Table 9.2 for the phantom measurement. This result clearly shows the develop-
ment process, where superficial heat is being reduced from one applicator to another.
However, the bandwidth and operating frequency was enhanced between each model
converging to the required operating frequency of the 2.45 GHz ISM band. SAR ratio
of muscle to skin is also listed in table for contrasting current and original numerical
models.
The purpose of applicators was to introduce dilation to local tissue, for optical
monitors to measure the changes. The oxygenation result has validated the operation
of the applicator. The thermal response indicated that an increase in blood flow due
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to the microwave heating. However, the skin hot spots in applicator I contribute to the
obtained oxygenation measurements. Since NIRS measurement is more sensitive to
changes in the superficial layer, therefore, the measured thermal response was predom-
inantly due to the change in skin blood flow. The two investigated subjects had distinc-
tive physiological responses, which partially caused by the difference in fat thickness.
This was an early indication of muscle response, as lower fat thickness will increase
thermal response due to larger EM penetration in deep tissue. Experiment trial was
repeated for Applicator II with the incorporated skin cooling system which can reduce
superficial hotspots caused by the microwave warming. In addition, a temperature sen-
sor and a laser Doppler probe were also incorporated with the applicator. The hybrid
monitor was used for in-vivo human experiment on calf. The LDF result showed a de-
crease in microcirculation during microwave warming with active cooling. However,
the LDF and temperature measurement is located at the centre of the applicator. There-
fore, the measurement is only valid for localised region. Based on those reasons, the
measured NIRS signals (∆HbO2/∆HHb/∆HbT) with and without skin, cooling had
large thermal responses, subsequently the vasodilation was also in all tissue layers. All
the obtained measurement indicated the hybrid system can successfully induce heat
into the muscle and simultaneously can be detected along with the superficial blood
volume. The new developed applicators will be used to reduce the skin dilation, with
its effective cooling technique.
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9.2 Future Work
The experience gained from the carried out work in this thesis is invaluable, and con-
sequently, can be used to highlight the prospective development of the hybrid system.
This section discusses some of the upcoming and future development of the system
which is sub divided accordingly.
Applicator
• Further investigate the use of thicker superstrate layer at 3.5 to 5.0 mm. This
essentially allows for uniform deposition of EM energy since it will be operating
in the radiating near field. In this configuration, a TEC module can be placed right
at the centre of the applicator for equally even cooling distribution. The obvious
limitation of this configuration is the increase of thermal resistance, hence the
requirement of in-depth study on the efficiency of the cooling in this method
with higher HTC material.
• Applicator III showed a potential of mitigating skin temperature. However, the
feed point and transmission line had an influence to the elevating skin tempera-
ture. This problem can be resolved by either increasing superstrate thickens or
by increasing substrate dielectric properties to confine the fringing field within
the medium. The SAR deposition will also be enhanced by this approach, as the
transmission line is not radiating to the tissue.
• CP Applicator has a potential if multi-feed approach is adopted. This can be
implemented with exploitation of transmission approach used in Applicator III.
Dual-fed transmission line can be implemented to provide consistent CP excita-
tion regardless of tissue thickness. This is achieved with two orthogonal inset
transmission line with the coaxial feed point can be implemented from the side
of the applicator to provide larger surface area for the TEC placement.
• The leakage power was relatively low and under the standard. However, mi-
crowave absorbing material will be added inside the applicator to reduce leakage
to the patient and interference to other devices.
• Developed applicators may require SAR validation in the future, for deeper un-
derstanding and validation to the simulation model. This step is essential in ver-
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ifying the absorption caused by the feed point, where it is expected to be signifi-
cantly higher than simulation.
• The applicator placement on human calf, provided some discomfort to the sub-
jects from the straps. Additionally, on some occasion the applicator placement
was not even on the surface, where one strap is tighter than other. This could
introduce air gaps between applicator and tissue, where the undesired effect may
occur. This was just recently resolved with the use special calf wrap that covers
the applicator for even placement to human subject as shown in Figure 9.1.
Figure 9.1: Applicator embedded into a calf wrap.
Cooling system
• The current system is based on thermostatic approach, which has its limitation
with the continues temperature variation (hysteresis) of 1 about 1 ◦C. This can be
mitigated with use of PID controlled for gradual applied cooling. This is already
in working progress, where H-bridge MOSFET configuration is currently added
to control the TEC. Therefore, only PID program will be implemented on the
microcontroller.
• One of the limiting factors of the cooling system, is the feed back temperature
which is allocated at the centre of the applicator. The cooling system aims to
maintain the skin temperature at that specified local region. Consequently, For
sufficient monitoring and cooling the temperature probe needs reallocation in a
more effective region. Furthermore, investigate other techniques with an embed-
ded SMD thermistors to the superstrate or by optical thermometry.
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• Dividing the peltier coolers into smaller multi elements array configuration will
provide a configurable cooling. This is useful to cover the entire region of the
applicator, and each element can be configured to specific cooling power with
respect to geometry and the microwave heating pattern.
RF system
• The system requires RF isolator for protection from high-power reflection when
the applicator is not matched to tissue. This can be easily integrated between the
bi-directional coupler and applicator.
• Calibrated VSWR measurement, which can be achieved by collecting all series
of measurements of terminated cable, just terminated system to eliminate the
standing wave produced by the cable. In addition, real time system response is
measured and can be a self-correction by data processing.
• From our studies, we have never surpassed output power of 5 watts RMS. There-
fore, RF system could be miniaturized with selection of low gain power amplifier
and system integration onto single PCB.
• Embedding the user interface to LabView is an essential step to combining si-
multaneous operation of microwave and optical systems.
Optical system
• The operation of NIRS and LDF monitors cannot be used simultaneously at the
same time, which is caused by the light interference. This can be mitigated by
sampling the lasers of each system accordingly to prevent such interference.
• The current NIRS system is based on a simple CW with the single detector at
predetermined separation. Deploying NIRS system based on SRS would be an
interesting for enhancing validation and understanding of the hybrid system con-
cept. This allows to include several detectors spaced accordingly for blood vol-
ume measurement at different depths. This technique can be used for.
• The LDF monitor provides an indication of skin perfusion by a measure of blood
velocity. The data cannot be fused with the NIRS measurement as it is completely
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irrelevant. However, an added expansion to the used LDF system (moorVMD-
OXY) will allow the same probe configuration to monitor the skin oxygenation as
well as the perfusion. This could be useful for directly comparison of skin oxy-
genation with the deeper measurements obtained by the NIRS. This will provide
further insight of blood volume contribution from the muscle.
Protocol
• The majority of studies have been focused on short duration of 5-minutes of
microwave exposure. It is important to understand human physiological respect
to the induced warming and duration. We are currently exploring other protocols
such as operating at approximately one hour of exposure and with just 1 Watt
of RF power. Change in protocol requires adaptation of RF and cooling power
levels until optimum solution is met.
• Larger clinical trial with at least 20 subjects is required for statistical analysis and
allows for further evaluation of different parameters, including age, gender and
placement of the applicator.
• Distinguishing core applicator, as have been discussed previously this technology
can be used already used for diagnostic of superficial layers in many clinical
areas. However, we are aiming at deeper tissue studies such as with free flap
reconstruction and perhaps other domains might be promoted after larger-scale
trials.
207
Appendix A
Phantom Preparation
The general phantom preparation procedure based on literature is shown below.
• Mix p-toluic acid powder with propanol, place in a beaker which is placed in a
hot water bath, let the acid dissolve.
• With stirring insert bloom gelatin with de-ionized water.
• Mix both solutions in a beaker and cover with cling film to avoid evaporation,
place inside the hot water bath for uniform heating.
• Use kitchen thermistor to monitor the solution temperature.
• When the mixture reaches approximate 85 ◦C it should be clear and no air bub-
bles on the surface of the solution.
• Remove the beaker and stir the mixture to remove any air bubble from the surface.
• Immerse the beaker in a cool bath of water and Stir the mixture until it cools to
50 ◦C and add liquid detergent (fairy liquid).
• In parallel heat up the oil solution to approximately 50 ◦C, then pour the gelatin
solution to the oil solution at 50 ◦C with continuous stirring until the solution.
becomes uniform of single color.
• Cool the emulsion to 40 ◦C by immersing the beaker to the water bath, at this
point no longer need to stir.
• Cool the solution to approximately 35 ◦C, and pour into the container for mold-
ing.
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Appendix B
System Design
B.1 Microwave System Characteristics
This section presents the measured characteristics of the microwave system. The
measurement’s compromise of scattering parameters of individual components, by
analysing through measurements (|S21|). The measurement was possible with full two
ports calibration Rohd&Shwarz ZVH8 network analyser (VNA). Figure B.1 shows the
measured |S21| of the digital step attenuator at user defined attenuation of 0 dB, 7 dB
and 15.5 dB. The insertion loss of the attenuator at the reference point (no attenua-
tion) between the frequency of interest 2.4-2.6 GHz was approximately 2.5 dB, which
matches the manufacturer specification. However, at 7 dB attenuation the in line lose is
almost negligible; this is occurring due to the change in impedance with respect to at-
tenuation step. The in-line loss was approximately 2 dB, during the maximum applied
attenuation of 15.5 dB. The fluctuation of insertion loss has an impact to the actual
delivered power during the diagnosis when variable power might be of interest. This
factor is mitigated with the use of power meter and adjusting the attenuation accord-
ingly.
The characteristics of band pass filter using through measurement is shown in
Figure B.2. The 3 dB cut of is between 1.7 to 3.2 GHz, the maximum insertion loss in
the pass band at the desired frequency is about 2 dB. About 35 dB rejection at about 4
GHz, which is essential for minimizing harmonics.
Figure B.3 shows the measured |S21| characteristics of the RF power amplifier. To
measure the high-power amplifier, was achieved with 10 dB and 40 dB input output
attenuation to prevent damage to the VNA. The characteristic of each attenuator was
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Figure B.1: Characteristics of digital step attenuator.
1 1.5 2 2.5 3 3.5 4
−70
−60
−50
−40
−30
−20
−10
0
Frequency (GHz)
|S2
1| (
dB
)
Figure B.2: Characteristics of band-pass filter.
obtained and subtracted from the full measurement. The amplifier stand-alone reading
is presented in Figure B.3, using a reference input power of 0 dBm. At frequency range
of 2.4-2.6 GHz, the gain of the amplifier was estimated at 44 dB with fluctuation of
about 0.5dB , in contrast to 45 dB gain in the data sheet. The maximum saturated
output power is 42dBm (approximately 16 watts) given by the data sheet.
The Bi-directional coupler has four ports, through measurements were completed
with two ports at a time, while other ports are terminated with 50Ω match load. Port
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Figure B.3: Characteristics of RF power amplifier.
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Figure B.4: Measurement of bi-directional coupler.
1 and port 2 and the input and output respectively. Port 3 and ports 4 are the coupled
input and reflected power correspondingly. The measured |S21|, |S12| shown in Fig-
ure B.4, where the insertion loss is just a fraction at about 0.25 dB and have linear
characteristics between 1-3.5 GHz. This clearly indicates there is no isolation between
the input and output port. This indicates the system is vulnerable without any reverse
high-power protection. The through measurement of coupled ports |S31|, |S42| show an
approximately 20 dB coupling between input and the forward coupled port and similar
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characteristics for output to reverse coupled port. The power received at the coupled
ports are always 20 dB lower of original signal, which is necessary to estimate the
actual delivered and reflected powers. The coupled port has non linear characteristics
with the operating frequency; however, it can be neglected at the operating frequency
range.
B.2 Thermoelectric Theory
Cooling or maintaining a temperature of an object can be achieved by defining the
cooling requirements. This includes the amount of heat to be dissipated (pumped away
by the TE), the heat sink efficiency along with forced-air cooling. Low heat loads
require reduced TE power unless further cooling is desired. The heat load can be either
active, passive or both simultaneously. Active head loads are generally related to the
power of device being cooled, and this is expressed by the standard power equation
shown in equationB.2.1. In hybrid applicator scenario, this active cooling is directly
related to the absorbed RF power in the tissue.
Qactive = V
2/R = V I = I2R (B.2.1)
the parasitic or passive heat load’s compromise of conduction, convection and
radiation. In most applications, including hybrid applicator, the conduction heat load
is the most superior and considered in the effectiveness of TEC devices. The general
expression for passive heat load (Q, watts) is described in equation B.2.2.
Qpassive = Qcond +Qconv +Qrad (B.2.2)
Heat is transferred by internal collision means of an object resulted by changes
from high to a low-temperature region. Heat conduction occurs in the entire thermal
model, from heat transferred from the skin surface to the applicator to TE module
and finally to the heat sink for dissipation. The basic equation of heat transfer by
conduction (Watts) in the steady state is given by equation B.2.3. Where k, A and
L are thermal conductivity (W/m◦C), cross sectional area (m2) and length of the heat
path (m). Temperature difference (◦C) between hot and cold objects is represented by
Th and Tc
Qcond =
kA
L
(Th − Tc) (B.2.3)
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The remaining passive heat loading is from convection, give by equation B.2.4.
Where h is convective heat transferee coefficient (W/m2◦C). Convection is considered
for heat transferred from the surface of heat sink and applicator.
Qconv = hA(Th − Tc) (B.2.4)
In the case of hybrid system operating in short duration time, when the thermal
equilibrium of the system is not met, it is essential to model as a transient temperature
change as shown in equation B.2.5. Where t is the time interval (seconds), m is the
weight of object (kg),Cp is the specific heat capacity (J/(kg ◦C)), ∆T is the temperature
change (◦C) and Q is the added or removed heat (Watts).
t = (m× Cp×∆T )/Q (B.2.5)
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Appendix C
Applicators Design
C.1 Applicator I
C.1.1 Design Parameters
Table C.1: Applicator I parameters
Parameters Dimensions (mm)
lp (Patch element length) 34.9
wp (Patch element width) 44
fl (Feed position from centre) 10.5
de (optical emitter diameter) 8
ls (optical emitter/detector separation) 38
al (substrate length) 47.3
wa (substrate width) 51
h1 (substrate thickness) 1.587
h2 (superstrate thickness) 1.587
C.1.2 Original Simulation Model Thermal Study
Superstrate thickness comparison with the original simulation model with 2 mm skin
and 10 mm muscle thickness. Thermal distribution are illustrated in Figure C.1, where
(a and c) are the 1.6 mm thick and (b,d) is the 3.2 mm superstrate thickness .The peak
temperature profile presented in Figure C.2. The results clearly indicate the advantage
of 1.6 mm superstrate over thicker dielectric material. The peak temperature in yz-plane
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are equivalent in the skin-fat interface for both thickness. However in the xz-plane, the
1.6 mm superstrate was 4 ◦C lower in the skin layer and just 1.5 ◦C lower in the muscle.
Figure C.1: Thermal distribution at of simulated patch antenna at different superstrate
thickness. (a,b) yz-plane at 1.6, 3.2 mm thickness, (c,d) xz-plane at 1.6, 3.2 mm thickness
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Figure C.2: Peak temperature at different superstrate thickness after 5-minutes of exposure. (a)
across yz-plane, (b) across xz-plane
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C.1.3 Phantom study
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Figure C.3: Measured Thermal distribution on phantom surface without heating, (a) Phantom
tempreature, (b) Phantom temperature with applicator placed (passive heating)
C.2 Applicator II
C.2.1 Design Parameters
Table C.2: Applicator II parameters.
Parameters Dimensions (mm)
Do (Element external diameter) 29.6
Di (Element internal diameter) 9.0
fp (Feed position from centre) 8.50
lo (Substrate/superstate diameter) 55.0
Ct (Exterior housing thickness) 7.35
Dl (LDF probe diameter) 6.0
Dn (NIRS optodes diameter) 10.0
Ns (NIRS optodes separation) 40.0
h1 (Substrate thickness) 1.52
h2 (Superstrate thickness) 2.0
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C.2.2 Cooling Element
Figure C.4 illustrates the measured thermal distribution at the surface of Applicator
II with active cooling. It can be seen, the cooling distribution is clearly non-uniform,
although uniformity may also be a function of time, thermal resistance and area. As
previously shown the heating pattern on the skin surface have an identical distribution,
therefore positioning the TE module on the radiating edges may significantly reduce
the superficial hotspots.
Figure C.4: Captured thermal image of Applicator II surface with active cooling
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C.3 CP Applicator
C.3.1 Design Parameters
Table C.3: CP Applicator parameters
Parameters Dimensions (mm)
wn (Notch width) 5.0
ln (Notch length) 4.2
Dz (Element External diameter) 29.4
Du (Element Internal diameter) 8.0
fs (Feed position from centre) 11
Dr (Element Internal diameter) 29.1
wr (Notch width) 2.4
lr (Notch Length) 3.3
ws (Stub width) 3.4
ls (Stub length) 2.1
C.3.2 In-vivo Passive Cooling
(a) (b)
Figure C.5: Captured skin thermal distribution of applicator passive cooling at: (a) original
tissue without applicator, (b) after 10 minutes of thermal equilibrium of applicator placement
without microwave or active cooling
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Appendix D
Commercialisation of Hybrid System
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This chapter covers the commercial aspect of the hybrid system. This includes
various models of innovation, Intellectual property (IP), medical devices regulatory,
market research and future plans.
D.1 Introduction
The purpose of the device is to assist physicians to diagnose the physiological responses
of a patient when their muscle is thermally stimulated, which to date can only be
achieved superficially on the skin. The developed device facilitates the investigation of
thermoregulation in the muscle (1.5 cm below the skin surface). The device is based on
a non-invasive novel microwave radiator (antenna) to induce non-ionising radiation for
local warming, in a few centimetres square, in the muscle. Local warming causes the
blood vessels to dilate for cooling down the heat; it is part of the human thermoregula-
tion process. This thermal response, in the form of increase of blood flow, is monitored
by the integrated near infrared spectroscopy (NIRS) probes. An in-house built inte-
grated system prototype has been used to demonstrate that muscle thermal stimulation
can be obtained and monitored. The measurement shows the device is capable of mea-
suring the changes of blood haemoglobin levels in the muscle while suppressing the
changes in the skin layer. Current commercially available devices in health care today
are only able to monitor superficial thermal responses. This limits the efficacy of the
diagnosis and cannot determine the state of the muscle tissue alone. The hybrid mon-
itor has an innovative advantage which allows to be competing against other present
devices but more significantly it is a possible new diagnosis segment.
Starting a business is a complicated process, and in most cases, the success rate
is influenced by the factor that cannot be controlled. Commercialising new technology
holds the highest amount risks but there is also a possibility of high amount prospect.
Having established the technology, it is necessary to consider the individual and the
commercial goals, which is presented in the route to marketing flowchart shown in
Figure D.1 [165]. The personal goal is to develop and commercialise a medical device
to assist in evolving the technology used in today’s and future health care. While the
initial commercial goal is to initiate collaboration with a research clinician to develop
the device, and meet consumer needs. As with the majority of commercial product’s
research is the start of the key chain that leads to new inventions, which requires further
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Figure D.1: Commercialisation path.
literature review, disclosure and market research. In this scenario, the research and
the developed device are conducted as part of research degree in the university, lean-
ing toward a university led commercialisation. As with most of the new inventions,
IP protection is the initial step to commercialise a product. The invention is created
in the higher education institutes, thus the inventors will possess the IPs, however,
the inventors must also consider the revenue share with the institute when the prod-
uct is successfully commercialised. Subsequently, a business model is necessary after
identifying a patent, which include market research, segment sales activities, financial
strategies and product development. Alternative paths outside the academia are led by
the inventors directly or support/grant program where the IP is entirely owned by the
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inventors or by the fund sponsors respectively. Typically new business does not have
enough resources, licensing option is essential and must be consider carefully, which
applies to excising company or university led spin-off companies.
D.2 Innovation and Technology Transfer
Innovation begins when a particular problem needs to be solved to satisfy customer
needs. Creating an innovative technology is the foundation of a successful business
that increases competitiveness and economic growth of the company [166]. Successful
innovation requires both technical and consumer need to be fulfilled. This is achieved
by balancing the requirement of the product, development and organization. In other
words, it is the knowledge and the diffusion of the knowledge. There are four types of
innovation to be considered [167]:
• Product Innovation: A new product which is significantly enhanced against cur-
rent products.
• Process Innovation: Improvement in production method (Reduction in cost and
time, increase quality).
• Marketing Innovation: Involve changes in product design, promotion and ad-
dressing customer needs to essentially boost sales.
• Organizational innovation: Organising the firm internally such as reduction in
administrative costs and increase in work efficiency.
D.2.1 Innovation Model
Technology transfer is founded from research, knowledge and development activi-
ties. This procedure is initially considered as a sequential process as shown in Figure
D.2.The linear technology transfer advances in a unidirectional manner where scientific
theory creates innovation, which leads to development, followed by production (man-
ufacturing) and finally to consumers [168]. This model was adopted at the beginning
of 1950 and is commonly known as the market push strategy, where the suppliers drive
the technology toward consumers based on a predicted demand. The push model lacks
both feedback and loops between each stage, subsequently the delivered technology is
limited by the original source where the demands are uncertain. Not until 1970 the
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second model is emerged, which is known as the market pull strategy, this is based on
the same linear concept but in the reverse order. In this scenario, consumer demands
a product, which leads back to the research and initiates the linear cycle again. The
downside of market pull is the lead time required to respond the market demands.
Research Development Production Marketing
Figure D.2: Linear model of innovation.
To address the criticism of the linear model, a more realistic and complex model
was developed by Stephen J. Kline in 1985 known as the Chain-Linked model as shown
in Figure D.3 [169]. It can be seen from Figure D.3, research, and knowledge are often
linked with each other, this is to address any raised doubts during the process. The
knowledge and the science are different at each stage, such as pure science is required
during the invention. However, in the design and development stage the science is
based on analysis how each component of system interact with each other, while in
production stage the research is needed to consider further improvement and cost re-
duction. Multiple feedbacks and loop are considered in the model to ensure the product
serves market need by considering users 6 perspective for potential improvement of the
product. There are many other innovation transfer models, including Network Model
and open innovation [170] [171].
Innovation is a complicated, non-linear and iterative process. Industry tries to pre-
dict this process to increase profit and reduce risks. None of the innovation models
are accurate, particularly in different industries, where requirements and product lines
are diverse. In academia, information is transformed from a large-scale study to scien-
tific knowledge to investigate the success and failures of the possible innovation for an
increase in the prediction of success [170].
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Figure D.3: Chain-linked model of innovation.
D.2.2 Diffusion of Innovation
Diffusion of innovation theory developed and published by Everett Rogers in 1962, the
theory explains how innovation or idea diffuses to social groups (consumers) where it
has been adopted and accepted by individuals in the group. The diffusion theory is most
suitable for examining adoption of innovation in higher-education [172]. Adoption
of new product does not occur concurrently within the social group, but it occurs in
some individuals who choose to adopt early because they perceive the technology as
innovative [173]. This shows individuals who adopt technology earlier than others
have distinctive characteristics. During the promotion of the technology is important to
understand these individual characteristics to boost the adoption of innovation. Roger’s
technology adoption curve shown in Figure D.4 including product life cycle, which
consists of four essential stages to for evaluating corporate strategies:
• The introductory stage of commercialisation often starts with a narrow and fo-
cused user group that helps in identifying early problems with the product. This
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would be the ideal starting scenario of the hybrid system.
• Growth stage is where customer stratification and loyalty are established, with
continuous improvement and increase in distribution with larger companies.
• At the Maturity stage, a brand has now been built, require to improve customer
service and considering other possibilities of the technology.
• Decline is the final stage of product life cycle, and it is impossible stop it. The
options are either to exit or slow down the decline.
Innovators
2.5%
Early 
Adopters
13.5%
Early
Majority
34%
Late 
Majority
34%
Laggards
16%
Introduction Growth Maturity Decline
Figure D.4: Diffusion of innovation adoption curve.
Having established technology life-cycle, the next step is to understand the char-
acteristics of each customer group, and they are five types of adopter shown Figure
D.4.
• The inventors stage is the introductory stage representing only about 2.5% of
individuals that are interested in the new idea, those individuals (usually technol-
ogists) are willing to take risks and further develop the product. This is would be
the starting point for the hybrid system, by attracting research physicians to solve
the desired customer problem.
• The early adopters representing 13.5% of population, those individuals are vi-
sionary who take the product on faith to solve a particular customer problem, and
aware of need to change and comfortable with adopting new ideas.
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• Early Majority covers 34% of adopters, those individuals known as pragmatists
and require solid evidence before adopting new innovation. The product would
be stable and reliable during this stage. To attract this group must provide publi-
cation or reports to show the success of the technology.
• Later majority also covers 34% of adopters, and considered as conservative and
only adopt when the majority have adopted. To tackle this group by providing
market statistics.
• Laggards represent 16% of the population, and they are the last individuals to
adopt. This group is sceptic and difficult to take on board, however the strategy
is to apply pressure.
D.3 Proof of Concept and Intellectual Property (IP)
This section briefly discusses the designed technology prototype and subsequent future
stages including IP protection, product regulatory and quality system management.
D.3.1 Product Prototype
For successful commercialisation, it is essential to prove the claimed technology works,
which will require a working prototype. Fortunately, the first prototype was designed
and developed during the research degree and in working condition. Experimental
trial has been conducted on a tissue mimicked material and directly on human calf.
This was approved by UCL ethics to deploy on a maximum of five subjects. The
prototype already considers a fail-safe mechanism to eliminate any hazards caused by
the radiating microwave. The developed prototype will be used to demonstration to the
potential early adopters. The prototype was initially intended as a research tool, with
further modification it can be used for larger-scale study with a supported physician.
The prototype has not been through any external testing or regulatory at the moment.
However, it will be the next stage as it is a requirement before conducting a large case
study. For future purposes there will be a fully documented design brief that includes
operation manual and specification of the device, as this is an essential and a must step
for a certified technology.
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D.3.2 IP Protection
Successfully commercialising innovation in the medical device’s domain, rely on the
intellectual property right (IPR), including patent, copyright, trademark. Novelty and
effectiveness are criteria to consider for innovations that are applicable for a patent. For
novelty, the technology must be new, performs precisely as stated and beneficial prod-
uct. In addition the idea must not be revealed to public including research publication,
particularly before applying to a patent.
The combined hybrid system consisting of microwave, optical, cooling systems
and the probe are unique and have not been investigated before. The particular concept
of measuring thermal responses in the muscle tissue alone was not previously achieved
unless an invasive approach is used. However, the patent will be on the design of the
probe, rather than the optical or microwave system as they are already well established
concepts. The design of the probe is where the integration of three systems, which
operates simultaneously to measure thermal response in the muscle. The established
prototype was used for human experimental trials; the obtained trial results was evalu-
ated and further design tweaking is currently being implemented. The goal is to ensure
the probe operate as intended to before applying for design patent. The invention must
be documented with in depth technical description, drawing and including the computer
program used. These are necessary steps along with evidence of results, and advantages
of the technology compared to current commercial devices.
The implementation of the hybrid system is university-based commercialisation.
Any applied patents are possessed by the authors while still registered in the university.
A complication of IP ownership could arise if the research was partially funded by
industry. However, in case of the hybrid system, there are no sponsors for the project
and as a result the IP options are between the university and the authors. Furthermore,
there is a revenue sharing scheme for the university led commercialisation that must be
taken into account. Inventors at early stage with net profit less than £50,000 receives
the largest share of 50% in contrast to 30% share when profit is greater. The share
agreements for University College London are shown in Table D.1
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Table D.1: University College London IPR revenue sharing arrangements
Net Income Exploitation fee Inventor(s) UCL Central Funds Department
<50k 30% 50% 10% 10%
>50k 30% 30% 30% 10%
D.3.3 Medical Device Compliance
Applying medical technology to clinics is a complicated and extensive procedure. To
achieve this goal, one must have a comprehensive set of organisation skills. Moreover,
small inexperience companies are expected to seek out for guidance from a qualified
agency in handling the regulatory, quality management and commercialisation proce-
dure. Alternatively, an early stage industrial collaboration would be favourable for
some; further knowledge could be gained from clinical trials and commercialisation
aspects. Design of medical devices requires considerations of the material, ergonomic
and environmental implications such as minimising the microwave leakage from the
hybrid probe to the surrounding. The initial intention is to obtain CE marking through
a European commission (EC) Medical Device Directive; the regulatory will allow the
product to be used in EU.
All medical devices must comply with the regulatory procedure, and they are clas-
sified according to the risk level, as demonstrated in Figure D.5(a). Majority of devices
are categorised as Class I, which have the least regulative control as it possesses a low
risk such as elastic bandages [174]. Intermediate regulatory controls are applied to
class II devices; this is where the hybrid system fall into the category with medium
risks. Meanwhile, Class III devices are only 10% of overall devices and pose the high-
est risks, and they are typically invasive such as pacemaker implants. Figure D.5(b)
shows the section of medical device classification that is identifying the hybrid system;
it can be seen class II is divided further into IIa and IIb. The developed system falls
into the category of class IIb, which requires additional regulatory control, including
quality assessment ISO 13485. The hybrid system is intended for diagnostic, which in-
corporates a low-power therapeutic characteristic that is necessary to produce changes
in physiology.
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Figure D.5: Medical devices classification. (a) risk levels, (b) detailed classification
Quality management system (ISO 13485) is an addition to the regulative approval,
where the inventors must demonstrate the abilities of providing devices that fulfils cus-
tomer and CE compliance needs. To achieve this, numerous steps are required to com-
ply with the medical regulatory as shown in Fig. 7. The Initial step requires some
research and documentation starting with identifying the correct classification for the
device as mentioned in Figure D.5(b). Risk management is an essential requirement to
determine the safety of the device and is often is in congestion with ISO 13485 when
higher level of regulation control is required. The device specification, clinical study
evaluation and application are all to be documented and submitted accordingly. When
the device is initially approved, the next procedure is inspection and declaration of
conformity, upon successful compliance the product could be placed on the market.
Research Approval Commercialisation
• Regulatory classification
• Risk analysis (ISO 14971)
• Summary of technical documents
• Clinical study applications
• Clinical evaluation reports
• Class IIa, IIb and III Submission 
for product assessment
• Inspection audit
• Declaration of comformity
• Pre-Market notificaiton
• Technichal product dossier
• Product design extensions
• Signficant design change applica-
tion
• Post market analysis
• Product renewal application
Figure D.6: Medical device regulatory and quality management system procedure.
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D.4 Market Research
Commercialising a technology is more than just developing an innovative product, it
is about understanding how the technology meets the market need. Having established
the basic principles of innovation, IPR and regulatory it is important to implement a
market research simultaneously to identify if the technology is already developed or
patented, and if there is a market need for the product. All this would be discussed in
the following section.
D.4.1 Medical Devices Industry
Technologies are constantly being implanted to improve the health of many individuals,
to treat the variety of diseases and conditions. Medical device’s sector grew by approx-
imately 5.6% in 2011 and currently worth £214bn and will gain additional £64bn by
2016 according to the forecast [175]. This clearly indicates medical devices are attrac-
tive segment in the healthcare domain, with more than 500,000 products are commer-
cialised [176]. The largest healthcare market expenditure is the US, whereas in UK,
holds approximately 11% of EU and 3% of the global market based on statistics from
2009 [177]. The market share sector breakdown is shown in Figure D.7 [176]. Patient
monitoring equipment and therapies are the second largest amount of transactions ap-
Figure D.7: Medical devices sub-sector breakdown in 2012.
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proved. This sector includes many other medical devices, which can be narrowed down
further to reach to electro-medical devices, where the hybrid system and other active
diagnostic devices, including MRI and ultrasound.
D.4.2 Commercially Available Thermoregulation Monitors
There are two successful devices, which compromise of NIRS by Hamamatsu Photon-
ics and laser Doppler flowmetry (LDF) by Moor instruments. These existing devices
are already in use for various clinical diagnosis and research purposes. The NIRS
monitor are typically used to monitor brain activities and muscle physiology in sports
activities [178]. However, the measurement incorporates thermal responses from mus-
cle, fat and skin layer inclusively. For that reason, NIRS system independently cannot
be used to estimate muscle physiology alone, thus it must be used in conjunction with
other devices to eliminate responses from skin and fat layer. Whereas the LDF monitor
commonly used for burn assessment [179], flap monitoring [40] and Reynold’s phe-
nomena [180]. This device is reasonably priced, non-invasive and easily deployable.
Moreover, the main disadvantage is the diagnosis limited to on skin layer only.
Having established the limitations of competitor’s devices, the hybrid system has
utilises the integrates NIRS probes which are capable of measuring the skin, fat and
muscle physiological responses. However, it operates in conjunction to a microwave
antenna that induces heat in the muscle. The heat is an essential process to produce
change in blood volume. Furthermore, cooling system is incorporated to maintain tem-
perature on the superficial layers, and produce changes in the muscle alone, in this
manner the NIRS will only monitor the muscle haemodynamics. Studies shows mea-
suring physiological response in the muscle can be performed by an invasive technique
using radioactive tracer. This method is highly regulated and rarely applied in practice
[181, 3]. Consequently the objective is to introduce a non-invasive device that’s capable
of monitoring muscle thermal response. This monitor is beneficial to physiotherapist
and doctors in current common clinical difficulties, including free flap reconstruction
where replanted flaps require deep tissue assessment of blood supply to evaluate tissue
recovery and alert for flap failure [182]. The device can also address 14 other ap-
plications, including monitoring amputation level, vascular diseases and sport science
[183].It has been established the need of a non-invasive muscle thermoregulation mon-
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itor in the market. The next stage is to identify the early adopters to use and develop
the device.
D.4.3 Market Needs
The objective is to maintain narrow market segment, and attempt to attract clinicians
who can support and assist developing the device to solve a common problem. At the
moment, we are consulting physicians from University College Hospital for collabo-
ration to aid in the investigation and clinical trials. With this collaboration, it will be
possible to assess the market need of the developed product, which may also divert the
target segment. The hybrid system will be built around the early adopters, where profit
will not be generated, rather only to improve customer need by taking the feedback on
board. For the clinical trial, the aim is to develop a second prototype which would be a
robust design and reduce the cost by eliminating extra unnecessary functionality. The
current prototype would be used to demonstrate the concept to clinicians, and the final
prototype will be used for trials. Clinical trials would be a step toward CE compliance,
then device can be promoted to attract more customers.
In every commercial sector, there is a specific market drive that will attract ad-
ditional customers. In the medical sector, there are two crucial factors, and they are
economic and social market drives [177]. The economic drives, mainly about reducing
the cost level but have a positive impact such as non-invasive treatments, which is a key
feature of the hybrid system. Early diagnosis is another important factor, identifying a
condition in early stages, will aid to improve quality of life, and also cost saving. The
diagnosis of the hybrid system is the ability to study diseases or condition in deeper
muscle, which allows for early prediction of flap failure during surgery. Social drivers,
which have an important role in the success and failure of the device, this includes
ageing population where a high-potential market demands to increase life expectancy.
Furthermore, it’s about safety, and this can be addressed by various regulatory certifi-
cation and also additional safety interlock features such as implemented for the hybrid
system.
D.4.4 Market Strategy
In the early phases of technology development are accompanied by frequent design
changes until the requirements are fulfilled. A common commercialization pitfall is
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launching a prototype directly into production; this is a typical problem applied to com-
pany to force production. The products will eventually cause problems during launch
as quality assurance, functionality is not fully met, and production cost is generally
higher. Resource management is essential in reducing production risks. This takes into
account when considering mass production. Research prototypes are designed to work
for study purposes without consideration of mass production, and robustness. There
are often multiple design stages before reaching to the optimal design.
The development of first prototype was built for research purpose, as the develop-
ment cost was not a deciding factor. The original prototype costs approximately £5,210
as shown in Table D.2. The hardware expenses can be reduced for the second proto-
type by eliminating unnecessary functionality while maintaining the core technology.
The hardware cost can be deducted by approximately £810 from the first prototype
which essentially will be used for clinical trials. Furthermore, manufacturing cost at
this point is not considered as it will be designed mostly in department. The overall
highest comes from clinical investigation approximately £3,820, which is a necessary
process before obtaining CE marking, the cost of the trials depending on the device
classification (risk level) [184]. The overall cost of second prototype would be around
£8,160 in comparison to the £10,000 (Academic price) of the commercially available
device by Moor Instrument. As mentioned earlier those devices are only able to study
the thermoregulation on the superficial layer.
The device would have to be redesigned for manufacturing, when commencing to
commercialisation stage. Cost reduction can be implemented by redesigning the archi-
tecture as prototypes are often based on off-the-shelf parts, which are more expansive.
Mass production does reduce the overall costs, but the redesign to fit the core function-
ality can reduce further. However, this procedure requires organisation, planning time
and considering component cost. On the other hand, Using of the shelf parts ensures
highest quality and fastest time to commercialisation; this is still to be considered after
implementation of second prototype. The software package used for both prototypes
16 requires an annual license of approximately £1,000. Developing custom software is
crucial for cost reduction, also to provide a friendly and simple user interface.
A possible forecast can be drawn from second prototype to a commercial product.
The hybrid device will have custom software to eliminate the excess of license cost,
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Table D.2: Product cost comparison.
Cost division /
Devices
Prototype 1
(research)
Prototype 2
(clinical trials)
Commercial
device
Commercially
available
(LDF)
Hardware £4,210 £3,400 £3,000 £10,000
Software (p.a) £1,000 £1,000 NA Included
Manufacturing In-house In-house £500 NA
Clinical trials NA £3,820 NA Included
Overhead NA NA £1500 NA
Overall £5,210 £8,160 £5,000 £10,000
Sale price NA NA £6,250 £10,000
Profit NA NA £1,250 NA
and designing the program to meet customer requirement. Large-scale production is not
always necessary for starting companies, unless high demands, however, cost reduction
can be achieved. The hardware cost of the commercial product could be in the region
of £3,000, with consideration of design improvement gained from the earlier prototype.
Manufacturing cost per unit would approximately be £500 and overhead of £1,500. The
overhead expense covers all the ongoing company expenses, including CE compliance
cost, wages and to finance equipments. Starting companies may have to take risks
in lowering cost to cause’s market penetration. The overall cost per unit is estimated
to about £5,000. Unit sale price is about £6,250 and producing a 20% sales profit of
about £1,250. The pricing is aggressive in comparison to competitors. However, this is
essential to produce a push in the market and develop large customer community.
D.5 Summary and Future Plans
hybrid system has the potential to compete in the market, by solving a difficult prob-
lem in the clinical sector. The development and commercialisation of medical devices
in medical segment is a complicated process, as there are many considerations to take
into account. The essential steps are advancing through the medical trials, regulatory
compliances and the quality management system. This establishes a robust device,
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which attracts more customers. The route to successful marketing is achieved by eval-
uating customer feedback of the small adopters community (such as the physicians).
The collaboration will be beneficial, and a must step to continue the innovation pro-
cess. The market research shows the hybrid system have a unique advantages and open
doors for many possible opportunities that is yet to be discovered. These advantages
allows for better market penetration if priced correctly. In the market strategy, we put
together the costs of each prototype and forecast the price of the actual commercial
product.
There are few procedures are required to continue the commercialisation and de-
velopment of the hybrid system, and they are:
• Establishing IP protection, as mentioned this is crucial step, and we are currently
in touch with the university to commence this procedure.
• Applying for grant to continue research and development, this is the most im-
portant step. Currently, we require funds to develop new prototypes, apply for
clinical trials and compliances. At this moment research grant is being applied.
However, we will also consider business funding such as Invention for Innova-
tion program (i4i). This program supports development and commercialisation
of medical devices and allows for collaboration between industry and academia.
A typical route of early stage development is Venture Capital, which needs to be
considered carefully.
• The next procedure is maintaining contact with research clinicians and physician,
to establish early collaboration and develop the product to fit customer needs.
• Alternatively industrial collaboration, by communicating with Moor Instruments,
which we already have established contact
• Considering license options or agreements, to allow collaborative partners to
commercialise the product, this is the scenario when resources are restricted.
• Further device development is required in clinical trials and cost reduction im-
plementation for the commercialised the product.
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• Spin-off Company from university commercialisation is an option to be con-
sidered upon the success of previous steps, at this stage business plan must be
carefully done.
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